ChangeUID	ChangeUID (old file)	IndexString	IndexString (old file)	Score	Coverage	Coverage (old file)	ACount	ACount (old file)	CCount	CCount (old file)	GCount	GCount (old file)	TCount	TCount (old file)	MutCount	MutCount (old file)	SumQualityScore	SumQualityScore (old file)	MinQualityScore	MinQualityScore (old file)	MaxQualityScore	MaxQualityScore (old file)	AverageQualityScore	AverageQualityScore (old file)	Forward	Forward (old file)	Reverse	Reverse (old file)	DistinctCoverage	DistinctCoverage (old file)	DistinctTags	DistinctTags (old file)	DistinctPairs	DistinctPairs (old file)	MutPct	MutPct (old file)	MutType	MutType (old file)	Chrom	Chrom (old file)	Start	Start (old file)	End	End (old file)	BaseFrom	BaseFrom (old file)	BaseTo	BaseTo (old file)	LookupKey	LookupKey (old file)	ENSG	ENSG (old file)	GeneName	GeneName (old file)	Transcript	Transcript (old file)	TxBaseFrom	TxBaseTo	TxBaseTo (old file)	AminoStart	AminoStart (old file)	AminoEnd	AminoEnd (old file)	AAFrom	AAFrom (old file)	AATo	AATo (old file)	Consequence	Consequence (old file)	Exon Rank	Exon Rank (old file)	Transcript GeneName	Transcript GeneName (old file)	HUGO GeneName	HUGO GeneName (old file)	Description	Description (old file)	Deleted	Deleted (old file)	SNP	SNP (old file)	NormalMutCount	NormalMutCount (old file)	NormalRawCoverage	NormalRawCoverage (old file)	NormalPhredCoverage	NormalPhredCoverage (old file)	NormalEffectiveCoverage	NormalEffectiveCoverage (old file)	NormalDistinctRawCoverage	NormalDistinctRawCoverage (old file)	NormalDistinctPhredCoverage	NormalDistinctPhredCoverage (old file)	NormalDistinctEffectiveCoverage	NormalDistinctEffectiveCoverage (old file)	GermlineNormMutPct	GermlineNormMutPct (old file)	Germline?	Germline? (old file)	TotalNormalMutCount	TotalNormalMutCount (old file)	NormalDistinctMutPairs	NormalDistinctMutPairs (old file)	ExcludeConsequence?	ExcludeConsequence? (old file)	Silent?	Silent? (old file)	NormMutPct	NormMutPct (old file)	CosmicGene	CosmicGene (old file)	CosmicTx	CosmicTx (old file)	CosmicAAChange	CosmicAAChange (old file)	CosmicEffect	CosmicEffect (old file)	CosmicID	CosmicID (old file)	DistMutPairsEORA	DistMutPairsEORA (old file)	DistMutPairsEORB	DistMutPairsEORB (old file)	NormalDistMutPairsEORA	NormalDistMutPairsEORA (old file)	NormalDistMutPairsEORB	NormalDistMutPairsEORB (old file)	DistMutPairsEORA+B	DistMutPairsEORA+B (old file)	EORMutPct	EORMutPct (old file)	NormalEORMutPct	NormalEORMutPct (old file)	Ignore	Ignore (old file)	IgnoreB	IgnoreB (old file)	AddlInfo	AddlInfo (old file)	LookupKeyB	LookupKeyB (old file)	AAChange	AAChange (old file)	ReportedMutation	ReportedMutation (old file)	ReportedConsequence	ReportedConsequence (old file)	PGDX Transcript	PGDX Transcript (old file)	PGDX CDS Length	PGDX CDS Length (old file)	PGDX Protein Length	PGDX Protein Length (old file)	LiftOver ID	LiftOver ID (old file)	Liftover hg18 Position	Liftover hg18 Position (old file)	LiftOver hg19 position	LiftOver hg19 position (old file)	sameLocation_Lookup	sameLocation_Lookup (old file)	Changes_SameLocation	Changes_SameLocation (old file)	Changes_Adjacent	Changes_Adjacent (old file)	polyN:ChangeUID	polyN:ChangeUID (old file)	PolyN_Dust	PolyN_Dust (old file)	Sample Name	Sample Name (old file)	CDD: #Gene	CDD: #Gene (old file)	CDD: Key	CDD: Key (old file)	CDD: Size Check	CDD: Size Check (old file)	CDD: Position of Mutation Within a Protein Domain	CDD: Position of Mutation Within a Protein Domain (old file)	CDD: Position of Mutation Near to a Protein Domain	CDD: Position of Mutation Near to a Protein Domain (old file)	COSMIC: Key	COSMIC: Key (old file)	COSMIC: Samples reported with the exact genomic change	COSMIC: Samples reported with the exact genomic change (old file)	COSMIC: Samples reported with a change in the same AA (Missense)	COSMIC: Samples reported with a change in the same AA (Missense) (old file)	COSMIC: Samples reported with a nearby change	COSMIC: Samples reported with a nearby change (old file)	COSMIC: Samples reported with any mutation in this gene	COSMIC: Samples reported with any mutation in this gene (old file)	COSMIC: Number of Exact Hits	COSMIC: Number of Exact Hits (old file)	PGDX Clinical: Gene_symbol	PGDX Clinical: Gene_symbol (old file)	PGDX Clinical: Gene_name	PGDX Clinical: Gene_name (old file)	PGDX Clinical: Gene_summary	PGDX Clinical: Gene_summary (old file)	PGDX Clinical: Gene_aliases	PGDX Clinical: Gene_aliases (old file)	PGDX Clinical: Pathway	PGDX Clinical: Pathway (old file)	PGDX Clinical: Prognostic text	PGDX Clinical: Prognostic text (old file)	PGDX Clinical: Prognostic ref	PGDX Clinical: Prognostic ref (old file)	PGDX Clinical: Prognostic fig	PGDX Clinical: Prognostic fig (old file)	PGDX Clinical: Prognostic fig legend	PGDX Clinical: Prognostic fig legend (old file)	PGDX Clinical: Prognostic fig ref	PGDX Clinical: Prognostic fig ref (old file)	PGDX Clinical: Predictive/Therapeutic text	PGDX Clinical: Predictive/Therapeutic text (old file)	PGDX Clinical: Predictive/Therapeutic ref	PGDX Clinical: Predictive/Therapeutic ref (old file)	PGDX Clinical: Predictive/Therapeutic fig	PGDX Clinical: Predictive/Therapeutic fig (old file)	PGDX Clinical: Predictive/Therapeutic fig legend	PGDX Clinical: Predictive/Therapeutic fig legend (old file)	PGDX Clinical: Predictive/Therapeutic fig ref	PGDX Clinical: Predictive/Therapeutic fig ref (old file)	PGDX: Gene Lookup	PGDX: Gene Lookup (old file)	PGDX: Biologically significant gene	PGDX: Biologically significant gene (old file)	PGDX: Clinically significant gene	PGDX: Clinically significant gene (old file)	PGDX: Chip Gene	PGDX: Chip Gene (old file)	CHASM: MUTID	CHASM: MUTID (old file)	CHASM: MUT	CHASM: MUT (old file)	CHASM: CHASM BRCA	CHASM: CHASM BRCA (old file)	CHASM: PValue BRCA	CHASM: PValue BRCA (old file)	CHASM: BHFDR BRCA	CHASM: BHFDR BRCA (old file)	VEST: MUTID	VEST: MUTID (old file)	VEST: MUT	VEST: MUT (old file)	VEST: VEST	VEST: VEST (old file)	VEST: PValue	VEST: PValue (old file)	VEST: BHFDR	VEST: BHFDR (old file)	PANTHER: Gene Symbol	PANTHER: Gene Symbol (old file)	PANTHER: Gene Identifier	PANTHER: Gene Identifier (old file)	PANTHER: Protein ID	PANTHER: Protein ID (old file)	PANTHER: SF ID	PANTHER: SF ID (old file)	PANTHER: Family Name	PANTHER: Family Name (old file)	PANTHER: Subfamily Name	PANTHER: Subfamily Name (old file)	PANTHER: Molecular function	PANTHER: Molecular function (old file)	PANTHER: Biological process	PANTHER: Biological process (old file)	PANTHER: Cellular components	PANTHER: Cellular components (old file)	PANTHER: Protein class	PANTHER: Protein class (old file)	PANTHER: Pathway	PANTHER: Pathway (old file)	OMIM_gene_symbol	OMIM_gene_symbol (old file)	OMIM_status	OMIM_status (old file)	OMIM_method	OMIM_method (old file)	OMIM_diseases	OMIM_diseases (old file)	OMIM_mim	OMIM_mim (old file)	VEP: ChangeUID	VEP: ChangeUID (old file)	VEP: Position	VEP: Position (old file)	VEP: Gene	VEP: Gene (old file)	VEP: Transcript	VEP: Transcript (old file)	VEP: Consequence	VEP: Consequence (old file)	VEP: cDNA Position	VEP: cDNA Position (old file)	VEP: CDS Position	VEP: CDS Position (old file)	VEP: Protein Position	VEP: Protein Position (old file)	VEP: Strand	VEP: Strand (old file)	VEP: AAChange	VEP: AAChange (old file)	VEP: Codon Change	VEP: Codon Change (old file)	VEP: HGVS Codon Change	VEP: HGVS Codon Change (old file)	VEP: HGVS AAChange	VEP: HGVS AAChange (old file)	snpEff360: ChangeUID	snpEff360: ChangeUID (old file)	snpEff360: GeneID	snpEff360: GeneID (old file)	snpEff360: GeneName	snpEff360: GeneName (old file)	snpEff360: Transcript	snpEff360: Transcript (old file)	snpEff360: CodonFrom	snpEff360: CodonFrom (old file)	snpEff360: CodonTo	snpEff360: CodonTo (old file)	snpEff360: codonStart	snpEff360: codonStart (old file)	snpEff360: codonEnd	snpEff360: codonEnd (old file)	snpEff360: AAFrom	snpEff360: AAFrom (old file)	snpEff360: AATo	snpEff360: AATo (old file)	snpEff360: Consequence	snpEff360: Consequence (old file)	snpEff360: Score	snpEff360: Score (old file)	dbSNP: Sample	dbSNP: Sample (old file)	dbSNP: Other dbSNP hits	dbSNP: Other dbSNP hits (old file)	dbSNP: SNPLookup	dbSNP: SNPLookup (old file)	dbSNP: Chrom	dbSNP: Chrom (old file)	dbSNP: Start	dbSNP: Start (old file)	dbSNP: End	dbSNP: End (old file)	dbSNP: Name	dbSNP: Name (old file)	dbSNP: Strand	dbSNP: Strand (old file)	dbSNP: refUCSC	dbSNP: refUCSC (old file)	dbSNP: Observed	dbSNP: Observed (old file)	dbSNP: Class	dbSNP: Class (old file)	dbSNP: Valid	dbSNP: Valid (old file)	dbSNP: AvHet	dbSNP: AvHet (old file)	dbSNP: AvHetSE	dbSNP: AvHetSE (old file)	dbSNP: Func	dbSNP: Func (old file)	dbSNP: Weight	dbSNP: Weight (old file)	dbSNP: Exceptions	dbSNP: Exceptions (old file)	dbSNP: Submitters	dbSNP: Submitters (old file)	dbSNP: AlleleFreqCount	dbSNP: AlleleFreqCount (old file)	dbSNP: Alleles	dbSNP: Alleles (old file)	dbSNP: AlleleNs	dbSNP: AlleleNs (old file)	dbSNP: AlleleFreqs	dbSNP: AlleleFreqs (old file)	dbSNP: Bitfields	dbSNP: Bitfields (old file)	dbSNP: isCommon	dbSNP: isCommon (old file)	dbSNP: isFlagged	dbSNP: isFlagged (old file)	dbSNP: isMultiple	dbSNP: isMultiple (old file)	ESP: Chrom	ESP: Chrom (old file)	ESP: Start	ESP: Start (old file)	ESP: End	ESP: End (old file)	ESP: ESPKey	ESP: ESPKey (old file)	ESP: dbsnp hit	ESP: dbsnp hit (old file)	ESP: European Allele Count	ESP: European Allele Count (old file)	ESP: African Allele Count	ESP: African Allele Count (old file)	ESP: Total Allele	ESP: Total Allele (old file)	ESP: MAF	ESP: MAF (old file)	ESP: Observed	ESP: Observed (old file)	ESP: European Genotype Count	ESP: European Genotype Count (old file)	ESP: African Genotype Count	ESP: African Genotype Count (old file)	ESP: Total Genotype Count	ESP: Total Genotype Count (old file)	ESP: Average Sample Depth	ESP: Average Sample Depth (old file)	ESP: GeneList	ESP: GeneList (old file)	ESP: scorePhastCons	ESP: scorePhastCons (old file)	ESP: consScoreGERP	ESP: consScoreGERP (old file)	ESP: chimpAllele	ESP: chimpAllele (old file)	ESP: ClinicalAssociation	ESP: ClinicalAssociation (old file)	ESP: EXOME_CHIP	ESP: EXOME_CHIP (old file)	ESP: GWAS_PUBMED	ESP: GWAS_PUBMED (old file)	ESP: Accession	ESP: Accession (old file)	ESP: functionGVS	ESP: functionGVS (old file)	ESP: aminoAcidChange	ESP: aminoAcidChange (old file)	ESP: proteinPosition	ESP: proteinPosition (old file)	ESP: cDNAPosition	ESP: cDNAPosition (old file)	ESP: granthamScore	ESP: granthamScore (old file)	ESP: polyPhen	ESP: polyPhen (old file)	AutoBLATHuman	AutoBLATHuman (old file)	Seq window	Seq window (old file)	BLAT sequence	BLAT sequence (old file)	BLAT URL	BLAT URL (old file)	PGDX Norm: Count	PGDX Norm: Count (old file)	PGDX Norm: rs	PGDX Norm: rs (old file)	Report: Sample Name	Report: Sample Name (old file)	Report: Alternate ID	Report: Alternate ID (old file)	Report: Tumor Type	Report: Tumor Type (old file)	Report: GeneName	Report: GeneName (old file)	Report: Description	Report: Description (old file)	Report: Transcript	Report: Transcript (old file)	Report: LookupKey	Report: LookupKey (old file)	Report: CodonChange	Report: CodonChange (old file)	Report: AAChange	Report: AAChange (old file)	Report: Exon Rank	Report: Exon Rank (old file)	Report: ReportedMutation	Report: ReportedMutation (old file)	Report: ReportedConsequence	Report: ReportedConsequence (old file)	Report: Seq window	Report: Seq window (old file)	Report: SupermutantMutPct	Report: SupermutantMutPct (old file)	Report: 95% Confidence Interval for % Mutant Reads	Report: 95% Confidence Interval for % Mutant Reads (old file)	Report: SupermutantCov	Report: SupermutantCov (old file)	Report: SupermutantCount	Report: SupermutantCount (old file)	Report: Mutant Molecules per mL	Report: Mutant Molecules per mL (old file)	Report: ENSG	Report: ENSG (old file)	Report: Pathway Analysis (GO Molecular Function)	Report: Pathway Analysis (GO Molecular Function) (old file)	Report: Pathway Analysis (GO Biological Process)	Report: Pathway Analysis (GO Biological Process) (old file)	Report: Pathway Analysis (Additional Information)	Report: Pathway Analysis (Additional Information) (old file)	Report: Samples with the Identical Somatic Mutation	Report: Samples with the Identical Somatic Mutation (old file)	Report: Somatic Mutations in the Same Amino Acid Residue	Report: Somatic Mutations in the Same Amino Acid Residue (old file)	Report: Somatic Mutations in Nearby Amino Acid Residues	Report: Somatic Mutations in Nearby Amino Acid Residues (old file)	Report: Gene Somatically Mutated in the Following Cancers	Report: Gene Somatically Mutated in the Following Cancers (old file)	Report: Position of Mutation Within a Protein Domain	Report: Position of Mutation Within a Protein Domain (old file)	Report: Position of Mutation Near to a Protein Domain	Report: Position of Mutation Near to a Protein Domain (old file)	Report: CHASM Score	Report: CHASM Score (old file)	Report: PValue	Report: PValue (old file)	Report: BHFDR	Report: BHFDR (old file)	Report: refUCSC	Report: refUCSC (old file)	Report: Observed	Report: Observed (old file)	Report: Class	Report: Class (old file)	Report: Valid	Report: Valid (old file)	Report: AvHet	Report: AvHet (old file)	Report: AvHetSE	Report: AvHetSE (old file)	Report: Func	Report: Func (old file)	Report: Weight	Report: Weight (old file)	Report: Exceptions	Report: Exceptions (old file)	Report: Submitters	Report: Submitters (old file)	Report: AlleleFreqCount	Report: AlleleFreqCount (old file)	Report: Alleles	Report: Alleles (old file)	Report: AlleleNs	Report: AlleleNs (old file)	Report: AlleleFreqs	Report: AlleleFreqs (old file)	Report: VEST	Report: VEST (old file)	Report: VEST(PValue)	Report: VEST(PValue) (old file)	Report: VEST(BHFDR)	Report: VEST(BHFDR) (old file)	Report: OMIM Diseases	Report: OMIM Diseases (old file)	Report: MIM#	Report: MIM# (old file)	Report: PGDX: Chip Gene	Report: PGDX: Chip Gene (old file)	CleanDistinctPairs	CleanDistinctPairs (old file)	CleanMutPct	CleanMutPct (old file)	OverlapsTumor	OverlapsTumor (old file)	OverlapsNormal	OverlapsNormal (old file)	IndelCount	IndelCount (old file)	NumAlleles	NumAlleles (old file)	NumIndelAlleles	NumIndelAlleles (old file)	Supermutant	Supermutant (old file)	SupermutantAvg	SupermutantAvg (old file)	SupermutantPct	SupermutantPct (old file)	SupermutantCov	SupermutantCov (old file)	CycleDist	CycleDist (old file)	Read1Dist	Read1Dist (old file)	Read2Dist	Read2Dist (old file)	MutReadDist	MutReadDist (old file)	ProperPairs	ProperPairs (old file)	ProperPairsPct	ProperPairsPct (old file)	MMTumor	MMTumor (old file)	LQTumor	LQTumor (old file)	MMAvg	MMAvg (old file)	MutMMAvg	MutMMAvg (old file)	LQAvg	LQAvg (old file)	MutLQAvg	MutLQAvg (old file)	MaskedPairs	MaskedPairs (old file)	MaskedMutPct	MaskedMutPct (old file)	PolyN	PolyN (old file)	PolyNN	PolyNN (old file)	PolyNNN	PolyNNN (old file)	PolyMut	PolyMut (old file)	Dust	Dust (old file)	RptMask	RptMask (old file)	MutCountCov	MutCountCov (old file)	SNP_Allele_Fraction_Normal	SNP_Allele_Fraction_Normal (old file)	SNP_Allele_Fraction_Tumor	SNP_Allele_Fraction_Tumor (old file)	Ref_Allele_Fraction_Tumor	Ref_Allele_Fraction_Tumor (old file)	Observed_MAF	Observed_MAF (old file)	Calculated_MAF_Amplification	Calculated_MAF_Amplification (old file)	dbSNP:ChangeUID	dbSNP:ChangeUID (old file)	ESPKEY	ESPKEY (old file)	ESP:ESPLookupID	ESP:ESPLookupID (old file)	PGDX Norm: ChangeUID	PGDX Norm: ChangeUID (old file)	CI ChangeUID	CI ChangeUID (old file)	95% Confidence Interval	95% Confidence Interval (old file)	CUID	CUID (old file)	HematopoiesisAssociations	HematopoiesisAssociations (old file)	SMChangeUID	SMChangeUID (old file)	SMExcludeCUID	SMExcludeCUID (old file)	IChangeUID	IChangeUID (old file)	OlapIndels	OlapIndels (old file)	ExcludeIndel	ExcludeIndel (old file)	HChangeUID	HChangeUID (old file)	HotList	HotList (old file)	CHChangeUID	CHChangeUID (old file)	CosmicHotSpot	CosmicHotSpot (old file)	Row	Row (old file)	Row	Row (old file)	Total	Total (old file)	Strand Bias Percentage (minimum strand)	Strand Bias Percentage (minimum strand) (old file)	Strand Bias p-value	Strand Bias p-value (old file)	BaseFrom/BaseTo	BaseFrom/BaseTo (old file)	Strand Bias Percentage Result	Strand Bias Percentage Result (old file)	Strand Bias p-value Result	Strand Bias p-value Result (old file)	Strand Bias Mutation Type	Strand Bias Mutation Type (old file)	OverallStrandBiasResult	OverallStrandBiasResult (old file)	Tum RMS MAPQ	Norm RMS MAPQ	Tum NERDist Mean	Tum NERDist SD	Tum Mut RMS MAPQ	GC count	AT count	RMD Score	Normal Bqual Mean	Fisher Left	Fisher Right	Fisher Two-tail	Var Type	Var Length	RepeatMasker	RepeatMaskerDistance	GC_Percent	BWA Tum Var Quality	BWA Tum Distinct Cov	BWA Tum Distinct Pairs	BWA Tum MAF	BWA Strand Bias Z	BWA Strand Bias 50CI_L	BWA Strand Bias 50CI_H	BWA Tum Mean Base Quality	BWA Tum NERDist Mean	BWA Tum NERDist SD	BWA Tum RMS MAPQ	BWA Tum Mut RMS MAPQ	BWA Tum Mean Num Mismatches	BWA Tum Mut Mean Num Mismatches	BWA Mut MAPQ Difference	BWA Supermut Count	BWA Supermut Avg	BWA Supermut MAF	BWA Supermut Cov	BT2 Tum Var Quality	BT2 Tum Distinct Cov	BT2 Tum Distinct Pairs	BT2 Tum MAF	BT2 Strand Bias Z	BT2 Strand Bias 50CI_L	BT2 Strand Bias 50CI_H	BT2 Tum Mean Base Quality	BT2 Tum NERDist Mean	BT2 Tum NERDist SD	BT2 Tum RMS MAPQ	BT2 Tum Mut RMS MAPQ	BT2 Tum Mean Num Mismatches	BT2 Tum Mut Mean Num Mismatches	BT2 Mut MAPQ Difference	BT2 Supermut Count	BT2 Supermut Avg	BT2 Supermut MAF	BT2 Supermut Cov	DUST	ensg_id	ensg_id2	GeneInfo_Transcript	ExAC: AC	ExAC: AF	ExAC: AN	ExAC: AN_Adj	ExAC: BaseQRankSum	ExAC: ClippingRankSum	ExAC: DP	ExAC: FS	ExAC: GQ_MEAN	ExAC: GQ_STDDEV	ExAC: MQ	ExAC: MQ0	ExAC: MQRankSum	ExAC: NCC	ExAC: QD	ExAC: ReadPosRankSum	ExAC: VQSLOD	ExAC: culprit	ExAC: DOUBLETON_DIST	ExAC: K1_RUN	ExAC: K2_RUN	ExAC: K3_RUN
chr1.fa:11174511-11174511_C_A	chr1.fa:11174511-11174511_C_A			0.939	2694	53746	300	313	782	807	0	3	0	2	706	14128	28110	558841	35	15			39.8159	38.421520	166	282	187	322	1082	1799	303	542	300	519	0.277264	0.288494			chr1.fa	chr1									chr1.fa:11174511-11174511_C_A	chr1.fa_11174511-11174511_C_A							-													3	52	COLUMN NOT FOUND	MTOR	COLUMN NOT FOUND	MTOR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr1_11174511-11174511_C_A	COLUMN NOT FOUND	7165-1G>T	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Splice site acceptor		CCDS127.1		7650		2550																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																										Oral Oncol. 2012 Jan 27, Cancer. 2011 Aug 11, Lung Cancer. 2012 Feb;75(2):217-22	"Oral Oncol. 2012 Jan 27, Cancer. 2011 Aug 11, Lung Cancer. 2012 Feb;75(2):217-22"							There are numerous inhibitors of MTOR.  The first to be developed was rapamycin and in addition to its analogs (everolimus, temsirolimus and ridaforolimus), a new generation of inhibitors that target the mTOR catalytic site are being assessed.  The mTOR inhibitor, ridaforolimus displayed positive results in clinical trials in sarcoma patients.  The combination of the mTOR inhibitor NVP-BEZ235 and sorafenib is effective against renal cell carcinoma in xenograft models.  	"There are numerous inhibitors of MTOR.  The first to be developed was rapamycin and in addition to its analogs (everolimus, temsirolimus and ridaforolimus), a new generation of inhibitors that target the mTOR catalytic site are being assessed.  The mTOR inhibitor, ridaforolimus displayed positive results in clinical trials in sarcoma patients.  The combination of the mTOR inhibitor NVP-BEZ235 and sorafenib is effective against renal cell carcinoma in xenograft models.  "	Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80, J Clin Oncol. 2012 Jan 1;30(1):78-84, Mol Cancer. 2011 Jul 26;10:90	"Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80, J Clin Oncol. 2012 Jan 1;30(1):78-84, Mol Cancer. 2011 Jul 26;10:90"																																																																																																																																																																																																																																	COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GTAACNTAGAA	COLUMN NOT FOUND	TCCATCACTGTGTGGCATGTGATTCTGTAGTTGCCATCCAGGCCTGTAACCTAGAAATGGGACAGAGCCACTCACCACAGGAGTTACTAACTCTCCACCCA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TCCATCACTGTGTGGCATGTGATTCTGTAGTTGCCATCCAGGCCTGTAACCTAGAAATGGGACAGAGCCACTCACCACAGGAGTTACTAACTCTCCACCCA'&Submit=submit","Run BLAT")																	chr1.fa:11174511-11174511_C_A	chr1_11174511-11174511_C_A					3	52	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Splice site acceptor	COLUMN NOT FOUND	GTAACNTAGAA	0.277264	0.272000	0.0266734495214181	0.0260033889346925	1082	1125	300	306																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																																	0	0.000000							2	3			300	306	2.35333	44.735294	0.277264	0.272000	1082	1125							COLUMN NOT FOUND	90	90	519	300	1.000000	1	5161	18	0	0	0.000000	0	1.067583	1.0085	0.000000	0	-1.000000	-1	23	7	0.044316	0.0233333	2	2	1			1	0					0	0.262866	0	0.000000	0.277264325323475	0.174470457079153	0.722735674676525	0.825529542920847	0.277264325323475	0.174470457079153	1.80333333333333	2.86581469648562											0.0266734495214181	0.0260033889346925																											353	604			0.1435	0.0562							COLUMN NOT FOUND	BIAS		NOBIAS
	0.262064	60	0	25.7539	14.8695	60	0	51	50	-101	0	1	SBS	0	0	-101	0.50495	227.234	1082	300	0.277264	1.0304	0.450784	0.489726	39.8159	0.257539	0.148695	60	60	0	1.0085	0	300	2.35333	0.277264	1082	226.596	1037	295	0.284474	0.585531	0.463319	0.50259	39.821	0.255812	0.149669	41.9955	41.9889	0	1.00852	0.0066	295	2.38644	0.284474	1037	0	ENSG00000198793	ENSG00000198793	CCDS127.1																						
chr1.fa:11184586-11184586_T_C	chr1.fa:11184586-11184586_T_C			0.898	2474	47395	0	2	19	22			954	990	48	894	1898	35346	35	14			39.5417	38.336227	16	26	8	15	973	1624	24	39	19	30	0.0195272	0.018473			chr1.fa	chr1									chr1.fa:11184586-11184586_T_C	chr1.fa_11184586-11184586_T_C							Aat															COLUMN NOT FOUND	MTOR	COLUMN NOT FOUND	MTOR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr1_11184586-11184586_T_C	COLUMN NOT FOUND	2211N>D	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS127.1		7650		2550																			COLUMN NOT FOUND	MTOR	COLUMN NOT FOUND	chr1.fa:11184586-11184586_T_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Phosphoinositide 3-kinase, catalytic domain (2184-2433); TOR (Target of rapamycin), catalytic domain (2153-2431)	COLUMN NOT FOUND	-																									Oral Oncol. 2012 Jan 27, Cancer. 2011 Aug 11, Lung Cancer. 2012 Feb;75(2):217-22	"Oral Oncol. 2012 Jan 27, Cancer. 2011 Aug 11, Lung Cancer. 2012 Feb;75(2):217-22"							There are numerous inhibitors of MTOR.  The first to be developed was rapamycin and in addition to its analogs (everolimus, temsirolimus and ridaforolimus), a new generation of inhibitors that target the mTOR catalytic site are being assessed.  The mTOR inhibitor, ridaforolimus displayed positive results in clinical trials in sarcoma patients.  The combination of the mTOR inhibitor NVP-BEZ235 and sorafenib is effective against renal cell carcinoma in xenograft models.  	"There are numerous inhibitors of MTOR.  The first to be developed was rapamycin and in addition to its analogs (everolimus, temsirolimus and ridaforolimus), a new generation of inhibitors that target the mTOR catalytic site are being assessed.  The mTOR inhibitor, ridaforolimus displayed positive results in clinical trials in sarcoma patients.  The combination of the mTOR inhibitor NVP-BEZ235 and sorafenib is effective against renal cell carcinoma in xenograft models.  "	Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80, J Clin Oncol. 2012 Jan 1;30(1):78-84, Mol Cancer. 2011 Jul 26;10:90	"Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80, J Clin Oncol. 2012 Jan 1;30(1):78-84, Mol Cancer. 2011 Jul 26;10:90"																																																																																																																																																																																																																																	COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GTCATNGGCCA	COLUMN NOT FOUND	TTTCAGGGTTTCTGAATACCTGAGGTTTTTCCGAAGAGATGTTGGGTCATTGGCCAGAAGGGTGTTAACCAGGCCGAAGAGCTGCATCACACGCTCATCCT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TTTCAGGGTTTCTGAATACCTGAGGTTTTTCCGAAGAGATGTTGGGTCATTGGCCAGAAGGGTGTTAACCAGGCCGAAGAGCTGCATCACACGCTCATCCT'&Submit=submit","Run BLAT")																	chr1.fa:11184586-11184586_T_C	chr1_11184586-11184586_T_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GTCATNGGCCA	0.0195272	0.017751	0.00869436360534409	0.00812765125859027	973	1014	19	18																			COLUMN NOT FOUND	 Phosphoinositide 3-kinase, catalytic domain (2184-2433); TOR (Target of rapamycin), catalytic domain (2153-2431)	COLUMN NOT FOUND	-																																																	0	0.000000									0	1	19	18	2.52632	48.722221	0.0195272	0.017751	973	1014	89	94					COLUMN NOT FOUND	86	86	30	19	1.000000	1	6312	50	0	0	0.000000	0	1.139913	1.08333	0.000000	0	-1.000000	-1	3	2	0.100000	0.105263	2	2	1			1	0					0	0.018863	0	0.000000	0.0195272353545735	0.0135635018495684	0.980472764645427	0.986436498150432	0.0195272353545735	0.0135635018495684	25.6052631578947	36.8636363636364											0.00869436360534409	0.00812765125859027																											24	41	0.33	0.37	0.0758	0.0586							COLUMN NOT FOUND	BIAS		NOBIAS
	0.0194018	60	0	22.7083	10.925	60	0	50	51	-101	0	1	SBS	0	0	-101	0.49505	118.456	973	19	0.0195272	1.45297	0.255963	0.410704	39.5417	0.227083	0.10925	60	60	0	1.08333	0	19	2.52632	0.0195272	973	114.17	939	17	0.0181044	1.49931	0.236387	0.399977	39.5	0.21913	0.118804	42	42	0	1.09091	0	17	2.58824	0.0181044	939	0	ENSG00000198793	ENSG00000198793	CCDS127.1																						
chr1.fa:115256530-115256530_G_T	chr1.fa:115256530-115256530_G_T			0.849	1912	35511	0	2			729	757	8	7	18	190	698	7423	35	15			38.7778	37.489899			6	10	737	1253	9	13	8	11	0.0108548	0.008779			chr1.fa	chr1									chr1.fa:115256530-115256530_G_T	chr1.fa_115256530-115256530_G_T							Caa															COLUMN NOT FOUND	NRAS	COLUMN NOT FOUND	NRAS													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr1_115256530-115256530_G_T	COLUMN NOT FOUND	61Q>K	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		NM_002524		570		190																			COLUMN NOT FOUND	NRAS	COLUMN NOT FOUND	chr1.fa:115256530-115256530_G_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Ras GTPase family containing H-Ras,N-Ras and K-Ras4A/4B (3-164)	COLUMN NOT FOUND	-																	This is an N-ras oncogene encoding a membrane protein that shuttles between the Golgi apparatus and the plasma membrane. This shuttling is regulated through palmitoylation and depalmitoylation by the ZDHHC9-GOLGA7 complex. The encoded protein, which has intrinsic GTPase activity, is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase activating protein. 	"This is an N-ras oncogene encoding a membrane protein that shuttles between the Golgi apparatus and the plasma membrane. This shuttling is regulated through palmitoylation and depalmitoylation by the ZDHHC9-GOLGA7 complex. The encoded protein, which has intrinsic GTPase activity, is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase activating protein. "							Pigment Cell Melanoma Res. 2011 Aug;24(4):666-72, Leukemia. 2011 Jun;25(6):1039-42	"Pigment Cell Melanoma Res. 2011 Aug;24(4):666-72, Leukemia. 2011 Jun;25(6):1039-42"									Blood. 2011 Feb 24;117(8):2433-40, Nature. 2010 Dec 16;468(7326):973-7, Lancet Oncol. 2010 Aug;11(8):753-62	"Blood. 2011 Feb 24;117(8):2433-40, Nature. 2010 Dec 16;468(7326):973-7, Lancet Oncol. 2010 Aug;11(8):753-62"																																																										NRAS		confirmed		REa, A		Autoimmune lymphoproliferative syndrome type IV;Noonan syndrome 6;Epidermal nevus, somatic;Thyroid carcinoma, follicular, somatic;Colorectal cancer, somatic		614470;613224;162900;188470;114500																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TTCTTNTCCAG	COLUMN NOT FOUND	GCCTTCGCCTGTCCTCATGTATTGGTCTCTCATGGCACTGTACTCTTCTTGTCCAGCTGTATCCAGTATGTCCAACAAACAGGTTTCACCATCTATAACCA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GCCTTCGCCTGTCCTCATGTATTGGTCTCTCATGGCACTGTACTCTTCTTGTCCAGCTGTATCCAGTATGTCCAACAAACAGGTTTCACCATCTATAACCA'&Submit=submit","Run BLAT")																	chr1.fa:115256530-115256530_G_T	chr1_115256530-115256530_G_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TTCTTNTCCAG	0.0108548	0.009138	0.00748106791203728	0.00673880399819346	737	766	8	7																			COLUMN NOT FOUND	 Ras GTPase family containing H-Ras,N-Ras and K-Ras4A/4B (3-164)	COLUMN NOT FOUND	-																																									-	Autoimmune lymphoproliferative syndrome type IV;Noonan syndrome 6;Epidermal nevus, somatic;Thyroid carcinoma, follicular, somatic;Colorectal cancer, somatic	-	614470;613224;162900;188470;114500					0	0.000000									0	1	8	7	2.25	26.571428	0.0108548	0.009138	737	766	73	93	184	175			COLUMN NOT FOUND	80	80	11	8	1.000000	1	4904	18	0	0	0.000000	0	1.065657	1	0.000000	0	-1.000000	-1	2	2	0.181818	0.25	0	0	1					1	0			0	0.005350	0	0.000000	0.0108548168249661	0.00559552358113509	0.989145183175034	0.994404476418865	0.0108548168249661	0.00559552358113509	46.0625	89.3571428571428											0.00748106791203728	0.00673880399819346																											9	13	0.33	0.23	0.2539	0.0461					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.00941423	60	0	23.4444	15.8827	60	0	47	54	-101	0	1	SBS	0	0	-101	0.465347	85.2035	737	8	0.0108548	0.942809	0.214097	0.452569	38.7778	0.234444	0.158827	60	60	0	1	0	8	2.25	0.0108548	737	74.7786	693	6	0.00865801	1.04978	0.148032	0.423396	38.4286	0.242857	0.178946	42	42	0	1	0	6	2.33333	0.00865801	693	0	ENSG00000213281	ENSG00000213281	NM_002524																						
chr2.fa:16082598-16082598_C_A	chr2.fa:16082598-16082598_C_A			0.95	1682	34288	178	186	462	486	0	2	0	2	478	9179	18994	365014	34	2			39.7364	37.719749	98	141	141	231	640	1058	216	348	178	278	0.278125	0.262760			chr2.fa	chr2									chr2.fa:16082598-16082598_C_A	chr2.fa_16082598-16082598_C_A							Cgc															COLUMN NOT FOUND	MYCN	COLUMN NOT FOUND	MYCN													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr2_16082598-16082598_C_A	COLUMN NOT FOUND	138R>S	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS1687.1		1395		465																			COLUMN NOT FOUND	MYCN	COLUMN NOT FOUND	chr2.fa:16082598-16082598_C_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Myc amino-terminal region (11-201)	COLUMN NOT FOUND	-															v-myc myelocytomatosis viral related oncogene, neuroblastoma derived	"v-myc myelocytomatosis viral related oncogene, neuroblastoma derived"									Science. 1984 Jun 8;224(4653):1121-4, J Clin Oncol. 2009 Apr 1;27(10):1627-36	"Science. 1984 Jun 8;224(4653):1121-4, J Clin Oncol. 2009 Apr 1;27(10):1627-36"																																																																				MYCN		confirmed		REa, A, Fd		Feingold syndrome		164280																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	ACGGCNGCGGG	COLUMN NOT FOUND	CCGCCCGCGAGAAGCTGGAGCGCGCCGTGAGCGAGAAGCTGCAGCACGGCCGCGGGCCGCCAACCGCCGGTTCCACCGCCCAGTccccgggagccggcgcc	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CCGCCCGCGAGAAGCTGGAGCGCGCCGTGAGCGAGAAGCTGCAGCACGGCCGCGGGCCGCCAACCGCCGGTTCCACCGCCCAGTccccgggagccggcgcc'&Submit=submit","Run BLAT")																	chr2.fa:16082598-16082598_C_A	chr2_16082598-16082598_C_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	ACGGCNGCGGG	0.278125	0.269231	0.0347149943822686	0.03343760752301	640	676	178	182																			COLUMN NOT FOUND	 Myc amino-terminal region (11-201)	COLUMN NOT FOUND	-																																									-	Feingold syndrome	-	164280					0	0.000000											178	182	2.68539	49.076923	0.278125	0.269231	640	676							COLUMN NOT FOUND	90	90	278	178	1.000000	1	4442	38	0	0	0.000000	0	1.073680	1.0251	0.000000	0	-1.000000	-1	29	7	0.104317	0.0393258	2			2	1	1	0					0	0.267703	0	0.000000	0.278125	0.176470588235294	0.721875	0.823529411764706	0.278125	0.176470588235294	1.79775280898876	2.83333333333333											0.0347149943822686	0.03343760752301																											239	372	0.41	0.38	0.0032	0							COLUMN NOT FOUND	BIAS		NOBIAS
	0.284185	60	0	25.3864	14.1033	60	0	80	21	-34	0	1	SBS	0	0	-34	0.792079	206.128	640	178	0.278125	2.40038	0.384764	0.43532	39.7364	0.253864	0.141033	60	60	0	1.0251	0	178	2.68539	0.278125	640	204.287	610	170	0.278689	2.42706	0.381061	0.432792	39.7316	0.251797	0.141878	42	42	0	1.02597	0	170	2.71765	0.278689	610	0	ENSG00000134323	ENSG00000134323	CCDS1687.1																						
chr2.fa:29416326-29416326_G_A	chr2.fa:29416326-29416326_G_A			0.925	2878	64403	298	322	0	1	868	887	0	2	726	15482	28848	609356	35	15			39.7355	38.256905	173	301	190	327	1164	2055	326	581	298	521	0.256014	0.253528			chr2.fa	chr2									chr2.fa:29416326-29416326_G_A	chr2.fa_29416326-29416326_G_A							Cct															COLUMN NOT FOUND	ALK	COLUMN NOT FOUND	ALK													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr2_29416326-29416326_G_A	COLUMN NOT FOUND	1543P>S	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS33172.1		4863		1621																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. 	"This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. "																	Cancer Cell. 2011 May 17;19(5):679-90, Mol Cancer Ther. 2011 Apr;10(4):569-79, Cancer Res. 2010 Dec 15;70(24):10038-43, J Thorac Oncol. 2011 Apr;6(4):774-80, J Clin Oncol. 2009 Sep 10;27(26):4247-53	"Cancer Cell. 2011 May 17;19(5):679-90, Mol Cancer Ther. 2011 Apr;10(4):569-79, Cancer Res. 2010 Dec 15;70(24):10038-43, J Thorac Oncol. 2011 Apr;6(4):774-80, J Clin Oncol. 2009 Sep 10;27(26):4247-53"																																																										ALK		confirmed		Ch, H		Neuroblastoma, susceptibility to, 3		613014																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GTTAGNTGGGA	COLUMN NOT FOUND	GGGCTCTAGGAGCAGTGAGGCCCCCGGAAGTCTCCCAGTTGCAACGTTAGGTGGGACAGTACAGCTTCCCTCCAGCCCCAGGTTACCCCTGTCGTGTGGCT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GGGCTCTAGGAGCAGTGAGGCCCCCGGAAGTCTCCCAGTTGCAACGTTAGGTGGGACAGTACAGCTTCCCTCCAGCCCCAGGTTACCCCTGTCGTGTGGCT'&Submit=submit","Run BLAT")																	chr2.fa:29416326-29416326_G_A	chr2_29416326-29416326_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GTTAGNTGGGA	0.253859	0.262376	0.0249812248031184	0.0247676305595571	1166	1212	296	318																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																									-	Neuroblastoma, susceptibility to, 3	-	613014					0	0.000000											296	318	2.43919	47.544025	0.253859	0.262376	1166	1212							COLUMN NOT FOUND	91	91	521	298	1.000000	1	28950	978	0	0	0.000000	0	1.743910	1.66667	0.000000	0	-1.000000	-1	20	12	0.038388	0.0402685	2	2	1			1	0					0	0.240393	0	0.000000	0.256013745704467	0.15692007797271	0.743986254295533	0.84307992202729	0.256013745704467	0.15692007797271	1.95302013422819	3.18633540372671											0.0249812248031184	0.0247676305595571																											363	628			0.2005	0.1592							COLUMN NOT FOUND	BIAS		NOBIAS
	0.252259	60	0	28.8598	14.0295	60	0	63	38	-101	0	1	SBS	0	0	-101	0.623762	226.51	1164	298	0.256014	0.808445	0.457048	0.49612	39.7355	0.288598	0.140295	60	60	0	1.66667	0	296	2.43919	0.253859	1166	224.679	1104	285	0.258152	0.776181	0.457034	0.496988	39.7241	0.28883	0.139034	41.8799	41.7468	0	1.68391	0.1331	285	2.44211	0.258152	1104	0	ENSG00000171094	ENSG00000171094	CCDS33172.1	1	8.236e-06	121412	121404	-5.011e+00	-1.243e+00	1965691	0.529	75.84	27.74	59.19	0	1.43	0	12.40	2.30	-9.302e-01	MQ	.	G:0	GT:0	GTG:0
chr2.fa:29420501-29420501_T_C	chr2.fa:29420501-29420501_T_C			0.933	2470	46532	0	1	241	254			766	791	600	10949	23890	433369	35	14			39.8167	38.742088	156	291	144	223	1007	1708	263	433	241	423	0.239325	0.247658			chr2.fa	chr2									chr2.fa:29420501-29420501_T_C	chr2.fa_29420501-29420501_T_C							tAt															COLUMN NOT FOUND	ALK	COLUMN NOT FOUND	ALK													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr2_29420501-29420501_T_C	COLUMN NOT FOUND	1327Y>C	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS33172.1		4863		1621																			COLUMN NOT FOUND	ALK	COLUMN NOT FOUND	chr2.fa:29420501-29420501_T_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase (1109-1385); Protein tyrosine kinase (1116-1383)	COLUMN NOT FOUND	-																	This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. 	"This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. "																	Cancer Cell. 2011 May 17;19(5):679-90, Mol Cancer Ther. 2011 Apr;10(4):569-79, Cancer Res. 2010 Dec 15;70(24):10038-43, J Thorac Oncol. 2011 Apr;6(4):774-80, J Clin Oncol. 2009 Sep 10;27(26):4247-53	"Cancer Cell. 2011 May 17;19(5):679-90, Mol Cancer Ther. 2011 Apr;10(4):569-79, Cancer Res. 2010 Dec 15;70(24):10038-43, J Thorac Oncol. 2011 Apr;6(4):774-80, J Clin Oncol. 2009 Sep 10;27(26):4247-53"																																																										ALK		confirmed		Ch, H		Neuroblastoma, susceptibility to, 3		613014																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GCATANATCCA	COLUMN NOT FOUND	TGGTGACAAACTCCAGAACTTCCTGGTTGCTTTTGCTGGGGTATGGCATATATCCAAGAGAAAAGATTTCCCATAGCAGCACTCCAAAGGACCTGGGCATG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TGGTGACAAACTCCAGAACTTCCTGGTTGCTTTTGCTGGGGTATGGCATATATCCAAGAGAAAAGATTTCCCATAGCAGCACTCCAAAGGACCTGGGCATG'&Submit=submit","Run BLAT")																	chr2.fa:29420501-29420501_T_C	chr2_29420501-29420501_T_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GCATANATCCA	0.239325	0.239006	0.0263532857804178	0.0258455085956447	1007	1046	241	250																			COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase (1109-1385); Protein tyrosine kinase (1116-1383)	COLUMN NOT FOUND	-																																									-	Neuroblastoma, susceptibility to, 3	-	613014					0	0.000000											241	250	2.48963	42.804001	0.239325	0.239006	1007	1046							COLUMN NOT FOUND	90	90	423	241	1.000000	1	4289	16	0	0	0.000000	0	1.058377	1.00333	0.000000	0	-1.000000	-1	37	25	0.087470	0.103734	0	0	3	3	1	1	0					0	0.235300	0	0.000000	0.239324726911619	0.14879906268307	0.760675273088381	0.85120093731693	0.239324726911619	0.14879906268307	2.08921161825726	3.36023622047244											0.0263532857804178	0.0258455085956447																											300	514	0.48	0.43	0.2627	0.0015					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.242915	60	0	24.9362	14.6309	60	0	48	53	-78	0	1	SBS	0	0	-78	0.475248	218.551	1007	241	0.239325	0.620967	0.458276	0.501724	39.8167	0.249362	0.146309	60	60	0	1.00333	0	241	2.48963	0.239325	1007	217.291	957	233	0.243469	0.526356	0.460665	0.504853	39.831	0.246578	0.147492	41.9833	41.9326	0	1.00345	0.0507	233	2.48927	0.243469	957	0	ENSG00000171094	ENSG00000171094	CCDS33172.1																						
chr3.fa:41266101-41266101_C_A	chr3.fa:41266101-41266101_C_A			0.941	2316	47124	205	216	704	713	0	2	0	2	508	10153	20238	401941	35	16			39.8386	38.797394	144	235	109	170	909	1454	226	367	205	331	0.225523	0.227648			chr3.fa	chr3									chr3.fa:41266101-41266101_C_A	chr3.fa_41266101-41266101_C_A							tCt															COLUMN NOT FOUND	CTNNB1	COLUMN NOT FOUND	CTNNB1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr3_41266101-41266101_C_A	COLUMN NOT FOUND	33S>Y	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS2694.1		2346		782																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																catenin (cadherin-associated protein), beta 1, 88kDa	"catenin (cadherin-associated protein), beta 1, 88kDa"	The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. 	"The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. "					Medulloblastomas with Wnt pathway activation, for example by CTNNB1 mutation, tend to have a good prognosis	"Medulloblastomas with Wnt pathway activation, for example by CTNNB1 mutation, tend to have a good prognosis"									The Wnt/betaCatenin signaling inhibitor, AV65 inhibits the proliferation of CML cells in vitro and is most effective when used in conjunction with imatinib.	"The Wnt/betaCatenin signaling inhibitor, AV65 inhibits the proliferation of CML cells in vitro and is most effective when used in conjunction with imatinib."																																																												CTNNB1		confirmed		A, REn, Psh, REc		Mental retardation, autosomal dominant 19;Colorectalcancer, somatic;Pilomatricoma, somatic;Ovarian cancer, somatic;Hepatocellular carcinoma, somatic		615075;114500;132600;167000;114550																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GGACTNTGGAA	COLUMN NOT FOUND	AGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AGACAGAAAAGCGGCTGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGTGCCACTACCACAGCTCCTTCTCTGAGTGGTAAAG'&Submit=submit","Run BLAT")																	chr3.fa:41266101-41266101_C_A	chr3_41266101-41266101_C_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GGACTNTGGAA	0.225523	0.228296	0.0271689907936666	0.0269333054022522	909	933	205	213																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																									-	Mental retardation, autosomal dominant 19;Colorectalcancer, somatic;Pilomatricoma, somatic;Ovarian cancer, somatic;Hepatocellular carcinoma, somatic	-	615075;114500;132600;167000;114550					0	0.000000									0	1	205	213	2.47805	46.408451	0.225523	0.228296	909	933							COLUMN NOT FOUND	90	90	331	205	1.000000	1	4096	10	0	0	0.000000	0	1.063514	1	0.000000	0	-1.000000	-1	5	4	0.015106	0.0195122	0	0	2	2	1	1	0					0	0.215453	0	0.000000	0.225522552255226	0.148965517241379	0.774477447744774	0.851034482758621	0.225522552255226	0.148965517241379	2.21707317073171	3.35648148148148											0.0271689907936666	0.0269333054022522																											253	405	0.43	0.42	0.0162	7e-04							COLUMN NOT FOUND	BIAS		NOBIAS
	0.219344	60	0	27.0387	14.7851	60	0	51	50	-101	0	1	SBS	0	0	-101	0.50495	212.255	909	205	0.225523	1.98073	0.407275	0.454385	39.8386	0.270387	0.147851	60	60	0	1	0	205	2.47805	0.225523	909	210.542	870	196	0.225287	2.0332	0.403297	0.451475	39.8512	0.268029	0.148735	42	42	0	1	0	196	2.46939	0.225287	870	0	ENSG00000168036	ENSG00000168036	CCDS2694.1																						
chr3.fa:178936091-178936091_G_A	chr3.fa:178936091-178936091_G_A			0.807	1444	16754			0	1	589	604	0	1	14	128	560	5051	40	16			40	38.853848	2	3	5	7	594	811	7	10	5	7	0.00841751	0.008631			chr3.fa	chr3									chr3.fa:178936091-178936091_G_A	chr3.fa_178936091-178936091_G_A							Gag															COLUMN NOT FOUND	PIK3CA	COLUMN NOT FOUND	PIK3CA													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr3_178936091-178936091_G_A	COLUMN NOT FOUND	545E>K	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS43171.1		3207		1069																			COLUMN NOT FOUND	PIK3CA	COLUMN NOT FOUND	chr3.fa:178936091-178936091_G_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Phosphoinositide 3-kinase (PI3K) class I, accessory domain  (525-696)	COLUMN NOT FOUND	-															phosphoinositide-3-kinase, catalytic, alpha polypeptide	"phosphoinositide-3-kinase, catalytic, alpha polypeptide"	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. 	"Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. "																					Patients with PIK3CA mutations have shorter progression free survival (PFS) when treated with panitumumab and cetuximab##Cell lines with PIK3CA mutations and wild type for PTEN are more sensitive to the mTOR inhibitor everolimus.  SF50, surviving fraction of 50% cells 72hr after treatment.	"Patients with PIK3CA mutations have shorter progression free survival (PFS) when treated with panitumumab and cetuximab##Cell lines with PIK3CA mutations and wild type for PTEN are more sensitive to the mTOR inhibitor everolimus.  SF50, surviving fraction of 50% cells 72hr after treatment."																																																						PIK3CA		provisional		REa, A		Ovarian cancer, somatic;Breast cancer, somatic;Colorectal cancer, somatic;Gastric cancer, somatic;Hepatocellular carcinoma, somatic;Nonsmall cell lung cancer, somatic;Keratosis, seborrheic, somatic;Nevus,epidermal, somatic;CLOVE syndrome, somatic;Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic;Cowden syndrome 5		167000;114480;114500;613659;114550;211980;182000;162900;612918;602501;603387;615108																																																																																																																																																															COLUMN NOT FOUND	OK - 2 hits no mut	COLUMN NOT FOUND	TCACTNAGCAG	COLUMN NOT FOUND	AAGAACAGCTCAAAGCAATTTCTACACGAGATCCTCTCTCTGAAATCACTGAGCAGGAGAAAGATTTTCTATGGAGTCACAGGTAAGTGCTAAAATGGAGA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AAGAACAGCTCAAAGCAATTTCTACACGAGATCCTCTCTCTGAAATCACTGAGCAGGAGAAAGATTTTCTATGGAGTCACAGGTAAGTGCTAAAATGGAGA'&Submit=submit","Run BLAT")																	chr3.fa:178936091-178936091_G_A	chr3_178936091-178936091_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TCACTNAGCAG	0.00841751	0.008183	0.00734715248552057	0.0071435743670495	594	611																					COLUMN NOT FOUND	 Phosphoinositide 3-kinase (PI3K) class I, accessory domain  (525-696)	COLUMN NOT FOUND	-																																									-	Ovarian cancer, somatic;Breast cancer, somatic;Colorectal cancer, somatic;Gastric cancer, somatic;Hepatocellular carcinoma, somatic;Nonsmall cell lung cancer, somatic;Keratosis, seborrheic, somatic;Nevus,epidermal, somatic;CLOVE syndrome, somatic;Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic;Cowden syndrome 5	-	167000;114480;114500;613659;114550;211980;182000;162900;612918;602501;603387;615108					0	0.000000													2.8	25.000000	0.00841751	0.008183	594	611							COLUMN NOT FOUND	77	77	7	5	1.000000	1	1924	18	0	0	0.000000	0	1.100000	1	0.000000	0	-1.000000	-1	0	0	0.000000			0	1					1	0			0	0.007640	0	0.000000	0.00841750841750842	0.00618046971569839	0.991582491582492	0.993819530284302	0.00841750841750842	0.00618046971569839	59.4	80.9											0.00734715248552057	0.0071435743670495																											7	10	0.29	0.3	0.2266	0.1719							COLUMN NOT FOUND	BIAS		NOBIAS
	0.00969529	56.6697	0	24.75	15.5755	54.9415	0	41	60	-101	0	1	SBS	0	0	-101	0.405941	71.6704	594	5	0.00841751	0.958315	0.134891	0.436537	40	0.2475	0.155755	56.6697	54.9415	0	1	1.7282	5	2.8	0.00841751	594	64.3775	569	4	0.00702988	0.666667	0.164708	0.501958	40	0.22375	0.162228	20.2093	11.8864	0	1	8.3229	4	3.5	0.00702988	569	0	ENSG00000121879	ENSG00000121879	CCDS43171.1	1	8.279e-06	120786	119906	-2.614e+00	-3.250e-01	1546837	0.570	64.36	14.70	52.57	0	0.694	1181	5.85	0.520	-4.703e-01	QD	.	G:0	GA:0	GAG:0
chr3.fa:178947865-178947865_G_A	chr3.fa:178947865-178947865_G_A			0.942	2012	31886	180	187			630	641			446	6986	17770	275681	35	16			39.843	38.811909	80	128	143	214	810	1186	205	312	180	273	0.222222	0.230185			chr3.fa	chr3									chr3.fa:178947865-178947865_G_A	chr3.fa_178947865-178947865_G_A							Gga															COLUMN NOT FOUND	PIK3CA	COLUMN NOT FOUND	PIK3CA													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr3_178947865-178947865_G_A	COLUMN NOT FOUND	914G>R	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS43171.1		3207		1069																			COLUMN NOT FOUND	PIK3CA	COLUMN NOT FOUND	chr3.fa:178947865-178947865_G_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain (699-1064); Phosphoinositide 3-kinase, catalytic domain (799-1017)	COLUMN NOT FOUND	-															phosphoinositide-3-kinase, catalytic, alpha polypeptide	"phosphoinositide-3-kinase, catalytic, alpha polypeptide"	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. 	"Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. "																					Patients with PIK3CA mutations have shorter progression free survival (PFS) when treated with panitumumab and cetuximab##Cell lines with PIK3CA mutations and wild type for PTEN are more sensitive to the mTOR inhibitor everolimus.  SF50, surviving fraction of 50% cells 72hr after treatment.	"Patients with PIK3CA mutations have shorter progression free survival (PFS) when treated with panitumumab and cetuximab##Cell lines with PIK3CA mutations and wild type for PTEN are more sensitive to the mTOR inhibitor everolimus.  SF50, surviving fraction of 50% cells 72hr after treatment."																																																						PIK3CA		provisional		REa, A		Ovarian cancer, somatic;Breast cancer, somatic;Colorectal cancer, somatic;Gastric cancer, somatic;Hepatocellular carcinoma, somatic;Nonsmall cell lung cancer, somatic;Keratosis, seborrheic, somatic;Nevus,epidermal, somatic;CLOVE syndrome, somatic;Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic;Cowden syndrome 5		167000;114480;114500;613659;114550;211980;182000;162900;612918;602501;603387;615108																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GAATTNGAGAT	COLUMN NOT FOUND	TTACACGTTCATGTGCTGGATACTGTGTAGCTACCTTCATTTTGGGAATTGGAGATCGTCACAATAGTAACATCATGGTGAAAGACGATGGACAAGTAATG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TTACACGTTCATGTGCTGGATACTGTGTAGCTACCTTCATTTTGGGAATTGGAGATCGTCACAATAGTAACATCATGGTGAAAGACGATGGACAAGTAATG'&Submit=submit","Run BLAT")																	chr3.fa:178947865-178947865_G_A	chr3_178947865-178947865_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GAATTNGAGAT	0.222222	0.224638	0.0286309046293216	0.0284272305890695	810	828	180	186																			COLUMN NOT FOUND	 Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain (699-1064); Phosphoinositide 3-kinase, catalytic domain (799-1017)	COLUMN NOT FOUND	-																																									-	Ovarian cancer, somatic;Breast cancer, somatic;Colorectal cancer, somatic;Gastric cancer, somatic;Hepatocellular carcinoma, somatic;Nonsmall cell lung cancer, somatic;Keratosis, seborrheic, somatic;Nevus,epidermal, somatic;CLOVE syndrome, somatic;Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic;Cowden syndrome 5	-	167000;114480;114500;613659;114550;211980;182000;162900;612918;602501;603387;615108					0	0.000000											180	186	2.47778	36.677418	0.222222	0.224638	810	828							COLUMN NOT FOUND	91	91	273	180	1.000000	1	3131	26	0	0	0.000000	0	1.094326	1.02242	0.000000	0	-1.000000	-1	15	2	0.054945	0.0111111	2			2	1	1	0					0	0.219093	0	0.000000	0.222222222222222	0.157672849915683	0.777777777777778	0.842327150084317	0.222222222222222	0.157672849915683	2.25	3.17112299465241											0.0286309046293216	0.0284272305890695																											223	342	0.36	0.37									COLUMN NOT FOUND	BIAS		NOBIAS
	0.22167	60	0	28.5665	12.6702	60	0	41	60	-101	0	1	SBS	0	0	-101	0.405941	207.124	810	180	0.222222	3.79029	0.333607	0.383881	39.843	0.285665	0.126702	60	60	0	1.02242	0	180	2.47778	0.222222	810	206.28	768	176	0.229167	3.39099	0.346776	0.397619	39.852	0.273083	0.133155	41.9959	41.9825	0	1.02242	0.0134	176	2.53409	0.229167	768	0	ENSG00000121879	ENSG00000121879	CCDS43171.1																						
chr3.fa:178952085-178952085_A_G	chr3.fa:178952085-178952085_A_G			0.938	2054	38296	636	653			193	200	0	1	478	8079	19010	319502	35	16			39.7699	38.559258	102	148	137	198	829	1335	222	328	193	284	0.232811	0.212734			chr3.fa	chr3									chr3.fa:178952085-178952085_A_G	chr3.fa_178952085-178952085_A_G							cAt															COLUMN NOT FOUND	PIK3CA	COLUMN NOT FOUND	PIK3CA													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr3_178952085-178952085_A_G	COLUMN NOT FOUND	1047H>R	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS43171.1		3207		1069																			COLUMN NOT FOUND	PIK3CA	COLUMN NOT FOUND	chr3.fa:178952085-178952085_A_G	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain (699-1064)	COLUMN NOT FOUND	 Phosphoinositide 3-kinase, catalytic domain (799-1017)															phosphoinositide-3-kinase, catalytic, alpha polypeptide	"phosphoinositide-3-kinase, catalytic, alpha polypeptide"	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. 	"Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. "																					Patients with PIK3CA mutations have shorter progression free survival (PFS) when treated with panitumumab and cetuximab##Cell lines with PIK3CA mutations and wild type for PTEN are more sensitive to the mTOR inhibitor everolimus.  SF50, surviving fraction of 50% cells 72hr after treatment.	"Patients with PIK3CA mutations have shorter progression free survival (PFS) when treated with panitumumab and cetuximab##Cell lines with PIK3CA mutations and wild type for PTEN are more sensitive to the mTOR inhibitor everolimus.  SF50, surviving fraction of 50% cells 72hr after treatment."																																																						PIK3CA		provisional		REa, A		Ovarian cancer, somatic;Breast cancer, somatic;Colorectal cancer, somatic;Gastric cancer, somatic;Hepatocellular carcinoma, somatic;Nonsmall cell lung cancer, somatic;Keratosis, seborrheic, somatic;Nevus,epidermal, somatic;CLOVE syndrome, somatic;Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic;Cowden syndrome 5		167000;114480;114500;613659;114550;211980;182000;162900;612918;602501;603387;615108																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGCACNTCATG	COLUMN NOT FOUND	AACTGAGCAAGAGGCTTTGGAGTATTTCATGAAACAAATGAATGATGCACATCATGGTGGCTGGACAACAAAAATGGATTGGATCTTCCACACAATTAAAC	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AACTGAGCAAGAGGCTTTGGAGTATTTCATGAAACAAATGAATGATGCACATCATGGTGGCTGGACAACAAAAATGGATTGGATCTTCCACACAATTAAAC'&Submit=submit","Run BLAT")																	chr3.fa:178952085-178952085_A_G	chr3_178952085-178952085_A_G							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TGCACNTCATG	0.232811	0.231850	0.028769445264529	0.0283043887282088	829	854	193	198																			COLUMN NOT FOUND	 Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain (699-1064)	COLUMN NOT FOUND	 Phosphoinositide 3-kinase, catalytic domain (799-1017)																																									-	Ovarian cancer, somatic;Breast cancer, somatic;Colorectal cancer, somatic;Gastric cancer, somatic;Hepatocellular carcinoma, somatic;Nonsmall cell lung cancer, somatic;Keratosis, seborrheic, somatic;Nevus,epidermal, somatic;CLOVE syndrome, somatic;Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic;Cowden syndrome 5	-	167000;114480;114500;613659;114550;211980;182000;162900;612918;602501;603387;615108					0	0.000000											193	198	2.47668	40.303032	0.232811	0.231850	829	854							COLUMN NOT FOUND	90	90	284	193	1.000000	1	3511	14	0	0	0.000000	0	1.057688	1.00837	0.000000	0	-1.000000	-1	4	2	0.014085	0.0103627	0	0	1	1	2	2	0					0	0.210962	0	0.000000	0.232810615199035	0.149925037481259	0.767189384800965	0.850074962518741	0.232810615199035	0.149925037481259	2.14766839378238	3.335											0.028769445264529	0.0283043887282088																											239	346			0.0138	0.0042							COLUMN NOT FOUND	BIAS		NOBIAS
	0.232717	60	0	26.2957	14.255	60	0	39	62	-101	0	1	SBS	0	0	-101	0.386139	209.502	829	193	0.232811	2.03446	0.402502	0.451054	39.7699	0.262957	0.14255	60	60	0	1.00837	0	193	2.47668	0.232811	829	208.2	789	187	0.237009	2.09003	0.398919	0.448243	39.7598	0.263198	0.142169	42	42	0	1.00873	0	187	2.4492	0.237009	789	0	ENSG00000121879	ENSG00000121879	CCDS43171.1	1	8.275e-06	120848	120230	0.870	0.830	2360969	0.596	87.15	29.71	59.77	0	0.197	1105	5.58	-2.080e-01	-3.962e-01	QD	.	A:0	AT:0	ATC:0
chr4.fa:55575642-55575642_T_C	chr4.fa:55575642-55575642_T_C			0.901	1728	24892			7	10			680	691	18	362	720	14358	40	16			40	38.700809	6	14	3	5	687	1037	9	19	7	15	0.0101892	0.014465			chr4.fa	chr4									chr4.fa:55575642-55575642_T_C	chr4.fa_55575642-55575642_T_C							Tac															COLUMN NOT FOUND	KIT	COLUMN NOT FOUND	KIT													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr4_55575642-55575642_T_C	COLUMN NOT FOUND	390Y>H	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS3496.1		2931		977																			COLUMN NOT FOUND	KIT	COLUMN NOT FOUND	chr4.fa:55575642-55575642_T_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) (311-411)	COLUMN NOT FOUND	-																	This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	"This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). "															Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	"Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504"	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	"N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908."			Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	"Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504"																																																						KIT		confirmed		REa, A, H, Ch, H, REn		Piebaldism;Gastrointestinal stromal tumor, familial;Mast cell disease;Leukemia, acute myeloid;Germ cell tumors		172800;606764;154800;601626;273300																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GCACTNACACA	COLUMN NOT FOUND	ACGTAAGTGAACTTCATCTAACGAGATTAAAAGGCACCGAAGGAGGCACTTACACATTCCTAGTGTCCAATTCTGACGTCAATGCTGCCATAGCATTTAAT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='ACGTAAGTGAACTTCATCTAACGAGATTAAAAGGCACCGAAGGAGGCACTTACACATTCCTAGTGTCCAATTCTGACGTCAATGCTGCCATAGCATTTAAT'&Submit=submit","Run BLAT")																	chr4.fa:55575642-55575642_T_C	chr4_55575642-55575642_T_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GCACTNACACA	0.0101892	0.011396	0.00750973206095507	0.00785190672558561	687	702	7	8																			COLUMN NOT FOUND	 Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) (311-411)	COLUMN NOT FOUND	-																																									-	Piebaldism;Gastrointestinal stromal tumor, familial;Mast cell disease;Leukemia, acute myeloid;Germ cell tumors	-	172800;606764;154800;601626;273300					0	0.000000					0	1			0	1	7	8	2.57143	44.125000	0.0101892	0.011396	687	702	75	80	96	99			COLUMN NOT FOUND	64	63	15	7	1.000000	1	7069	290	0	0	0.000000	0	1.037736	1	0.000000	0	-1.000000	-1	0	0	0.000000	0	2			2	1	1	0					0	0.014543	0	0.000000	0.0101892285298399	0.00964320154291225	0.98981077147016	0.990356798457088	0.0101892285298399	0.00964320154291225	49.0714285714286	51.85											0.00750973206095507	0.00785190672558561																											9	19	0.33	0.26	0.2539	0.0318					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.0104167	60	0	26.3333	11.702	60	0	42	59	-101	0	1	SBS	0	0	-101	0.415842	83.1777	687	7	0.0101892	0.881917	0.205864	0.460802	40	0.263333	0.11702	60	60	0	1	0	7	2.57143	0.0101892	687	83.1777	662	7	0.010574	0.881917	0.205864	0.460802	40	0.263333	0.11702	42	42	0	1	0	7	2.57143	0.010574	662	0	ENSG00000157404	ENSG00000157404	CCDS3496.1																						
chr7.fa:55241707-55241707_G_A	chr7.fa:55241707-55241707_G_A			0.933	2324	39265	191	198			789	807	0	1	454	7829	18046	308943	35	14			39.7489	38.037800	81	113	146	221	979	1512	206	312	191	286	0.195097	0.189153			chr7.fa	chr7									chr7.fa:55241707-55241707_G_A	chr7.fa_55241707-55241707_G_A							Ggc															COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	EGFR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_55241707-55241707_G_A	COLUMN NOT FOUND	719G>S	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5514.1		3633		1211																			COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	chr7.fa:55241707-55241707_G_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																									Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8	"Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8"							High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer.	"High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer."	J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30	"J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30"																																																										EGFR		confirmed		S, Fd, D, REa		Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to		211980;211980;211980																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGCTGNGCTCC	COLUMN NOT FOUND	CTCTCTTGAGGATCTTGAAGGAAACTGAATTCAAAAAGATCAAAGTGCTGGGCTCCGGTGCGTTCGGCACGGTGTATAAGGTAAGGTCCCTGGCACAGGCC	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CTCTCTTGAGGATCTTGAAGGAAACTGAATTCAAAAAGATCAAAGTGCTGGGCTCCGGTGCGTTCGGCACGGTGTATAAGGTAAGGTCCCTGGCACAGGCC'&Submit=submit","Run BLAT")																	chr7.fa:55241707-55241707_G_A	chr7_55241707-55241707_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TGCTGNGCTCC	0.193878	0.190855	0.0247518294520726	0.0242840946587796	980	1006	190	192																			COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																																									-	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to	-	211980;211980;211980					0	0.000000									0	1	190	192	2.37895	39.062500	0.193878	0.190855	980	1006							COLUMN NOT FOUND	88	88	286	191	1.000000	1	4108	24	0	0	0.000000	0	1.060699	1.00441	0.000000	0	-1.000000	-1	22	13	0.076923	0.0680628	3	3	1			1	0					0	0.199389	0	0.000000	0.195097037793667	0.131039046988749	0.804902962206333	0.868960953011251	0.195097037793667	0.131039046988749	2.56282722513089	3.81565656565657											0.0247518294520726	0.0242840946587796																											227	334	0.36	0.34									COLUMN NOT FOUND	BIAS		NOBIAS
	0.195353	60	0	28.6904	14.4547	60	0	52	49	-101	0	1	SBS	0	0	-101	0.514851	208.98	979	191	0.195097	3.95735	0.332426	0.381231	39.7489	0.286904	0.144547	60	60	0	1.00441	0	190	2.37895	0.193878	980	206.841	939	181	0.192758	4.10557	0.32235	0.372485	39.7465	0.285333	0.14484	41.9745	41.867	0	1.00469	0.1075	181	2.35359	0.192758	939	0	ENSG00000146648	ENSG00000146648	CCDS5514.1																						
chr7.fa:55242465-55242479_GGAATTAAGAGAAGC_	chr7.fa:55242465-55242479_GGAATTAAGAGAAGC_			0.699	2728	49349	1107	1135			0	2	0	1	22	558	876	55800	39	100	40	100	39.8182	100.000000	7	10			1115	1781	11	12	8	10	0.00717489	0.00561482313307131			chr7.fa	chr7									chr7.fa:55242465-55242479_GGAATTAAGAGAAGC_	chr7.fa_55242465-55242479_GGAATTAAGAGAAGC_							aaGGAATTAAGAGAAGCa															COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	EGFR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_55242465-55242479_GGAATTAAGAGAAGC_	COLUMN NOT FOUND	745KELREA>K	COLUMN NOT FOUND	Deletion	COLUMN NOT FOUND	In-frame deletion		CCDS5514.1		3633		1211																			COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	chr7.fa:55242465-55242479_GGAATTAAGAGAAGC_	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																									Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8	"Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8"							High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer.	"High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer."	J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30	"J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30"																																																										EGFR		confirmed		S, Fd, D, REa		Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to		211980;211980;211980																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	ATCAANGAATT	COLUMN NOT FOUND	GGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCGTCGCTATCAAGGAATTAAGAGAAGCAACATCTCCGAAAGCCAACAAGGAAATCCTCGATGT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCGTCGCTATCAAGGAATTAAGAGAAGCAACATCTCCGAAAGCCAACAAGGAAATCCTCGATGT'&Submit=submit","Run BLAT")																	chr7.fa:55242465-55242479_GGAATTAAGAGAAGC_	chr7_55242465-55242479_GGAATTAAGAGAAGC_							COLUMN NOT FOUND	Deletion	COLUMN NOT FOUND	In-frame deletion	COLUMN NOT FOUND	ATCAANGAATT	0.00717489	0.006114	0.00495407496702326	0.0045151064344507	1115	1145	8	7																			COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																																									-	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to	-	211980;211980;211980			8	0	1	0.000000					8	7			1	2	8	7	2.75	79.285713	0.00717489	0.006114	1115	1145							COLUMN NOT FOUND	48	48	10	8	1.000000	1	5579	22	0	0	0.000000	0	1.041219	1	0.000000	0	-1.000000	-1	0	0	0.000000	0	2	2	1					1	0			0	0.011378																					0.00495407496702326	0.0045151064344507																											11	14	0.36	0.29	0.2744	0.0898							COLUMN NOT FOUND	NOBIAS - Indel		NOBIAS
	0.00806452	60	0	31.7273	6.51829	60	0	46	55	-101	0	1	DEL	15	0	-101	0.455446	87.4895	1115	8	0.00717489	0.771389	0.2444	0.482872	39.8182	0.317273	0.0651829	60	60	0	1	0	8	2.75	0.00717489	1115	64.3775	1064	4	0.0037594	0.285714	0.259946	0.597196	40	0.297143	0.0358211	41.8525	3.02372	0	1	38.8288	4	3.5	0.0037594	1064	0	ENSG00000146648	ENSG00000146648	CCDS5514.1																						
chr7.fa:55249071-55249071_C_T	chr7.fa:55249071-55249071_C_T			0.847	4230	120089	0	6	1664	1719	0	2	15	24	34	1009	1358	40178	39	16			39.9412	38.228355	9	23	8	23	1679	3191	17	45	15	38	0.00893389	0.011908			chr7.fa	chr7									chr7.fa:55249071-55249071_C_T	chr7.fa_55249071-55249071_C_T							aCg															COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	EGFR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_55249071-55249071_C_T	COLUMN NOT FOUND	790T>M	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5514.1		3633		1211																			COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	chr7.fa:55249071-55249071_C_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																									Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8	"Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8"							High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer.	"High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer."	J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30	"J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30"																																																										EGFR		confirmed		S, Fd, D, REa		Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to		211980;211980;211980																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	CATCANGCAGC	COLUMN NOT FOUND	CGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCACGCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCACGCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAG'&Submit=submit","Run BLAT")																	chr7.fa:55249071-55249071_C_T	chr7_55249071-55249071_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CATCANGCAGC	0.00893389	0.007424	0.00450093061104453	0.00402090131591533	1679	1751	15	13																			COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																																									-	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to	-	211980;211980;211980					0	0.000000							2	3	0	1	15	13	2.26667	75.307693	0.00893389	0.007424	1679	1751	65	95					COLUMN NOT FOUND	77	77	38	15	1.000000	1	16626	62	0	0	0.000000	0	1.073264	1	0.000000	0	-1.000000	-1	7	4	0.184211	0.266667	0	0	1			1	0					0	0.008402	0	0.000000	0.00893388921977368	0.00754005655042413	0.991066110780226	0.992459943449576	0.00893388921977368	0.00754005655042413	55.9666666666667	66.3125											0.00450093061104453	0.00402090131591533																											17	46	0.47	0.5	0.5	0.5585							COLUMN NOT FOUND	BIAS		NOBIAS
	0.00803783	60	0	33	13.6317	60	0	64	37	-101	0	1	SBS	0	0	-101	0.633663	110.741	1679	15	0.00893389	0.227823	0.383511	0.557666	39.9412	0.33	0.136317	60	60	0	1	0	15	2.26667	0.00893389	1679	99.2052	1567	11	0.00701978	0.255125	0.359853	0.563223	39.9231	0.305714	0.138548	41.9858	42	0	1	-0.0142	11	2.36364	0.00701978	1567	0	ENSG00000146648	ENSG00000146648	CCDS5514.1	5	4.118e-05	121412	121292	0.664	-3.910e-01	2448706	2.506	82.91	26.96	59.45	0	-7.840e-01	0	12.39	1.54	1.06	InbreedingCoeff	.	C:0	CG:0	CGC:0
chr7.fa:55259515-55259515_T_G	chr7.fa:55259515-55259515_T_G			0.881	3210	59448	0	1	0	3	11	13	1292	1320	26	638	1040	25499	40	14			40	38.286785	4	6	9	19	1303	2079	13	24	11	22	0.00844206	0.010582			chr7.fa	chr7									chr7.fa:55259515-55259515_T_G	chr7.fa_55259515-55259515_T_G							cTg															COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	EGFR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_55259515-55259515_T_G	COLUMN NOT FOUND	858L>R	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5514.1		3633		1211																			COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	chr7.fa:55259515-55259515_T_G	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																									Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8	"Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8"							High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer.	"High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer."	J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30	"J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30"																																																										EGFR		confirmed		S, Fd, D, REa		Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to		211980;211980;211980																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGGGCNGGCCA	COLUMN NOT FOUND	GAACGTACTGGTGAAAACACCGCAGCATGTCAAGATCACAGATTTTGGGCTGGCCAAACTGCTGGGTGCGGAAGAGAAAGAATACCATGCAGAAGGAGGCA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GAACGTACTGGTGAAAACACCGCAGCATGTCAAGATCACAGATTTTGGGCTGGCCAAACTGCTGGGTGCGGAAGAGAAAGAATACCATGCAGAAGGAGGCA'&Submit=submit","Run BLAT")																	chr7.fa:55259515-55259515_T_G	chr7_55259515-55259515_T_G							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TGGGCNGGCCA	0.00844206	0.008975	0.00496783367651186	0.00505542326378737	1303	1337	11	12																			COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019); Tyrosine kinase, catalytic domain (713-968)	COLUMN NOT FOUND	-																																									-	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to	-	211980;211980;211980					0	0.000000							2	3	0	1	11	12	2.36364	52.000000	0.00844206	0.008975	1303	1337	89	99	203	204			COLUMN NOT FOUND	72	72	22	11	1.000000	1	7924	50	0	0	0.000000	0	1.058559	1	0.000000	0	-1.000000	-1	0	0	0.000000			0	1			1	2	2	0			0	0.010732	0	0.000000	0.00844205679201842	0.00626506024096386	0.991557943207982	0.993734939759036	0.00844205679201842	0.00626506024096386	59.2272727272727	79.8076923076923											0.00496783367651186	0.00505542326378737																											13	25	0.31	0.24	0.1334	0.0073					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.00809969	60	0	24.875	15.349	60	0	51	50	-101	0	1	SBS	0	0	-101	0.50495	99.3963	1303	11	0.00844206	1.27562	0.206007	0.409377	40	0.24875	0.15349	60	60	0	1	0	11	2.36364	0.00844206	1303	92.1034	1221	9	0.00737101	0.818182	0.251219	0.476053	40	0.301818	0.138894	41.9805	42	0	1	-0.0195	9	2.44444	0.00737101	1221	0	ENSG00000146648	ENSG00000146648	CCDS5514.1																						
chr7.fa:55268980-55268980_T_C	chr7.fa:55268980-55268980_T_C			0.934	3978	96334	0	3	309	326			1268	1314	790	18614	31480	736457	35	2			39.8481	38.403141	206	404	189	335	1577	3043	328	615	309	582	0.195942	0.191259			chr7.fa	chr7									chr7.fa:55268980-55268980_T_C	chr7.fa_55268980-55268980_T_C							Tac															COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	EGFR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_55268980-55268980_T_C	COLUMN NOT FOUND	1016Y>H	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5514.1		3633		1211																			COLUMN NOT FOUND	EGFR	COLUMN NOT FOUND	chr7.fa:55268980-55268980_T_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019)	COLUMN NOT FOUND	-																									Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8	"Ann Oncol. 2004 Jan;15(1):28-32, Oral Oncol. 2011 Aug 8"							High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer.	"High EGFR gene copy number may be an effective predictor of gefitinib efficacy in NSCLC. Mutations in the tyrosine kinase domain of EGFR and amplifications are associated with sensitivity of lung cancers to erlotinib and gefitinib.  However, secondary EGFR mutations conferring resistance to erlotinib and gefitinib have also been described.  Gene Amplification of EGFR has been associated with improved response to small molecule and antibody therapy (panitumumab and erbitux), including in wild type KRAS metastatic cancer."	J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30	"J Natl Cancer Inst. 2005 May 4;97(9):643-55, Proc Natl Acad Sci USA 2004 Sep 7;101(36):13306-11, Clin Transl Oncol. 2010 Feb;12(2):75-80, N Engl J Med 2004 May 20;350(21):2129-39, Nat Rev Cancer. 2007 Mar;7(3):169-81, J Clin Oncol. 2005 Oct 1;23(28):6829-37, Br J Cancer. 2011 Jul 12;105(2):255-62, J Clin Oncol. 2009 Dec 10;27(35):5924-30"																																																										EGFR		confirmed		S, Fd, D, REa		Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to		211980;211980;211980																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	ACGAGNACCTC	COLUMN NOT FOUND	GTGCCCTGATGGATGAAGAAGACATGGACGACGTGGTGGATGCCGACGAGTACCTCATCCCACAGCAGGGCTTCTTCAGCAGCCCCTCCACGTCACGGACT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GTGCCCTGATGGATGAAGAAGACATGGACGACGTGGTGGATGCCGACGAGTACCTCATCCCACAGCAGGGCTTCTTCAGCAGCCCCTCCACGTCACGGACT'&Submit=submit","Run BLAT")																	chr7.fa:55268980-55268980_T_C	chr7_55268980-55268980_T_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	ACGAGNACCTC	0.195942	0.192331	0.0195905846873793	0.0190580617137579	1577	1643	309	316																			COLUMN NOT FOUND	 Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor (704-1019)	COLUMN NOT FOUND	-																																									-	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in;Adenocarcinoma of lung, response to tyrosine kinase inhibitor in;Nonsmall cell lung cancer, susceptibility to	-	211980;211980;211980					0	0.000000							2	3	0	1	309	316	2.55663	56.962025	0.195942	0.192331	1577	1643							COLUMN NOT FOUND	90	90	582	309	1.000000	1	9802	24	0	0	0.000000	0	1.065860	1.00506	0.000000	0	-1.000000	-1	18	18	0.030928	0.0582524	0	0	1			1	0					0	0.193224	0	0.000000	0.195941661382372	0.107236842105263	0.804058338617628	0.892763157894737	0.195941661382372	0.107236842105263	2.55177993527508	4.66257668711656											0.0195905846873793	0.0190580617137579																											395	739	0.48	0.45	0.2104	0.0062					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.198592	60	0	25.8565	14.6507	60	0	60	41	-101	0	1	SBS	0	0	-101	0.594059	228.592	1577	309	0.195942	0.756539	0.459296	0.497667	39.8481	0.258565	0.146507	60	60	0	1.00506	0	309	2.55663	0.195942	1577	225.69	1471	287	0.195105	0.780483	0.457058	0.496872	39.8537	0.256025	0.146292	41.9753	42	0	1.00542	-0.0247	287	2.57143	0.195105	1471	0	ENSG00000146648	ENSG00000146648	CCDS5514.1																						
chr7.fa:140453136-140453136_A_T	chr7.fa:140453136-140453136_A_T			0.935	3046	47605	873	876	0	1	0	2	350	371	832	12415	33178	490679	35	15			39.8774	38.575394	212	302	204	332	1223	1810	351	555	350	528	0.286182	0.291713			chr7.fa	chr7									chr7.fa:140453136-140453136_A_T	chr7.fa_140453136-140453136_A_T							gTg															COLUMN NOT FOUND	BRAF	COLUMN NOT FOUND	BRAF													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_140453136-140453136_A_T	COLUMN NOT FOUND	600V>E	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5863.1		2301		767																			COLUMN NOT FOUND	BRAF	COLUMN NOT FOUND	chr7.fa:140453136-140453136_A_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Protein Kinases, catalytic domain (463-715); Protein kinase domain (457-713)	COLUMN NOT FOUND	-																	This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. 	"This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. "							J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300	"J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300"							Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885	"Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885"																																																												BRAF		confirmed		A, REa		Melanoma, malignant, somatic;Colorectal cancer, somatic;Adenocarcinoma of lung, somatic;Nonsmall cell lung cancer, somatic;Cardiofaciocutaneous syndrome;Noonan syndrome 7;LEOPARD syndrome 3		;;211980;;115150;613706;613707																																																																																																																																																															COLUMN NOT FOUND	OK - 2 hits no mut	COLUMN NOT FOUND	ATTTCNCTGTA	COLUMN NOT FOUND	TGGATCCAGACAACTGTTCAAACTGATGGGACCCACTCCATCGAGATTTCACTGTAGCTAGACCAAAATCACCTATTTTTACTGTGAGGTCTTCATGAAGA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TGGATCCAGACAACTGTTCAAACTGATGGGACCCACTCCATCGAGATTTCACTGTAGCTAGACCAAAATCACCTATTTTTACTGTGAGGTCTTCATGAAGA'&Submit=submit","Run BLAT")																	chr7.fa:140453136-140453136_A_T	chr7_140453136-140453136_A_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	ATTTCNCTGTA	0.286182	0.293600	0.0253313030047045	0.025246689320606	1223	1250	350	367																			COLUMN NOT FOUND	 Protein Kinases, catalytic domain (463-715); Protein kinase domain (457-713)	COLUMN NOT FOUND	-																																									-	Melanoma, malignant, somatic;Colorectal cancer, somatic;Adenocarcinoma of lung, somatic;Nonsmall cell lung cancer, somatic;Cardiofaciocutaneous syndrome;Noonan syndrome 7;LEOPARD syndrome 3	-	;;211980;;115150;613706;613707					0	0.000000									0	1	350	367	2.37714	32.970028	0.286182	0.293600	1223	1250					255	420	COLUMN NOT FOUND	90	90	527	350	0.998106	1	3619	16	0	0	0.000000	0	1.073428	1.01923	0.000000	0	-1.000000	-1	32	27	0.060606	0.0771429	0	0	1			1	0					0	0.260792	0	0.000000	0.286181520850368	0.205312672938572	0.713818479149632	0.794687327061428	0.286181520850368	0.205312672938572	1.74714285714286	2.43530997304582											0.0253313030047045	0.025246689320606																											416	634	0.49	0.48	0.3657	0.1247							COLUMN NOT FOUND	BIAS		NOBIAS
	0.273145	60	0	27.39	14.3571	60	0	43	58	-101	0	1	SBS	0	0	-101	0.425743	233.713	1223	350	0.286182	0.359775	0.472358	0.508411	39.8774	0.2739	0.143571	60	60	0	1.01923	0	350	2.37714	0.286182	1223	233.006	1169	344	0.294269	0.0449086	0.480606	0.516973	39.8741	0.268425	0.145637	41.3368	41.5978	0	1.01937	-0.261	344	2.40116	0.294269	1169	0	ENSG00000157764	ENSG00000157764	CCDS5863.1	2	1.647e-05	121410	121220	1.10	-3.230e-01	2557053	0.000	88.90	30.48	59.50	0	-1.290e-01	11	12.29	0.358	4.08	FS	0.0600866041643	A:0	AC:0	ACT:0
chr7.fa:140476794-140476794_A_G	chr7.fa:140476794-140476794_A_G			0.861	3218	55188	1278	1321			16	18	0	2	34	606	1358	24081	39	16			39.9412	38.468052	8	13	9	20	1294	2054	17	31	16	31	0.0123648	0.015093			chr7.fa	chr7									chr7.fa:140476794-140476794_A_G	chr7.fa_140476794-140476794_A_G							Tat															COLUMN NOT FOUND	BRAF	COLUMN NOT FOUND	BRAF													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_140476794-140476794_A_G	COLUMN NOT FOUND	538Y>H	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS5863.1		2301		767																			COLUMN NOT FOUND	BRAF	COLUMN NOT FOUND	chr7.fa:140476794-140476794_A_G	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Protein Kinases, catalytic domain (463-715); Protein kinase domain (457-713)	COLUMN NOT FOUND	-																	This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. 	"This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. "							J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300	"J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300"							Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885	"Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885"																																																												BRAF		confirmed		A, REa		Melanoma, malignant, somatic;Colorectal cancer, somatic;Adenocarcinoma of lung, somatic;Nonsmall cell lung cancer, somatic;Cardiofaciocutaneous syndrome;Noonan syndrome 7;LEOPARD syndrome 3		;;211980;;115150;613706;613707																																																																																																																																																															COLUMN NOT FOUND	OK - 2 hits no mut	COLUMN NOT FOUND	GTGATNCAAGC	COLUMN NOT FOUND	TATAAGTTTGATCATCTCAAATTTGGTCTCAATGATATGGAGATGGTGATACAAGCTGGAGCCCTCACACCACTGGGTAACAATAGCCAGTTGTGGCTTTG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TATAAGTTTGATCATCTCAAATTTGGTCTCAATGATATGGAGATGGTGATACAAGCTGGAGCCCTCACACCACTGGGTAACAATAGCCAGTTGTGGCTTTG'&Submit=submit","Run BLAT")																	chr7.fa:140476794-140476794_A_G	chr7_140476794-140476794_A_G							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GTGATNCAAGC	0.0123648	0.011931	0.00602115871408404	0.00581140088298408	1294	1341																					COLUMN NOT FOUND	 Protein Kinases, catalytic domain (463-715); Protein kinase domain (457-713)	COLUMN NOT FOUND	-																																									-	Melanoma, malignant, somatic;Colorectal cancer, somatic;Adenocarcinoma of lung, somatic;Nonsmall cell lung cancer, somatic;Cardiofaciocutaneous syndrome;Noonan syndrome 7;LEOPARD syndrome 3	-	;;211980;;115150;613706;613707					0	0.000000													2.125	36.875000	0.0123648	0.011931	1294	1341					195	200	COLUMN NOT FOUND	77	72	31	16	1.000000	1	6212	20	0	0	0.000000	0	1.054313	1	0.000000	0	-1.000000	-1	0	0	0.000000			0	1			1	0					0	0.010981	0	0.000000	0.0123647604327666	0.0087719298245614	0.987635239567233	0.991228070175439	0.0123647604327666	0.0087719298245614	40.4375	57											0.00602115871408404	0.00581140088298408																											17	33	0.47	0.39	0.5	0.1481							COLUMN NOT FOUND	BIAS		NOBIAS
	0.0105656	60	0	26.8333	12.6771	60	0	43	58	-101	0	1	SBS	0	0	-101	0.425743	113.162	1294	16	0.0123648	0.235294	0.386276	0.554901	39.9412	0.268333	0.126771	60	60	0	1	0	16	2.125	0.0123648	1294	113.162	1248	16	0.0128205	0.235294	0.386276	0.554901	39.9412	0.268333	0.126771	37.3451	39.2188	0	1	-1.8737	16	2.125	0.0128205	1248	0	ENSG00000157764	ENSG00000157764	CCDS5863.1																						
chr7.fa:140494209-140494209_G_A	chr7.fa:140494209-140494209_G_A			0.927	3498	65622	228	243			1163	1197	0	7	562	9981	22392	395875	35	16			39.8434	38.356262	142	235	139	232	1389	2231	250	418	228	377	0.164147	0.168983			chr7.fa	chr7									chr7.fa:140494209-140494209_G_A	chr7.fa_140494209-140494209_G_A							Cga									*	X					COLUMN NOT FOUND	BRAF	COLUMN NOT FOUND	BRAF													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr7_140494209-140494209_G_A	COLUMN NOT FOUND	347R>X	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsense		CCDS5863.1		2301		767																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. 	"This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. "							J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300	"J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300"							Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885	"Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885"																																																												BRAF		confirmed		A, REa		Melanoma, malignant, somatic;Colorectal cancer, somatic;Adenocarcinoma of lung, somatic;Nonsmall cell lung cancer, somatic;Cardiofaciocutaneous syndrome;Noonan syndrome 7;LEOPARD syndrome 3		;;211980;;115150;613706;613707																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGGTCNGAAGG	COLUMN NOT FOUND	GGATCGGTCTCGTTGCCCAAATTGATTTCGATGATCTTCATCTGCTGGTCGGAAGGGCTGTGGAATTGGAATGGATTTTGAAGGAGACGGACTGGTGAGAA	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GGATCGGTCTCGTTGCCCAAATTGATTTCGATGATCTTCATCTGCTGGTCGGAAGGGCTGTGGAATTGGAATGGATTTTGAAGGAGACGGACTGGTGAGAA'&Submit=submit","Run BLAT")																	chr7.fa:140494209-140494209_G_A	chr7_140494209-140494209_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsense	COLUMN NOT FOUND	TGGTCNGAAGG	0.162473	0.161714	0.0193857478073252	0.0189710602720594	1391	1447	226	234																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																									-	Melanoma, malignant, somatic;Colorectal cancer, somatic;Adenocarcinoma of lung, somatic;Nonsmall cell lung cancer, somatic;Cardiofaciocutaneous syndrome;Noonan syndrome 7;LEOPARD syndrome 3	-	;;211980;;115150;613706;613707					0	0.000000							2	3			226	234	2.46903	40.547009	0.162473	0.161714	1391	1447	95	98			278	277	COLUMN NOT FOUND	90	90	377	228	1.000000	1	7009	24	0	0	0.000000	0	1.073636	1.00356	0.000000	0	-1.000000	-1	35	26	0.092838	0.114035	2	2	1			1	0					0	0.152098	0	0.000000	0.16414686825054	0.109262589928058	0.83585313174946	0.890737410071942	0.16414686825054	0.109262589928058	3.04605263157895	4.5761316872428											0.0193857478073252	0.0189710602720594																											281	467	0.49	0.5	0.4525	0.4631							COLUMN NOT FOUND	BIAS		NOBIAS
	0.160663	60	0	28.1488	13.5144	60	0	49	52	-101	0	1	SBS	0	0	-101	0.485149	216.498	1389	228	0.164147	0.161206	0.472327	0.516997	39.8434	0.281488	0.135144	60	60	0	1.00356	0	226	2.46903	0.162473	1391	213.527	1313	211	0.160701	0.221769	0.469149	0.515584	39.8626	0.279234	0.13424	39.3958	40.1694	0	1.00382	-0.7736	210	2.48571	0.159817	1314	0	ENSG00000157764	ENSG00000157764	CCDS5863.1																						
chr10.fa:43604493-43604493_C_T	chr10.fa:43604493-43604493_C_T			0.937	2250	43558			741	758	0	3	169	177	428	8403	17066	332111	35	16			39.8738	38.766312	147	244	67	98	910	1463	189	309	169	277	0.185714	0.189337			chr10.fa	chr10									chr10.fa:43604493-43604493_C_T	chr10.fa_43604493-43604493_C_T							Cgg															COLUMN NOT FOUND	RET	COLUMN NOT FOUND	RET													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr10_43604493-43604493_C_T	COLUMN NOT FOUND	360R>W	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS7200.1		3345		1115																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. 	"This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. "							Curr Opin Oncol. 2009 Jan;21(1):5-10, J Clin Endocrinol Metab. 2008 Mar;93(3):682-7	"Curr Opin Oncol. 2009 Jan;21(1):5-10, J Clin Endocrinol Metab. 2008 Mar;93(3):682-7"							Vandetanib is a small molecule inhibitor of RET that has demonstrated clinical benefits in patients with medullary thyroid cancer and XL184 has shown similar promising results in clinical trials.  Some RET mutations, such as V804M confer resistance to vandetanib treatment	"Vandetanib is a small molecule inhibitor of RET that has demonstrated clinical benefits in patients with medullary thyroid cancer and XL184 has shown similar promising results in clinical trials.  Some RET mutations, such as V804M confer resistance to vandetanib treatment"	Clin Pharmacol Ther. 2012 Jan;91(1):71-80, J Clin Oncol. 2011 Jul 1;29(19):2660-6, Curr Opin Oncol. 2012 Feb 15, Endocr Relat Cancer. 2010 Nov 30;18(1):1-11	"Clin Pharmacol Ther. 2012 Jan;91(1):71-80, J Clin Oncol. 2011 Jul 1;29(19):2660-6, Curr Opin Oncol. 2012 Feb 15, Endocr Relat Cancer. 2010 Nov 30;18(1):1-11"																																																										RET		confirmed		A, REn, Fd, Ch, D		Multiple endocrine neoplasia IIA;Medullary thyroidcarcinoma;Multiple endocrine neoplasia IIB;Central hypoventilation syndrome, congenital;Pheochromocytoma;Renal agenesis;Hirschsprung disease, susceptibility to, 1		171400;155240;162300;209880;171300;191830;142623																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TCAACNGGAAC	COLUMN NOT FOUND	GCAGCTTGGTGGTCATTGTTGTGCCCCTACCTGCAGGGCTGGTTCTCAACCGGAACCTCTCCATCTCGGAGAACCGCACCATGCAGCTGGCGGTGCTGGTC	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GCAGCTTGGTGGTCATTGTTGTGCCCCTACCTGCAGGGCTGGTTCTCAACCGGAACCTCTCCATCTCGGAGAACCGCACCATGCAGCTGGCGGTGCTGGTC'&Submit=submit","Run BLAT")																	chr10.fa:43604493-43604493_C_T	chr10_43604493-43604493_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TCAACNGGAAC	0.185714	0.183369	0.025266578715766	0.0247645489332103	910	938	169	172																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																									-	Multiple endocrine neoplasia IIA;Medullary thyroidcarcinoma;Multiple endocrine neoplasia IIB;Central hypoventilation syndrome, congenital;Pheochromocytoma;Renal agenesis;Hirschsprung disease, susceptibility to, 1	-	171400;155240;162300;209880;171300;191830;142623					0	0.000000							2	3			169	172	2.53254	47.534885	0.185714	0.183369	910	938			199	243	243	244	COLUMN NOT FOUND	90	90	277	169	1.000000	1	4302	26	0	0	0.000000	0	1.089646	1.01869	0.000000	0	-1.000000	-1	19	14	0.068592	0.0828402	2	2	1			1	0					0	0.192915	0	0.000000	0.185714285714286	0.121232876712329	0.814285714285714	0.878767123287671	0.185714285714286	0.121232876712329	2.69230769230769	4.12429378531073											0.025266578715766	0.0247645489332103																											214	342	0.31	0.29									COLUMN NOT FOUND	BIAS		NOBIAS
	0.190222	60	0	26.3929	13.8868	60	0	62	39	-101	0	1	SBS	0	0	-101	0.613861	204.784	910	169	0.185714	4.85981	0.287142	0.339026	39.8738	0.263929	0.138868	60	60	0	1.01869	0	169	2.53254	0.185714	910	202.587	868	160	0.184332	4.87454	0.280655	0.333979	39.8683	0.26912	0.138317	42	42	0	1.01951	0	160	2.5625	0.184332	868	0	ENSG00000165731	ENSG00000165731	CCDS7200.1																						
chr11.fa:533838-533838_C_T	chr11.fa:533838-533838_C_T			0.88	3250	91382	0	1	1304	1352			27	41	66	1702	2676	68336	27	15			39.3529	37.671444	22	52	11	25	1331	2553	32	74	27	65	0.0202855	0.025460			chr11.fa	chr11									chr11.fa:533838-533838_C_T	chr11.fa_533838-533838_C_T							cGc															COLUMN NOT FOUND	HRAS	COLUMN NOT FOUND	HRAS													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr11_533838-533838_C_T	COLUMN NOT FOUND	73R>H	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		NM_176795		513		171																			COLUMN NOT FOUND	HRAS	COLUMN NOT FOUND	chr11.fa:533838-533838_C_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 GTPase SAR1 and related small G proteins [General function prediction only] (1-147); Ras GTPase family containing H-Ras,N-Ras and K-Ras4A/4B (3-150)	COLUMN NOT FOUND	-																	This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. 	"This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. "															HRAS mutations are associated with the development of cutaneous squamous cell carcinomas in patients treated with the BRAF inhibitor, vemurafenib.  Farnesyltransferase inhibitors block the post-translational modification of RAS proteins and are being tested clinically	"HRAS mutations are associated with the development of cutaneous squamous cell carcinomas in patients treated with the BRAF inhibitor, vemurafenib.  Farnesyltransferase inhibitors block the post-translational modification of RAS proteins and are being tested clinically"	N Engl J Med. 2012 Jan 19;366(3):207-15, Expert Opin Investig Drugs. 2003 Jun;12(6):943-54	"N Engl J Med. 2012 Jan 19;366(3):207-15, Expert Opin Investig Drugs. 2003 Jun;12(6):943-54"																																																										HRAS		confirmed		S		Bladder cancer, somatic;Costello syndrome;Thyroid carcinoma, follicular, somatic;Congenital myopathy with excess of muscle spindles;Nevus sebaceous, somatic;Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic		109800;218040;188470;218040;162900;163200																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	CGGTGNGCATG	COLUMN NOT FOUND	AAGACTTGGTGTTGTTGATGGCAAACACACACAGGAAGCCCTCCCCGGTGCGCATGTACTGGTCCCGCATGGCGCTGTACTCCTCCTGGCCGGCGGTATCC	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AAGACTTGGTGTTGTTGATGGCAAACACACACAGGAAGCCCTCCCCGGTGCGCATGTACTGGTCCCGCATGGCGCTGTACTCCTCCTGGCCGGCGGTATCC'&Submit=submit","Run BLAT")																	chr11.fa:533838-533838_C_T	chr11_533838-533838_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CGGTGNGCATG	0.0202855	0.019369	0.00757372733634666	0.00723482532406378	1331	1394																					COLUMN NOT FOUND	 GTPase SAR1 and related small G proteins [General function prediction only] (1-147); Ras GTPase family containing H-Ras,N-Ras and K-Ras4A/4B (3-150)	COLUMN NOT FOUND	-																																									-	Bladder cancer, somatic;Costello syndrome;Thyroid carcinoma, follicular, somatic;Congenital myopathy with excess of muscle spindles;Nevus sebaceous, somatic;Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	-	109800;218040;188470;218040;162900;163200					0	0.000000													2.44444	61.333332	0.0202855	0.019369	1331	1394							COLUMN NOT FOUND	88	88	65	27	1.000000	1	12128	46	0	0	0.000000	0	1.082690	1	0.000000	0	-1.000000	-1	0	0	0.000000			0	2	2	1	1	0					0	0.018625	0	0.000000	0.0202854996243426	0.0160658307210031	0.979714500375657	0.983934169278997	0.0202854996243426	0.0160658307210031	24.6481481481481	31.1219512195122											0.00757372733634666	0.00723482532406378																											33	77	0.33	0.32	0.0401	0.0014							COLUMN NOT FOUND	BIAS		NOBIAS
	0.0203077	60	0	19.3659	14.0961	60	0	61	40	-101	0	1	SBS	0	0	-101	0.60396	131.132	1331	27	0.0202855	1.73205	0.26843	0.398237	39.3529	0.193659	0.140961	60	60	0	1	0	27	2.44444	0.0202855	1331	131.132	1254	27	0.0215311	1.73205	0.26843	0.398237	39.3529	0.193659	0.140961	42	42	0	1	0	27	2.44444	0.0215311	1254	0	ENSG00000174775	ENSG00000174775	NM_176795																						
chr11.fa:108106541-108106541_T_A	chr11.fa:108106541-108106541_T_A			0.901	1616	22188			0	2			653	664	32	562	1276	22148	39	16			39.875	38.120483			11	17	665	960	16	21	12	18	0.0180451	0.018750			chr11.fa	chr11									chr11.fa:108106541-108106541_T_A	chr11.fa_108106541-108106541_T_A							aTa															COLUMN NOT FOUND	ATM	COLUMN NOT FOUND	ATM													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr11_108106541-108106541_T_A	COLUMN NOT FOUND	159I>K	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS31669.1		9171		3057																			COLUMN NOT FOUND	ATM	COLUMN NOT FOUND	chr11.fa:108106541-108106541_T_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Telomere-length maintenance and DNA damage repair (7-165)	COLUMN NOT FOUND	-																	The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. 	"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. "					Lower ATM expression is correlated with poor outcome in laryngeal, gastric and colorectal cancer patients	"Lower ATM expression is correlated with poor outcome in laryngeal, gastric and colorectal cancer patients"	Ann Oncol. 2011 May;22(5):1088-93, Mutat Res. 2008 Feb 1;638(1-2):17-25; Clin Cancer Res. 2006 Mar 1;12(5):1494-500	"Ann Oncol. 2011 May;22(5):1088-93, Mutat Res. 2008 Feb 1;638(1-2):17-25; Clin Cancer Res. 2006 Mar 1;12(5):1494-500"							Suppression of ATM sensitizes tumors to DNA-damaging chemotherapy in the absence of p53 mutations and has a protective effect when functional p53 is present in a mouse model.  Deficiencies in ATM lead to an increased sensitivity to gemcitabine in vitro.  The colorectal cell line SW1222, which is deficient in p53 and mutated in ATM is very sensitive to radiation.  Aberrant methylation of the ATM promoter correlates with increased radiosensitvity in the colorectal cancer cell line HCT-116.  Treatment of an ATM mutant lymphoma xenograft model with the PARP inhibitor olaparib leads to reduced tumor load and increased survival 	"Suppression of ATM sensitizes tumors to DNA-damaging chemotherapy in the absence of p53 mutations and has a protective effect when functional p53 is present in a mouse model.  Deficiencies in ATM lead to an increased sensitivity to gemcitabine in vitro.  The colorectal cell line SW1222, which is deficient in p53 and mutated in ATM is very sensitive to radiation.  Aberrant methylation of the ATM promoter correlates with increased radiosensitvity in the colorectal cancer cell line HCT-116.  Treatment of an ATM mutant lymphoma xenograft model with the PARP inhibitor olaparib leads to reduced tumor load and increased survival "	Genes Dev. 2009 Aug 15;23(16):1895-909,Cancer Res. 2008 Oct 1;68(19):7947-55, Acta Oncol. 2007;46(5):628-38, Oncogene. 2002 May 30;21(24):3864-71, Blood. 2010 Nov 25;116(22):4578-87	"Genes Dev. 2009 Aug 15;23(16):1895-909,Cancer Res. 2008 Oct 1;68(19):7947-55, Acta Oncol. 2007;46(5):628-38, Oncogene. 2002 May 30;21(24):3864-71, Blood. 2010 Nov 25;116(22):4578-87"																																																										ATM		confirmed		Fd, C, M		Ataxia-telangiectasia;Lymphoma, B-cell non-Hodgkin,somatic;Breast cancer, susceptibility to;Lymphoma, mantle cell;T-cell prolymphocytic leukemia, somatic		208900;;114480;;																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	TGAAANATCTC	COLUMN NOT FOUND	CAACATACTACTCAAAGACATTCTTTCTGTGAGAAAATACTGGTGTGAAATATCTCAGCAACAGTGGTTAGGTATGTTTTGAAGGTTGTTGTTTGTGAATT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CAACATACTACTCAAAGACATTCTTTCTGTGAGAAAATACTGGTGTGAAATATCTCAGCAACAGTGGTTAGGTATGTTTTGAAGGTTGTTGTTTGTGAATT'&Submit=submit","Run BLAT")																	chr11.fa:108106541-108106541_T_A	chr11_108106541-108106541_T_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TGAAANATCTC	0.0180451	0.017699	0.0101174441819582	0.00992520002952191	665	678																					COLUMN NOT FOUND	 Telomere-length maintenance and DNA damage repair (7-165)	COLUMN NOT FOUND	-																																									-	Ataxia-telangiectasia;Lymphoma, B-cell non-Hodgkin,somatic;Breast cancer, susceptibility to;Lymphoma, mantle cell;T-cell prolymphocytic leukemia, somatic	-	208900;;114480;;					0	0.000000													2.66667	46.333332	0.0180451	0.017699	665	678	49	60					COLUMN NOT FOUND	76	76	18	12	1.000000	1	2804	34	0	0	0.000000	0	1.051635	1	0.000000	0	-1.000000	-1	0	0	0.000000			0	2	2	1			1	0			0	0.025329	0	0.000000	0.0180451127819549	0.0125260960334029	0.981954887218045	0.987473903966597	0.0180451127819549	0.0125260960334029	27.7083333333333	39.9166666666667											0.0101174441819582	0.00992520002952191																											16	22	0.31	0.23	0.1051	0.0085					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.019802	60	0	27.9375	13.4089	60	0	35	66	-101	0	1	SBS	0	0	-101	0.346535	102.277	665	12	0.0180451	1.29904	0.215144	0.409856	39.875	0.279375	0.134089	60	60	0	1	0	12	2.66667	0.0180451	665	102.277	637	12	0.0188383	1.29904	0.215144	0.409856	39.875	0.279375	0.134089	41.9242	42	0	1	-0.0758	12	2.66667	0.0188383	637	0	ENSG00000149311	ENSG00000149311	CCDS31669.1																						
chr12.fa:25398284-25398284_C_T	chr12.fa:25398284-25398284_C_T			0.837	1966	28707	2	1	770	790			7	9	22	286	876	11350	39	15			39.8182	38.087250	4	5	7	10	779	1176	11	15	7	10	0.00898588	0.008503			chr12.fa	chr12									chr12.fa:25398284-25398284_C_T	chr12.fa_25398284-25398284_C_T							gGt															COLUMN NOT FOUND	KRAS	COLUMN NOT FOUND	KRAS													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr12_25398284-25398284_C_T	COLUMN NOT FOUND	12G>D	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		NM_033360		570		190																			COLUMN NOT FOUND	KRAS	COLUMN NOT FOUND	chr12.fa:25398284-25398284_C_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Ras GTPase family containing H-Ras,N-Ras and K-Ras4A/4B (3-164); Ras-like protein (1-189)	COLUMN NOT FOUND	-																	This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. 	"This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. "																																																																												KRAS		confirmed		REa, A, Fd		Lung cancer, somatic;Bladder cancer, somatic;Pancreatic carcinoma, somatic;Gastric cancer, somatic;Leukemia, acute myelogenous;Noonan syndrome 3;Cardiofaciocutaneous syndrome 2;Breast cancer, somatic;SFM syndrome, somatic mosaic		211980;109800;260350;137215;;609942;615278;114480;163200																																																																																																																																																															COLUMN NOT FOUND	OK - 2 hits no mut	COLUMN NOT FOUND	CGCCANCAGCT	COLUMN NOT FOUND	CAAAATGATTCTGAATTAGCTGTATCGTCAAGGCACTCTTGCCTACGCCACCAGCTCCAACTACCACAAGTTTATATTCAGTCATTTTCAGCAGGCCTTAT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CAAAATGATTCTGAATTAGCTGTATCGTCAAGGCACTCTTGCCTACGCCACCAGCTCCAACTACCACAAGTTTATATTCAGTCATTTTCAGCAGGCCTTAT'&Submit=submit","Run BLAT")																	chr12.fa:25398284-25398284_C_T	chr12_25398284-25398284_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CGCCANCAGCT	0.00898588	0.008750	0.00662685632721925	0.00645366925670971	779	800																					COLUMN NOT FOUND	 Ras GTPase family containing H-Ras,N-Ras and K-Ras4A/4B (3-164); Ras-like protein (1-189)	COLUMN NOT FOUND	-																																									-	Lung cancer, somatic;Bladder cancer, somatic;Pancreatic carcinoma, somatic;Gastric cancer, somatic;Leukemia, acute myelogenous;Noonan syndrome 3;Cardiofaciocutaneous syndrome 2;Breast cancer, somatic;SFM syndrome, somatic mosaic	-	211980;109800;260350;137215;;609942;615278;114480;163200					0	0.000000							3	2					3.14286	40.285713	0.00898588	0.008750	779	800	78	80					COLUMN NOT FOUND	58	58	10	7	1.000000	1	3116	12	0	0	0.000000	0	1.140940	1.09091	0.000000	0	-1.000000	-1	0	0	0.000000	0	2	2	1	1	2	2	0					0	0.009963	0	0.000000	0.00900900900900901	0.00765957446808511	0.990990990990991	0.992340425531915	0.00900900900900901	0.00765957446808511	55.5	65.2777777777778											0.00662685632721925	0.00645366925670971																											11	15	0.36	0.33	0.2744	0.1509							COLUMN NOT FOUND	BIAS		NOBIAS
	0.0111902	60	0	31.75	13.1685	60	0	43	58	-101	0	1	SBS	0	0	-101	0.425743	82.7996	779	7	0.00898588	0.721569	0.236167	0.491105	39.8182	0.3175	0.131685	60	60	0	1.09091	0	7	3.14286	0.00898588	779	82.7996	749	7	0.00934579	0.721569	0.236167	0.491105	39.8182	0.3175	0.131685	40.5244	39.6966	0	1.09091	0.8278	7	3.14286	0.00934579	749	0	ENSG00000133703	ENSG00000133703	NM_033360	2	1.647e-05	121404	101204	-1.069e+00	-2.890e-01	1462089	1.255	58.36	41.60	59.26	0	0.290	28	6.30	0.184	0.422	QD	0.0452045351707	C:1	CC:0	CCA:0
chr12.fa:58143289-58143289_T_C	chr12.fa:58143289-58143289_T_C			0.941	2144	32797	0	1	209	220			650	663	490	7343	19460	290631	36	14			39.7143	38.005886	96	141	149	210	858	1256	221	321	209	300	0.24359	0.238853			chr12.fa	chr12									chr12.fa:58143289-58143289_T_C	chr12.fa_58143289-58143289_T_C							-													2	5	COLUMN NOT FOUND	CDK4	COLUMN NOT FOUND	CDK4													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr12_58143289-58143289_T_C	COLUMN NOT FOUND	633-2A>G	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Splice site acceptor		CCDS8953.1		912		304																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																		The protein encoded by this gene is a member of the Ser/Thr protein kinase family.  It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). 	"The protein encoded by this gene is a member of the Ser/Thr protein kinase family.  It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). "															PD-0332991 is a CDK4/6 inhibitor that reduces proliferation of ovarian cancer cells in vitro and is most effective in Rb-proficient lines with low p16 expression.  This compound has also been shown to be highly effective in suppressing the growth of xenograft tumors in a GBM model, particularly in combination with radiation.  Mantel cell lymphoma cells are sensitive to CDK4 inhibition.	"PD-0332991 is a CDK4/6 inhibitor that reduces proliferation of ovarian cancer cells in vitro and is most effective in Rb-proficient lines with low p16 expression.  This compound has also been shown to be highly effective in suppressing the growth of xenograft tumors in a GBM model, particularly in combination with radiation.  Mantel cell lymphoma cells are sensitive to CDK4 inhibition."	Clin Cancer Res. 2011 Mar 15;17(6):1591-602, Cancer Res. 2010 Apr 15;70(8):3228-38, Blood. 2006 Sep 1;108(5):1744-50	"Clin Cancer Res. 2011 Mar 15;17(6):1591-602, Cancer Res. 2010 Apr 15;70(8):3228-38, Blood. 2006 Sep 1;108(5):1744-50"			Growth inhibitory effects of PD-0332991 in a panel of ovarian cancer cell lines##Sensitive lines have an IC50 < 1 umol/L, Increased survival in a GBM mouse model treated with the CDK4 inhibitor PD-0332991 and radiation therapy (RT)  	"Growth inhibitory effects of PD-0332991 in a panel of ovarian cancer cell lines##Sensitive lines have an IC50 < 1 umol/L, Increased survival in a GBM mouse model treated with the CDK4 inhibitor PD-0332991 and radiation therapy (RT)  "																																																						CDK4		confirmed		A		Melanoma, cutaneous malignant, 3		609048														-																																																																																																																																																	COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	AGGCCNAAGGT	COLUMN NOT FOUND	AAAGATTTTGCCCAACTGGTCGGCTTCAGAGTTTCCACAGAAGAGAGGCCTAAGGTGAGAAGGGATATAAGGTAGCAGTCATTTTCAAAGATATCTTAGTT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AAAGATTTTGCCCAACTGGTCGGCTTCAGAGTTTCCACAGAAGAGAGGCCTAAGGTGAGAAGGGATATAAGGTAGCAGTCATTTTCAAAGATATCTTAGTT'&Submit=submit","Run BLAT")																	chr12.fa:58143289-58143289_T_C	chr12_58143289-58143289_T_C					2	5	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Splice site acceptor	COLUMN NOT FOUND	AGGCCNAAGGT	0.242142	0.245198	0.0286476160479533	0.0283438775736865	859	885	208	217																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																									-	Melanoma, cutaneous malignant, 3	-	609048					0	0.000000					0	1			0	1	208	217	2.34615	33.359447	0.242142	0.245198	859	885							COLUMN NOT FOUND	89	89	300	209	1.000000	1	3278	12	0	0	0.000000	0	1.063162	1.00816	0.000000	0	-1.000000	-1	27	17	0.090000	0.0813397	0	0	1			1	0					0	0.223892	0	0.000000	0.243589743589744	0.175298804780877	0.756410256410256	0.824701195219123	0.243589743589744	0.175298804780877	2.05263157894737	2.85227272727273											0.0286476160479533	0.0283438775736865																											245	351	0.39	0.4	4e-04	1e-04							COLUMN NOT FOUND	BIAS		NOBIAS
	0.228545	60	0	26.5261	13.7988	60	0	42	59	-101	0	1	SBS	0	0	-101	0.415842	212.357	858	209	0.24359	3.1274	0.368509	0.415165	39.7143	0.265261	0.137988	60	60	0	1.00816	0	208	2.34615	0.242142	859	211.196	805	203	0.252174	2.84956	0.37633	0.42367	39.7125	0.255376	0.140972	42	42	0	1.00417	0	203	2.36453	0.252174	805	0	ENSG00000135446	ENSG00000135446	CCDS8953.1																						
chr15.fa:66727451-66727451_A_C	chr15.fa:66727451-66727451_A_C			0.924	2580	48236	790	812	250	261	0	2	0	2	600	10967	23788	433157	35	2			39.6467	38.434517	165	277	133	203	1040	1688	256	416	250	409	0.240385	0.242299			chr15.fa	chr15									chr15.fa:66727451-66727451_A_C	chr15.fa_66727451-66727451_A_C							cAg															COLUMN NOT FOUND	MAP2K1	COLUMN NOT FOUND	MAP2K1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr15_66727451-66727451_A_C	COLUMN NOT FOUND	56Q>P	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS10216.1		1182		394																			COLUMN NOT FOUND	MAP2K1	COLUMN NOT FOUND	chr15.fa:66727451-66727451_A_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	-	COLUMN NOT FOUND	 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 (62-392); Serine/Threonine protein kinases, catalytic domain (68-361)																	The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase.  This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. 	"The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase.  This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. "															The MAP2K1 inhibitor, AZD6244 has been shown to result in stable disease in a variety of advanced cancers in phase I trials and several other inhibitors are also being tested in cancer patients.  The MEK (MAP2K1) inhibitor, PD184352 inhibits colon xenograft tumor growth.  Mutations in MAP2K1 can lead to acquired resistance in patients treated with MEK inhibitors.	"The MAP2K1 inhibitor, AZD6244 has been shown to result in stable disease in a variety of advanced cancers in phase I trials and several other inhibitors are also being tested in cancer patients.  The MEK (MAP2K1) inhibitor, PD184352 inhibits colon xenograft tumor growth.  Mutations in MAP2K1 can lead to acquired resistance in patients treated with MEK inhibitors."	J Clin Oncol. 2008 May 1;26(13):2139-46, Ann Med. 2006;38(3):200-11, Nat Med. 1999 Jul;5(7):810-6, Cancer Res. 2011 Aug 15;71(16):5535-45	"J Clin Oncol. 2008 May 1;26(13):2139-46, Ann Med. 2006;38(3):200-11, Nat Med. 1999 Jul;5(7):810-6, Cancer Res. 2011 Aug 15;71(16):5535-45"			Mutant MAP2K1 (MEK) cells are less sensitive to inhibition by the MEK inhibitor, RO4987655##Change in size of tumor in patients treated with the inhibitor,  AZD6244	"Mutant MAP2K1 (MEK) cells are less sensitive to inhibition by the MEK inhibitor, RO4987655##Change in size of tumor in patients treated with the inhibitor,  AZD6244"																																																						MAP2K1		confirmed		R, REa, A		Cardiofaciocutaneous syndrome 3		615279																																																																																																																																																															COLUMN NOT FOUND	OK - 2 hits no mut	COLUMN NOT FOUND	TACCCNGAAGC	COLUMN NOT FOUND	GCTAGAGCTTGATGAGCAGCAGCGAAAGCGCCTTGAGGCCTTTCTTACCCAGAAGCAGAAGGTGGGAGAACTGAAGGATGACGACTTTGAGAAGATCAGTG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='GCTAGAGCTTGATGAGCAGCAGCGAAAGCGCCTTGAGGCCTTTCTTACCCAGAAGCAGAAGGTGGGAGAACTGAAGGATGACGACTTTGAGAAGATCAGTG'&Submit=submit","Run BLAT")																	chr15.fa:66727451-66727451_A_C	chr15_66727451-66727451_A_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TACCCNGAAGC	0.240385	0.238626	0.0259710562215972	0.0254569285874458	1040	1077	250	257																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 (62-392); Serine/Threonine protein kinases, catalytic domain (68-361)																																									-	Cardiofaciocutaneous syndrome 3	-	615279					0	0.000000									0	1	250	257	2.4	40.972763	0.240385	0.238626	1040	1077	97	99			258	271	COLUMN NOT FOUND	91	91	409	250	1.000000	1	4442	14	0	0	0.000000	0	1.067879	1.01	0.000000	0	-1.000000	-1	38	23	0.092910	0.092	0	0	1			1	0					0	0.227361	0	0.000000	0.240384615384615	0.154988123515439	0.759615384615385	0.845011876484561	0.240384615384615	0.154988123515439	2.08	3.22605363984674											0.0259710562215972	0.0254569285874458																											298	480	0.45	0.42	0.0362	4e-04							COLUMN NOT FOUND	BIAS		NOBIAS
	0.232558	60	0	25.9414	14.2788	60	0	52	49	-101	0	1	SBS	0	0	-101	0.514851	219.066	1040	250	0.240385	1.69787	0.424979	0.467638	39.6467	0.259414	0.142788	60	60	0	1.01	0	250	2.4	0.240385	1040	217.307	984	239	0.242886	1.76681	0.421042	0.464672	39.65	0.256797	0.147209	34.2583	33.7275	0	1.01071	0.5308	239	2.3431	0.242886	984	0	ENSG00000169032	ENSG00000169032	CCDS10216.1																						
chr15.fa:66729147-66729147_C_T	chr15.fa:66729147-66729147_C_T			0.928	3134	70704	0	1	935	950			328	340	824	18793	32828	744018	33	15			39.8398	38.722702	209	348	202	334	1263	2184	345	612	328	561	0.259699	0.256868			chr15.fa	chr15									chr15.fa:66729147-66729147_C_T	chr15.fa_66729147-66729147_C_T							Cat															COLUMN NOT FOUND	MAP2K1	COLUMN NOT FOUND	MAP2K1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr15_66729147-66729147_C_T	COLUMN NOT FOUND	119H>Y	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS10216.1		1182		394																			COLUMN NOT FOUND	MAP2K1	COLUMN NOT FOUND	chr15.fa:66729147-66729147_C_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 (62-392); Serine/Threonine protein kinases, catalytic domain (68-361)	COLUMN NOT FOUND	-																	The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase.  This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. 	"The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase.  This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. "															The MAP2K1 inhibitor, AZD6244 has been shown to result in stable disease in a variety of advanced cancers in phase I trials and several other inhibitors are also being tested in cancer patients.  The MEK (MAP2K1) inhibitor, PD184352 inhibits colon xenograft tumor growth.  Mutations in MAP2K1 can lead to acquired resistance in patients treated with MEK inhibitors.	"The MAP2K1 inhibitor, AZD6244 has been shown to result in stable disease in a variety of advanced cancers in phase I trials and several other inhibitors are also being tested in cancer patients.  The MEK (MAP2K1) inhibitor, PD184352 inhibits colon xenograft tumor growth.  Mutations in MAP2K1 can lead to acquired resistance in patients treated with MEK inhibitors."	J Clin Oncol. 2008 May 1;26(13):2139-46, Ann Med. 2006;38(3):200-11, Nat Med. 1999 Jul;5(7):810-6, Cancer Res. 2011 Aug 15;71(16):5535-45	"J Clin Oncol. 2008 May 1;26(13):2139-46, Ann Med. 2006;38(3):200-11, Nat Med. 1999 Jul;5(7):810-6, Cancer Res. 2011 Aug 15;71(16):5535-45"			Mutant MAP2K1 (MEK) cells are less sensitive to inhibition by the MEK inhibitor, RO4987655##Change in size of tumor in patients treated with the inhibitor,  AZD6244	"Mutant MAP2K1 (MEK) cells are less sensitive to inhibition by the MEK inhibitor, RO4987655##Change in size of tumor in patients treated with the inhibitor,  AZD6244"																																																						MAP2K1		confirmed		R, REa, A		Cardiofaciocutaneous syndrome 3		615279																																																																																																																																																															COLUMN NOT FOUND	OK - 2 hits no mut	COLUMN NOT FOUND	TTCTGNATGAG	COLUMN NOT FOUND	AGATCAAACCCGCAATCCGGAACCAGATCATAAGGGAGCTGCAGGTTCTGCATGAGTGCAACTCTCCGTACATCGTGGGCTTCTATGGTGCGTTCTACAGC	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AGATCAAACCCGCAATCCGGAACCAGATCATAAGGGAGCTGCAGGTTCTGCATGAGTGCAACTCTCCGTACATCGTGGGCTTCTATGGTGCGTTCTACAGC'&Submit=submit","Run BLAT")																	chr15.fa:66729147-66729147_C_T	chr15_66729147-66729147_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	TTCTGNATGAG	0.259699	0.257940	0.0241820866390182	0.0238655572416642	1263	1291	328	333																			COLUMN NOT FOUND	 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 (62-392); Serine/Threonine protein kinases, catalytic domain (68-361)	COLUMN NOT FOUND	-																																									-	Cardiofaciocutaneous syndrome 3	-	615279					0	0.000000									0	1	328	333	2.5122	55.141140	0.259699	0.257940	1263	1291							COLUMN NOT FOUND	91	91	561	328	1.000000	1	6440	52	0	0	0.000000	0	1.064276	1.00243	0.000000	0	-1.000000	-1	60	29	0.106952	0.0884146	0	0	1			1	0					0	0.265798	0	0.000000	0.259699129057799	0.155748969308291	0.740300870942201	0.844251030691709	0.259699129057799	0.155748969308291	1.92530487804878	3.21029411764706											0.0241820866390182	0.0238655572416642																											411	682			0.3837	0.3093							COLUMN NOT FOUND	BIAS		NOBIAS
	0.262923	60	0	27.3858	14.5774	60	0	53	48	-101	0	1	SBS	0	0	-101	0.524752	230.914	1263	328	0.259699	0.308456	0.472863	0.510106	39.8398	0.273858	0.145774	60	60	0	1.00243	0	328	2.5122	0.259699	1263	228.91	1185	312	0.263291	0.27036	0.473254	0.51144	39.8367	0.267862	0.146617	39.5149	38.6022	0	1.00255	0.9127	312	2.51282	0.263291	1185	0	ENSG00000169032	ENSG00000169032	CCDS10216.1																						
chr15.fa:66782085-66782085_A_G	chr15.fa:66782085-66782085_A_G			0.935	1678	21975	523	537			163	166			410	4937	16304	194461	35	2			39.7659	38.583530	97	134	108	158	686	1044	182	268	163	235	0.237609	0.225096			chr15.fa	chr15									chr15.fa:66782085-66782085_A_G	chr15.fa_66782085-66782085_A_G							gAt															COLUMN NOT FOUND	MAP2K1	COLUMN NOT FOUND	MAP2K1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr15_66782085-66782085_A_G	COLUMN NOT FOUND	351D>G	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS10216.1		1182		394																			COLUMN NOT FOUND	MAP2K1	COLUMN NOT FOUND	chr15.fa:66782085-66782085_A_G	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 (62-392); Serine/Threonine protein kinases, catalytic domain (68-361)	COLUMN NOT FOUND	-																	The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase.  This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. 	"The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase.  This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. "															The MAP2K1 inhibitor, AZD6244 has been shown to result in stable disease in a variety of advanced cancers in phase I trials and several other inhibitors are also being tested in cancer patients.  The MEK (MAP2K1) inhibitor, PD184352 inhibits colon xenograft tumor growth.  Mutations in MAP2K1 can lead to acquired resistance in patients treated with MEK inhibitors.	"The MAP2K1 inhibitor, AZD6244 has been shown to result in stable disease in a variety of advanced cancers in phase I trials and several other inhibitors are also being tested in cancer patients.  The MEK (MAP2K1) inhibitor, PD184352 inhibits colon xenograft tumor growth.  Mutations in MAP2K1 can lead to acquired resistance in patients treated with MEK inhibitors."	J Clin Oncol. 2008 May 1;26(13):2139-46, Ann Med. 2006;38(3):200-11, Nat Med. 1999 Jul;5(7):810-6, Cancer Res. 2011 Aug 15;71(16):5535-45	"J Clin Oncol. 2008 May 1;26(13):2139-46, Ann Med. 2006;38(3):200-11, Nat Med. 1999 Jul;5(7):810-6, Cancer Res. 2011 Aug 15;71(16):5535-45"			Mutant MAP2K1 (MEK) cells are less sensitive to inhibition by the MEK inhibitor, RO4987655##Change in size of tumor in patients treated with the inhibitor,  AZD6244	"Mutant MAP2K1 (MEK) cells are less sensitive to inhibition by the MEK inhibitor, RO4987655##Change in size of tumor in patients treated with the inhibitor,  AZD6244"																																																						MAP2K1		confirmed		R, REa, A		Cardiofaciocutaneous syndrome 3		615279																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	AGCAGNTTTGA	COLUMN NOT FOUND	CCTTGTCTTTCTTCCTTTAAGCTTAATAAAAAACCCCGCAGAGAGAGCAGATTTGAAGCAACTCATGGTGAGTCTATTTATTCCGGATTCTTACAGTACCT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CCTTGTCTTTCTTCCTTTAAGCTTAATAAAAAACCCCGCAGAGAGAGCAGATTTGAAGCAACTCATGGTGAGTCTATTTATTCCGGATTCTTACAGTACCT'&Submit=submit","Run BLAT")																	chr15.fa:66782085-66782085_A_G	chr15_66782085-66782085_A_G							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	AGCAGNTTTGA	0.237609	0.236131	0.0318503745917538	0.0313952734948156	686	703	163	166																			COLUMN NOT FOUND	 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 (62-392); Serine/Threonine protein kinases, catalytic domain (68-361)	COLUMN NOT FOUND	-																																									-	Cardiofaciocutaneous syndrome 3	-	615279					0	0.000000											163	166	2.51534	29.240963	0.237609	0.236131	686	703					244	291	COLUMN NOT FOUND	89	89	235	163	1.000000	1	6883	282	0	0	0.000000	0	1.068849	1.00976	0.000000	0	-1.000000	-1	12	8	0.051064	0.0490798	0	0	1			1	0					0	0.224664	0	0.000000	0.237609329446064	0.159003831417625	0.762390670553936	0.840996168582375	0.237609329446064	0.159003831417625	2.10429447852761	3.14457831325301											0.0318503745917538	0.0313952734948156																											205	292	0.47	0.46	0.2425	0.0891							COLUMN NOT FOUND	BIAS		NOBIAS
	0.244338	60	0	28.5667	12.3803	60	0	40	61	-101	0	1	SBS	0	0	-101	0.39604	202.801	686	163	0.237609	0.685066	0.446755	0.499586	39.7659	0.285667	0.123803	60	60	0	1.00976	0	163	2.51534	0.237609	686	202.049	671	160	0.23845	0.626194	0.448586	0.50191	39.7624	0.283333	0.123011	41.9928	41.9903	0	1.0099	0.0025	160	2.525	0.23845	671	0	ENSG00000169032	ENSG00000169032	CCDS10216.1																						
chr15.fa:88576232-88576232_G_C	chr15.fa:88576232-88576232_G_C			0.944	2166	41566	0	2	205	213	670	702	0	1	500	10282	19952	405752	38	14			39.904	38.628330	99	164	151	280	875	1507	226	410	205	369	0.234286	0.244857			chr15.fa	chr15									chr15.fa:88576232-88576232_G_C	chr15.fa_88576232-88576232_G_C							Ctg															COLUMN NOT FOUND	NTRK3	COLUMN NOT FOUND	NTRK3													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr15_88576232-88576232_G_C	COLUMN NOT FOUND	481L>V	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS10340.1		2478		826																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																neurotrophic tyrosine kinase, receptor, type 3	"neurotrophic tyrosine kinase, receptor, type 3"	This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. 	"This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. "															Lestaurtinib is an TRK inhibitor that has been effective in neuroblastoma models and is now in clinical trials and may be useful in the treatment of other tumors that overexpress TRK receptors, such as pancreatic and breast cancer	"Lestaurtinib is an TRK inhibitor that has been effective in neuroblastoma models and is now in clinical trials and may be useful in the treatment of other tumors that overexpress TRK receptors, such as pancreatic and breast cancer"																																																												NTRK3																																																																																																																																																																							COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GTGCANTGGGC	COLUMN NOT FOUND	CCCGGCATCCAGTGACGAGGGCGTGGTGATGCCGTGGTTGATGTGGTGCAGTGGGCTGGCTGAGTCCTCCTCACCACTGATGACAGCCACGGGACCTGCAC	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='CCCGGCATCCAGTGACGAGGGCGTGGTGATGCCGTGGTTGATGTGGTGCAGTGGGCTGGCTGAGTCCTCCTCACCACTGATGACAGCCACGGGACCTGCAC'&Submit=submit","Run BLAT")																	chr15.fa:88576232-88576232_G_C	chr15_88576232-88576232_G_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GTGCANTGGGC	0.234286	0.229847	0.0280645655587255	0.0272171711385669	875	918	205	211																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																																	0	0.000000											205	211	2.43902	47.592419	0.234286	0.229847	875	918							COLUMN NOT FOUND	89	89	369	205	1.000000	1	18482	720	0	0	0.000000	0	1.083682	1.016	0.000000	0	-1.000000	-1	19	12	0.051491	0.0585366	0	0	1			1	0					0	0.247366	0	0.000000	0.234285714285714	0.141622340425532	0.765714285714286	0.858377659574468	0.234285714285714	0.141622340425532	2.13414634146341	3.53051643192488											0.0280645655587255	0.0272171711385669																											250	444	0.4	0.37	6e-04	0							COLUMN NOT FOUND	BIAS		NOBIAS
	0.23084	60	0	24.7684	14.4043	60	0	65	36	-101	0	1	SBS	0	0	-101	0.643564	212.604	875	205	0.234286	2.97811	0.372445	0.419555	39.904	0.247684	0.144043	60	60	0	1.016	0	205	2.43902	0.234286	875	210.084	834	192	0.230216	3.05311	0.365492	0.414169	39.9195	0.247361	0.144092	42	42	0	1.01695	0	192	2.45833	0.230216	834	0	ENSG00000140538	ENSG00000140538	CCDS10340.1																						
chr17.fa:41246245-41246245_C_A	chr17.fa:41246245-41246245_C_A			0.939	2100	36312	231	245	625	640	0	2	0	2	544	9199	21640	362729	35	15			39.7794	38.621059	157	258	113	160	855	1292	238	380	231	363	0.270175	0.280960			chr17.fa	chr17									chr17.fa:41246245-41246245_C_A	chr17.fa_41246245-41246245_C_A							Gat															COLUMN NOT FOUND	BRCA1	COLUMN NOT FOUND	BRCA1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr17_41246245-41246245_C_A	COLUMN NOT FOUND	435D>Y	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS11456.2		5655		1885																			COLUMN NOT FOUND	BRCA1	COLUMN NOT FOUND	chr17.fa:41246245-41246245_C_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Serine-rich domain associated with BRCT (344-507)	COLUMN NOT FOUND	-															breast cancer 1, early onset	"breast cancer 1, early onset"	This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. 	"This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. "					Triple negative breast cancer patients with BRCA mutations have been shown to have a lower risk of relapse in some studies, but others have found no association between BRCA mutation status and prognosis in triple-negative cases	"Triple negative breast cancer patients with BRCA mutations have been shown to have a lower risk of relapse in some studies, but others have found no association between BRCA mutation status and prognosis in triple-negative cases"	Clin Cancer Res. 2011 Mar 1;17(5):1082-9, Breast Cancer Res Treat. 2011 Nov;130(1):145-53	"Clin Cancer Res. 2011 Mar 1;17(5):1082-9, Breast Cancer Res Treat. 2011 Nov;130(1):145-53"									Nature. 2005 Apr 14;434(7035):917-21; Curr Drug Targets. 2011 Jul 21, N Engl J Med. 2009 Jul 9;361(2):123-34	"Nature. 2005 Apr 14;434(7035):917-21; Curr Drug Targets. 2011 Jul 21, N Engl J Med. 2009 Jul 9;361(2):123-34"																																																										BRCA1		confirmed		Fd, REc		Breast-ovarian cancer, familial, 1;Pancreatic cancer,susceptibility to, 4		604370;614320																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	AGGATNACTGG	COLUMN NOT FOUND	TGATTTGGAGTGAACTCTTTCACTTTTACATATTAAAGCCTCATGAGGATCACTGGCCAGTAAGTCTATTTTCTCTGAAGAACCAGAATATTCATCTACCT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TGATTTGGAGTGAACTCTTTCACTTTTACATATTAAAGCCTCATGAGGATCACTGGCCAGTAAGTCTATTTTCTCTGAAGAACCAGAATATTCATCTACCT'&Submit=submit","Run BLAT")																	chr17.fa:41246245-41246245_C_A	chr17_41246245-41246245_C_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	AGGATNACTGG	0.268692	0.273341	0.0296959011546471	0.0292969780510731	856	889	230	243																			COLUMN NOT FOUND	 Serine-rich domain associated with BRCT (344-507)	COLUMN NOT FOUND	-																																									-	Breast-ovarian cancer, familial, 1;Pancreatic cancer,susceptibility to, 4	-	604370;614320					0	0.000000											230	243	2.34783	36.925926	0.268692	0.273341	856	889							COLUMN NOT FOUND	91	91	362	231	0.997245	1	2987	12	0	0	0.000000	0	1.064204	1.00368	0.000000	0	-1.000000	-1	24	18	0.066116	0.0779221	0	0	1					1	0			0	0.253332	0	0.000000	0.270175438596491	0.190217391304348	0.729824561403509	0.809782608695652	0.270175438596491	0.190217391304348	1.85064935064935	2.62857142857143											0.0296959011546471	0.0292969780510731																											270	418	0.42	0.38	0.0044	0							COLUMN NOT FOUND	BIAS		NOBIAS
	0.259048	60	0	24.1007	14.5959	60	0	37	64	-101	0	1	SBS	0	0	-101	0.366337	216.668	855	231	0.270175	2.47682	0.396329	0.440708	39.7794	0.241007	0.145959	60	60	0	1.00368	0	230	2.34783	0.268692	856	215.329	824	223	0.270631	2.49855	0.393759	0.438926	39.7899	0.236655	0.145617	41.9718	41.9468	0	1.00389	0.025	223	2.30493	0.270631	824	0	ENSG00000012048	ENSG00000012048	CCDS11456.2																						
chr17.fa:56435492-56435492_G_T	chr17.fa:56435492-56435492_G_T			0.941	2442	48915	0	4	0	2	775	804	242	257	572	12077	22764	477038	35	2			39.7972	38.402672	147	276	139	228	1017	1757	261	473	242	428	0.237955	0.243597			chr17.fa	chr17									chr17.fa:56435492-56435492_G_T	chr17.fa_56435492-56435492_G_T							Cac															COLUMN NOT FOUND	RNF43	COLUMN NOT FOUND	RNF43													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr17_56435492-56435492_G_T	COLUMN NOT FOUND	549H>N	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS11607.1		2352		784																			COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND																																																																																															RNF43																																																																																																																																																																							COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	GTAGTNGACAT	COLUMN NOT FOUND	ATGCCACTGGAACCGCTTTTTGTAGTGGTGGTGCCGGTGGCGGTGGTAGTGGACATGGCTGGAAACCTGGGTTTCCCCTGTGGGCACCACCGAGTCCAAGG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='ATGCCACTGGAACCGCTTTTTGTAGTGGTGGTGCCGGTGGCGGTGGTAGTGGACATGGCTGGAAACCTGGGTTTCCCCTGTGGGCACCACCGAGTCCAAGG'&Submit=submit","Run BLAT")																	chr17.fa:56435492-56435492_G_T	chr17_56435492-56435492_G_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	GTAGTNGACAT	0.237955	0.235239	0.0261717748929592	0.0254502107096514	1017	1067	242	251																			COLUMN NOT FOUND	-	COLUMN NOT FOUND	-																																																	0	0.000000							2	3			242	251	2.36364	46.211155	0.237955	0.235239	1017	1067			296	359			COLUMN NOT FOUND	90	89	428	242	1.000000	1	5141	12	0	0	0.000000	0	1.077121	1.0035	0.000000	0	-1.000000	-1	21	8	0.049065	0.0330578	2	2	1			1	0					0	0.246898	0	0.000000	0.23795476892822	0.146773272415762	0.76204523107178	0.853226727584238	0.23795476892822	0.146773272415762	2.10123966942149	3.40661478599222											0.0261717748929592	0.0254502107096514																											286	504	0.49	0.45	0.3395	0.0181					NOBIAS	BIAS	COLUMN NOT FOUND	BIAS		NOBIAS
	0.234234	60	0	27.0513	14.4233	60	0	61	40	-101	0	1	SBS	0	0	-101	0.60396	218.608	1017	242	0.237955	0.435143	0.464335	0.507693	39.7972	0.270513	0.144233	60	60	0	1.0035	0	242	2.36364	0.237955	1017	217.692	976	237	0.242828	0.707182	0.455125	0.498939	39.7809	0.266503	0.143428	41.995	42	0	1.00353	-0.005	237	2.38819	0.242828	976	0	ENSG00000108375	ENSG00000108375	CCDS11607.1																						
chr19.fa:50906813-50906813_T_C	chr19.fa:50906813-50906813_T_C			0.881	3190	84080			12	15			1260	1289	34	835	1358	33336	39	2			39.9412	37.924915	9	20	8	23	1272	2342	17	42	12	30	0.00943396	0.012810			chr19.fa	chr19									chr19.fa:50906813-50906813_T_C	chr19.fa_50906813-50906813_T_C							Ttc															COLUMN NOT FOUND	POLD1	COLUMN NOT FOUND	POLD1													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chr19_50906813-50906813_T_C	COLUMN NOT FOUND	401F>L	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS12795.1		3324		1108																			COLUMN NOT FOUND	POLD1	COLUMN NOT FOUND	chr19.fa:50906813-50906813_T_C	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 DEDDy 3'-5' exonuclease domain of eukaryotic DNA polymerase delta, a family-B DNA polymerase (304-517); DNA polymerase delta catalytic subunit (81-1100)	COLUMN NOT FOUND	-																																																																																														POLD1		confirmed		Psh, REa, A		Colorectal cancer, susceptibility to, 10;Mandibularhypoplasia, deafness, progeroid features, and lipodystrophy syndrome		612591;615381																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	AGAACNTCGAC	COLUMN NOT FOUND	TCATCCGTATCATGGACCCCGACGTGATCACCGGTTACAACATCCAGAACTTCGACCTTCCGTACCTCATCTCTCGGGCCCAGACCCTCAAGGTGAGGGCT	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='TCATCCGTATCATGGACCCCGACGTGATCACCGGTTACAACATCCAGAACTTCGACCTTCCGTACCTCATCTCTCGGGCCCAGACCCTCAAGGTGAGGGCT'&Submit=submit","Run BLAT")																	chr19.fa:50906813-50906813_T_C	chr19_50906813-50906813_T_C							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	AGAACNTCGAC	0.00943396	0.009969	0.00531252883096626	0.00539230540634581	1272	1304	12	13																			COLUMN NOT FOUND	 DEDDy 3'-5' exonuclease domain of eukaryotic DNA polymerase delta, a family-B DNA polymerase (304-517); DNA polymerase delta catalytic subunit (81-1100)	COLUMN NOT FOUND	-																																									-	Colorectal cancer, susceptibility to, 10;Mandibularhypoplasia, deafness, progeroid features, and lipodystrophy syndrome	-	612591;615381					0	0.000000											12	13	2.83333	62.384617	0.00943396	0.009969	1272	1304	93	95					COLUMN NOT FOUND	81	81	30	12	1.000000	1	11608	32	0	0	0.000000	0	1.098976	1	0.000000	0	-1.000000	-1	0	0	0.000000	0	2	2	1			1	0					0	0.009931	0	0.000000	0.00943396226415094	0.00640478223740393	0.990566037735849	0.993595217762596	0.00943396226415094	0.00640478223740393	53	78.0666666666667											0.00531252883096626	0.00539230540634581																											17	43			0.5	0.3804							COLUMN NOT FOUND	BIAS		NOBIAS
	0.0106583	60	0	25.2222	13.6341	60	0	57	44	-101	0	1	SBS	0	0	-101	0.564356	102.447	1272	12	0.00943396	0.203771	0.373233	0.567944	39.9412	0.252222	0.136341	60	60	0	1	0	12	2.83333	0.00943396	1272	102.447	1203	12	0.00997506	0.203771	0.373233	0.567944	39.9412	0.252222	0.136341	42	42	0	1	0	12	2.83333	0.00997506	1203	0	ENSG00000062822	ENSG00000062822	CCDS12795.1																						
chrX.fa:66765142-66765142_G_A	chrX.fa:66765142-66765142_G_A			0.891	2132	31271	165	172			711	768	0	2	398	5378	15788	214535	31	2			39.6683	38.112453	79	128	116	205	876	1579	165	273	165	277	0.188356	0.175427			chrX.fa	chrX									chrX.fa:66765142-66765142_G_A	chrX.fa_66765142-66765142_G_A							Gcc															COLUMN NOT FOUND	AR	COLUMN NOT FOUND	AR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chrX_66765142-66765142_G_A	COLUMN NOT FOUND	52A>T	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS14387.1		2763		921																			COLUMN NOT FOUND	AR	COLUMN NOT FOUND	chrX.fa:66765142-66765142_G_A	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Androgen receptor (6-449)	COLUMN NOT FOUND	-																	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	"The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. "					Low AR expression, prior to hormonal therapy, is associated with tumor progression.	"Low AR expression, prior to hormonal therapy, is associated with tumor progression."											Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	"Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16"																																																										AR		confirmed		S, Fd, REa, A		Androgen insensitivity;Spinal and bulbar muscularatrophy of Kennedy;Androgen insensitivity, partial, with or without breast cancer;Prostate cancer, susceptibility to;Hypospadias 1, X-linked		300068;313200;312300;176807;300633																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	CCGGCNCCAGT	COLUMN NOT FOUND	AGAACCCGGGCCCCAGGCACCCAGAGGCCGCGAGCGCAGCACCTCCCGGCGCCAGTTTGCTGCTGCTgcagcagcagcagcagcagcagcagcagcagcag	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='AGAACCCGGGCCCCAGGCACCCAGAGGCCGCGAGCGCAGCACCTCCCGGCGCCAGTTTGCTGCTGCTgcagcagcagcagcagcagcagcagcagcagcag'&Submit=submit","Run BLAT")																	chrX.fa:66765142-66765142_G_A	chrX_66765142-66765142_G_A							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	CCGGCNCCAGT	0.188356	0.177282	0.0258926609532255	0.0243887085597223	876	942	165	167																			COLUMN NOT FOUND	 Androgen receptor (6-449)	COLUMN NOT FOUND	-																																									-	Androgen insensitivity;Spinal and bulbar muscularatrophy of Kennedy;Androgen insensitivity, partial, with or without breast cancer;Prostate cancer, susceptibility to;Hypospadias 1, X-linked	-	300068;313200;312300;176807;300633					0	0.000000									0	1	165	167	2.41212	31.203592	0.188356	0.177282	876	942							COLUMN NOT FOUND	90	88	277	165	1.000000	1	8792	214	0	0	0.000000	0	1.148872	1.05528	0.000000	0	-1.000000	-1	12	5	0.043321	0.030303	0	0	2	2	1	1	0	0	49	49	0	0	0.171980	0	0.000000	0.188356164383562	0.109067850348763	0.811643835616438	0.890932149651237	0.188356164383562	0.109067850348763	2.65454545454545	4.5843023255814											0.0258926609532255	0.0243887085597223																											195	333	0.41	0.38	0.0049	0							COLUMN NOT FOUND	BIAS		NOBIAS
	0.186679	60	0	26.4266	13.0365	60	0	72	29	-17	0	1	SBS	0	0	-17	0.712871	202.784	876	165	0.188356	2.4373	0.378873	0.431383	39.6683	0.264266	0.130365	60	60	0	1.05528	0	165	2.41212	0.188356	876	200.835	827	157	0.189843	2.50599	0.373085	0.426916	39.6703	0.262816	0.133649	41.5554	41.3784	0	1.1027	0.177	157	2.35669	0.189843	827	49	ENSG00000169083	ENSG00000169083	CCDS14387.1	2	1.653e-05	120964	81279	-2.471e+00	-1.025e+00	1275714	0.000	49.83	22.27	60.00	0	0.262	692		0.501	4.76	MQ	.	G:0	GC:0	GCC:0
chrX.fa:66765905-66765905_C_T	chrX.fa:66765905-66765905_C_T			0.936	2306	57920	0	1	678	702	0	1	251	258	612	14616	24378	578795	35	14			39.8333	38.630116	159	271	147	249	929	1662	277	478	251	432	0.270183	0.259928			chrX.fa	chrX									chrX.fa:66765905-66765905_C_T	chrX.fa_66765905-66765905_C_T							aCt															COLUMN NOT FOUND	AR	COLUMN NOT FOUND	AR													0	0.000000					0	0.000000	0	0.000000							COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND	0	COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND		COLUMN NOT FOUND												0	0.000000	0	0.000000							COLUMN NOT FOUND	chrX_66765905-66765905_C_T	COLUMN NOT FOUND	306T>I	COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding		CCDS14387.1		2763		921																			COLUMN NOT FOUND	AR	COLUMN NOT FOUND	chrX.fa:66765905-66765905_C_T	COLUMN NOT FOUND	match	COLUMN NOT FOUND	 Androgen receptor (6-449)	COLUMN NOT FOUND	-																	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	"The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. "					Low AR expression, prior to hormonal therapy, is associated with tumor progression.	"Low AR expression, prior to hormonal therapy, is associated with tumor progression."											Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	"Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16"																																																										AR		confirmed		S, Fd, REa, A		Androgen insensitivity;Spinal and bulbar muscularatrophy of Kennedy;Androgen insensitivity, partial, with or without breast cancer;Prostate cancer, susceptibility to;Hypospadias 1, X-linked		300068;313200;312300;176807;300633																																																																																																																																																															COLUMN NOT FOUND	OK - 1 hit	COLUMN NOT FOUND	AGATANTGCTG	COLUMN NOT FOUND	ATGCAAAGGTTCTCTGCTAGACGACAGCGCAGGCAAGAGCACTGAAGATACTGCTGAGTATTCCCCTTTCAAGGGAGGTTACACCAAAGGGCTAGAAGGCG	COLUMN NOT FOUND	=hyperlink("http://genome.ucsc.edu/cgi-bin/hgBlat?org=Human&db=hg19&type=%22BLAT%27s%20guess%22&sort=%22query,score%22&output=hyperlink&userSeq='ATGCAAAGGTTCTCTGCTAGACGACAGCGCAGGCAAGAGCACTGAAGATACTGCTGAGTATTCCCCTTTCAAGGGAGGTTACACCAAAGGGCTAGAAGGCG'&Submit=submit","Run BLAT")																	chrX.fa:66765905-66765905_C_T	chrX_66765905-66765905_C_T							COLUMN NOT FOUND	Substitution	COLUMN NOT FOUND	Nonsynonymous coding	COLUMN NOT FOUND	AGATANTGCTG	0.270183	0.266112	0.0285551343636718	0.0279264541556409	929	962	251	256																			COLUMN NOT FOUND	 Androgen receptor (6-449)	COLUMN NOT FOUND	-																																									-	Androgen insensitivity;Spinal and bulbar muscularatrophy of Kennedy;Androgen insensitivity, partial, with or without breast cancer;Prostate cancer, susceptibility to;Hypospadias 1, X-linked	-	300068;313200;312300;176807;300633					0	0.000000											251	256	2.43825	56.050781	0.270183	0.266112	929	962	98	99	262	280			COLUMN NOT FOUND	91	91	432	251	1.000000	1	6036	20	0	0	0.000000	0	1.068211	1.01307	0.000000	0	-1.000000	-1	17	8	0.039352	0.0318725	0	0	1	1	2	2	1	1	0			0	0.252348	0	0.000000	0.270182992465016	0.155421686746988	0.729817007534984	0.844578313253012	0.270182992465016	0.155421686746988	1.85059760956175	3.21705426356589											0.0285551343636718	0.0279264541556409																											306	520			0.2648	0.1786							COLUMN NOT FOUND	BIAS		NOBIAS
	0.265395	60	0	24.0152	14.0403	60	0	52	49	-101	0	1	SBS	0	0	-101	0.514851	220.255	929	251	0.270183	0.621293	0.459105	0.501679	39.8333	0.240152	0.140403	60	60	0	1.01307	0	251	2.43825	0.270183	929	218.388	884	239	0.270362	0.644151	0.457352	0.500982	39.8472	0.238971	0.141966	42	42	0	1.01042	0	239	2.41004	0.270362	884	0	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
Changes Gained (In new file but not in old):
ChangeUID	IndexString	Score	Coverage	ACount	CCount	GCount	TCount	MutCount	SumQualityScore	MinQualityScore	MaxQualityScore	AverageQualityScore	Forward	Reverse	DistinctCoverage	DistinctTags	DistinctPairs	MutPct	MutType	Chrom	Start	End	BaseFrom	BaseTo	LookupKey	ENSG	GeneName	Transcript	TxBaseFrom	TxBaseTo	AminoStart	AminoEnd	AAFrom	AATo	Consequence	Exon Rank	Transcript GeneName	HUGO GeneName	Description	Deleted	SNP	NormalMutCount	NormalRawCoverage	NormalPhredCoverage	NormalEffectiveCoverage	NormalDistinctRawCoverage	NormalDistinctPhredCoverage	NormalDistinctEffectiveCoverage	GermlineNormMutPct	Germline?	TotalNormalMutCount	NormalDistinctMutPairs	ExcludeConsequence?	Silent?	NormMutPct	CosmicGene	CosmicTx	CosmicAAChange	CosmicEffect	CosmicID	DistMutPairsEORA	DistMutPairsEORB	NormalDistMutPairsEORA	NormalDistMutPairsEORB	DistMutPairsEORA+B	EORMutPct	NormalEORMutPct	Ignore	IgnoreB	AddlInfo	LookupKeyB	AAChange	ReportedMutation	ReportedConsequence	PGDX Transcript	PGDX CDS Length	PGDX Protein Length	LiftOver ID	Liftover hg18 Position	LiftOver hg19 position	sameLocation_Lookup	Changes_SameLocation	Changes_Adjacent	polyN:ChangeUID	PolyN_Dust	Sample Name	CDD: #Gene	CDD: Key	CDD: Size Check	CDD: Position of Mutation Within a Protein Domain	CDD: Position of Mutation Near to a Protein Domain	COSMIC: Key	COSMIC: Samples reported with the exact genomic change	COSMIC: Samples reported with a change in the same AA (Missense)	COSMIC: Samples reported with a nearby change	COSMIC: Samples reported with any mutation in this gene	COSMIC: Number of Exact Hits	PGDX Clinical: Gene_symbol	PGDX Clinical: Gene_name	PGDX Clinical: Gene_summary	PGDX Clinical: Gene_aliases	PGDX Clinical: Pathway	PGDX Clinical: Prognostic text	PGDX Clinical: Prognostic ref	PGDX Clinical: Prognostic fig	PGDX Clinical: Prognostic fig legend	PGDX Clinical: Prognostic fig ref	PGDX Clinical: Predictive/Therapeutic text	PGDX Clinical: Predictive/Therapeutic ref	PGDX Clinical: Predictive/Therapeutic fig	PGDX Clinical: Predictive/Therapeutic fig legend	PGDX Clinical: Predictive/Therapeutic fig ref	PGDX: Gene Lookup	PGDX: Biologically significant gene	PGDX: Clinically significant gene	PGDX: Chip Gene	CHASM: MUTID	CHASM: MUT	CHASM: CHASM BRCA	CHASM: PValue BRCA	CHASM: BHFDR BRCA	VEST: MUTID	VEST: MUT	VEST: VEST	VEST: PValue	VEST: BHFDR	PANTHER: Gene Symbol	PANTHER: Gene Identifier	PANTHER: Protein ID	PANTHER: SF ID	PANTHER: Family Name	PANTHER: Subfamily Name	PANTHER: Molecular function	PANTHER: Biological process	PANTHER: Cellular components	PANTHER: Protein class	PANTHER: Pathway	OMIM_gene_symbol	OMIM_status	OMIM_method	OMIM_diseases	OMIM_mim	VEP: ChangeUID	VEP: Position	VEP: Gene	VEP: Transcript	VEP: Consequence	VEP: cDNA Position	VEP: CDS Position	VEP: Protein Position	VEP: Strand	VEP: AAChange	VEP: Codon Change	VEP: HGVS Codon Change	VEP: HGVS AAChange	snpEff360: ChangeUID	snpEff360: GeneID	snpEff360: GeneName	snpEff360: Transcript	snpEff360: CodonFrom	snpEff360: CodonTo	snpEff360: codonStart	snpEff360: codonEnd	snpEff360: AAFrom	snpEff360: AATo	snpEff360: Consequence	snpEff360: Score	dbSNP: Sample	dbSNP: Other dbSNP hits	dbSNP: SNPLookup	dbSNP: Chrom	dbSNP: Start	dbSNP: End	dbSNP: Name	dbSNP: Strand	dbSNP: refUCSC	dbSNP: Observed	dbSNP: Class	dbSNP: Valid	dbSNP: AvHet	dbSNP: AvHetSE	dbSNP: Func	dbSNP: Weight	dbSNP: Exceptions	dbSNP: Submitters	dbSNP: AlleleFreqCount	dbSNP: Alleles	dbSNP: AlleleNs	dbSNP: AlleleFreqs	dbSNP: Bitfields	dbSNP: isCommon	dbSNP: isFlagged	dbSNP: isMultiple	ESP: Chrom	ESP: Start	ESP: End	ESP: ESPKey	ESP: dbsnp hit	ESP: European Allele Count	ESP: African Allele Count	ESP: Total Allele	ESP: MAF	ESP: Observed	ESP: European Genotype Count	ESP: African Genotype Count	ESP: Total Genotype Count	ESP: Average Sample Depth	ESP: GeneList	ESP: scorePhastCons	ESP: consScoreGERP	ESP: chimpAllele	ESP: ClinicalAssociation	ESP: EXOME_CHIP	ESP: GWAS_PUBMED	ESP: Accession	ESP: functionGVS	ESP: aminoAcidChange	ESP: proteinPosition	ESP: cDNAPosition	ESP: granthamScore	ESP: polyPhen	AutoBLATHuman	Seq window	BLAT sequence	BLAT URL	PGDX Norm: Count	PGDX Norm: rs	Report: Sample Name	Report: Alternate ID	Report: Tumor Type	Report: GeneName	Report: Description	Report: Transcript	Report: LookupKey	Report: CodonChange	Report: AAChange	Report: Exon Rank	Report: ReportedMutation	Report: ReportedConsequence	Report: Seq window	Report: SupermutantMutPct	Report: 95% Confidence Interval for % Mutant Reads	Report: SupermutantCov	Report: SupermutantCount	Report: Mutant Molecules per mL	Report: ENSG	Report: Pathway Analysis (GO Molecular Function)	Report: Pathway Analysis (GO Biological Process)	Report: Pathway Analysis (Additional Information)	Report: Samples with the Identical Somatic Mutation	Report: Somatic Mutations in the Same Amino Acid Residue	Report: Somatic Mutations in Nearby Amino Acid Residues	Report: Gene Somatically Mutated in the Following Cancers	Report: Position of Mutation Within a Protein Domain	Report: Position of Mutation Near to a Protein Domain	Report: CHASM Score	Report: PValue	Report: BHFDR	Report: refUCSC	Report: Observed	Report: Class	Report: Valid	Report: AvHet	Report: AvHetSE	Report: Func	Report: Weight	Report: Exceptions	Report: Submitters	Report: AlleleFreqCount	Report: Alleles	Report: AlleleNs	Report: AlleleFreqs	Report: VEST	Report: VEST(PValue)	Report: VEST(BHFDR)	Report: OMIM Diseases	Report: MIM#	Report: PGDX: Chip Gene	CleanDistinctPairs	CleanMutPct	OverlapsTumor	OverlapsNormal	IndelCount	NumAlleles	NumIndelAlleles	Supermutant	SupermutantAvg	SupermutantPct	SupermutantCov	CycleDist	Read1Dist	Read2Dist	MutReadDist	ProperPairs	ProperPairsPct	MMTumor	LQTumor	MMAvg	MutMMAvg	LQAvg	MutLQAvg	MaskedPairs	MaskedMutPct	PolyN	PolyNN	PolyNNN	PolyMut	Dust	RptMask	MutCountCov	SNP_Allele_Fraction_Normal	SNP_Allele_Fraction_Tumor	Ref_Allele_Fraction_Tumor	Observed_MAF	Calculated_MAF_Amplification	dbSNP:ChangeUID	ESPKEY	ESP:ESPLookupID	PGDX Norm: ChangeUID	CI ChangeUID	95% Confidence Interval	CUID	HematopoiesisAssociations	SMChangeUID	SMExcludeCUID	IChangeUID	OlapIndels	ExcludeIndel	HChangeUID	HotList	CHChangeUID	CosmicHotSpot	Row	Row	Total	Strand Bias Percentage (minimum strand)	Strand Bias p-value	BaseFrom/BaseTo	Strand Bias Percentage Result	Strand Bias p-value Result	Strand Bias Mutation Type	OverallStrandBiasResult	Tum RMS MAPQ	Norm RMS MAPQ	Tum NERDist Mean	Tum NERDist SD	Tum Mut RMS MAPQ	GC count	AT count	RMD Score	Normal Bqual Mean	Fisher Left	Fisher Right	Fisher Two-tail	Var Type	Var Length	RepeatMasker	RepeatMaskerDistance	GC_Percent	BWA Tum Var Quality	BWA Tum Distinct Cov	BWA Tum Distinct Pairs	BWA Tum MAF	BWA Strand Bias Z	BWA Strand Bias 50CI_L	BWA Strand Bias 50CI_H	BWA Tum Mean Base Quality	BWA Tum NERDist Mean	BWA Tum NERDist SD	BWA Tum RMS MAPQ	BWA Tum Mut RMS MAPQ	BWA Tum Mean Num Mismatches	BWA Tum Mut Mean Num Mismatches	BWA Mut MAPQ Difference	BWA Supermut Count	BWA Supermut Avg	BWA Supermut MAF	BWA Supermut Cov	BT2 Tum Var Quality	BT2 Tum Distinct Cov	BT2 Tum Distinct Pairs	BT2 Tum MAF	BT2 Strand Bias Z	BT2 Strand Bias 50CI_L	BT2 Strand Bias 50CI_H	BT2 Tum Mean Base Quality	BT2 Tum NERDist Mean	BT2 Tum NERDist SD	BT2 Tum RMS MAPQ	BT2 Tum Mut RMS MAPQ	BT2 Tum Mean Num Mismatches	BT2 Tum Mut Mean Num Mismatches	BT2 Mut MAPQ Difference	BT2 Supermut Count	BT2 Supermut Avg	BT2 Supermut MAF	BT2 Supermut Cov	DUST	ensg_id	ensg_id2	GeneInfo_Transcript	ExAC: AC	ExAC: AF	ExAC: AN	ExAC: AN_Adj	ExAC: BaseQRankSum	ExAC: ClippingRankSum	ExAC: DP	ExAC: FS	ExAC: GQ_MEAN	ExAC: GQ_STDDEV	ExAC: MQ	ExAC: MQ0	ExAC: MQRankSum	ExAC: NCC	ExAC: QD	ExAC: ReadPosRankSum	ExAC: VQSLOD	ExAC: culprit	ExAC: DOUBLETON_DIST	ExAC: K1_RUN	ExAC: K2_RUN	ExAC: K3_RUN
chrX.fa:66765243-66765245_GCA_	0	0.248	1280	0	0	585	0	16	626	37	40	39.125	4	4	575	8	7	0.0121739	DEL	chrX.fa	66765243	66765245	GCA		chrX.fa:66765243-66765245_GCA_	ENSG00000169083	AR	CCDS14387.1	agGCAg	agg	85	85	RQ	R	inframe_deletion	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66765243-66765245_GCA_	chrX:66681968-66681970	chrX:66765243-66765245	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66765243-66765245_GCA_	stomach (1 cases)			large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	1	AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66765243-66765245_GCA_	X:66765243-66765245	ENSG00000169083	CCDS14387.1	inframe_deletion	255-257	255-257	85-86	1	RQ/R	agGCAg/agg	255_257delGCA	Q87del	chrX.fa:66765243-66765245_GCA_	ENSG00000169083	ENSG00000169083	CCDS14387.1	aggcag	agg	85	85	RQ	R	CODON_DELETION	1	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66765243-66765245_GCA_	255_257delGCA	Q87del	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00844595	0.00737186823568671	592	5	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	stomach (1 cases)	-	-	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	7	1	0	0	7	2	1	5	2.4	0.00844595	592	77	179	83	COLUMN NOT FOUND	58	7	1	430	0	0	1	0	-1	0	0	2	1	4	6	71	20						chrX.fa:66765243-66765245_GCA_	chrX_66765243_66765245			chrX.fa:66765243-66765245_GCA_	0.00737186823568671			chrX.fa:66765243-66765245_GCA_	SMExclude	chrX.fa:66765243-66765245_GCA_	chrX.fa:66765243-66765245_GCA_	Keep					66	66	8	0.5	0.6367	GCA/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0125	60	0	29.125	14.1367	60	0	64	37	20	0	1	DEL	3	20	20	0.633663	81.3582	575	7	0.0121739	0	0.372531	0.627469	39.125	0.29125	0.141367	60	60	0	1	0	5	2.4	0.00844595	592	81.3582	533	7	0.0131332	0	0.372531	0.627469	39.125	0.29125	0.141367	41.7845	41.509	0	1	0.2755	5	2.4	0.00912409	548	71	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr17.fa:37855841-37855841_G_A	0	0.879	2218	211	0	641	1	550	21910	37	40	39.8364	116	154	851	236	211	0.247944	SBS	chr17.fa	37855841	37855841	G	A	chr17.fa:37855841-37855841_G_A	ENSG00000141736	ERBB2	CCDS32642.1	-				-		upstream_gene_variant	3	COLUMN NOT FOUND	COLUMN NOT FOUND	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr17.fa:37855841-37855841_G_A	chr17:35109367-35109367	chr17:37855841-37855841	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr17.fa:37855841-37855841_G_A				lung (104 cases),large_intestine (78 cases),breast (42 cases),stomach (39 cases),urinary_tract (36 cases),skin (30 cases),ovary (17 cases),pancreas (15 cases),haematopoietic_and_lymphoid_tissue (12 cases),upper_aerodigestive_tract (12 cases),endometrium (11 cases),kidney (10 cases),oesophagus (8 cases),biliary_tract (8 cases),central_nervous_system (7 cases),small_intestine (7 cases),liver (6 cases),prostate (6 cases),bone (1 cases),NS (1 cases),soft_tissue (1 cases),thyroid (1 cases)		ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2	This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. 	CD340;HER-2;HER-2/neu;HER2;MLN 19;NEU;NGL;TKR1	EGFR signaling	Amplification of ERBB2 is associated with a reduced overall survival and time to relapse in breast cancer and poor outcome in gastric cancer.	Science. 1987 Jan 9;235(4785):177-82, J Clin Oncol. 1998 Feb;16(2):462-9, J Korean Med Sci. 2008 Jun;23(3):414-20, J Clin Oncol. 2011 Aug 1;29(22):3030-6	S:\Sample reports\Automated Report Info\Figures for gene slide subset\ERBB2_Prognostic1	Stage III breast cancer patients with ERBB2 amplification (solid) line display reduced survival compared to ERBB2-negative cases (dotted line)	J Korean Med Sci. 2008 Jun;23(3):414-20	Trastuzumab and lapatinib are effective in treating breast cancer patients with ERBB2 amplifications.  The combination of pertuzumab and trastuzumab has also been shown to be beneficial in patients with ERBB2-positive metastatic breast cancer that progressed during earlier trastuzumab therapy.  Breast cancer patients with a positive ERBB2 status respond poorly to tamoxifen and radiotherapy treatments.	Semin Oncol. 1999 Aug;26(4 Suppl 12):78-83, Eur J Cancer. 2001 Jan;37 Suppl 1:18-24, J Clin Oncol. 1996 Mar;14(3):737-44, Drugs Today (Barc). 2006 Jul;42(7):441-53, N Engl J Med. 2006 Dec 28;355(26):2733-43, J Clin Oncol. 2010 Mar 1;28(7):1138-44, J Clin Oncol. 1998 Feb;16(2):462-9	S:\Sample reports\Automated Report Info\Figures for gene slide subset\ERBB2_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\ERBB2_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\ERBB2_Therapeutic3##S:\Sample reports\Automated Report Info\Figures for gene slide subset\ERBB2_Therapeutic4	The addition of trastuzumab to chemotherapy in breast cancer improves survival in patients overexpressing ERBB2##Lapatinib plus Capecitabine  is effective in HER2-positive breast cancer##Kaplan-Meier curve of progression free survival in patients with ERBB2-expressing tumors treated with pertuzumab and trastuzumab##ERBB2 status predicts breast cancer response to tamoxifen and radiotherapy	Eur J Cancer. 2001 Jan;37 Suppl 1:18-24##N Engl J Med. 2006 Dec 28;355(26):2733-43##J Clin Oncol. 2010 Mar 1;28(7):1138-44##J Clin Oncol. 1998 Feb;16(2):462-9	ERBB2	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	ERBB2	HUMAN|ENSEMBL=ENSG00000141736|UniProtKB=P04626		PTHR24416:SF137	TYROSINE-PROTEIN KINASE RECEPTOR	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	apoptosis#GO:0006915;cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;nervous system development#GO:0007399;protein modification process#GO:0006464;cell proliferation#GO:0008283;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;cell-cell adhesion#GO:0016337;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197	Cadherin signaling pathway#P00012>EGFR#P00466;EGF receptor signaling pathway#P00018>EGFR#P00542						chr17.fa:37855841-37855841_G_A	17:37855841	ENSG00000141736	CCDS32642.1	upstream_gene_variant	-	-	-	1	-	-	-651G>A	N/A													SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	ERBB2	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2	CCDS32642.1	chr17.fa:37855841-37855841_G_A	-651G>A	N/A	3	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.245018	0.0288634739913387	853	209	COLUMN NOT FOUND	ENSG00000141736	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	apoptosis#GO:0006915;cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;nervous system development#GO:0007399;protein modification process#GO:0006464;cell proliferation#GO:0008283;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;cell-cell adhesion#GO:0016337;metabolic process#GO:0008152	Cadherin signaling pathway#P00012>EGFR#P00466;EGF receptor signaling pathway#P00018>EGFR#P00542	-	-	-	lung (104 cases),large_intestine (78 cases),breast (42 cases),stomach (39 cases),urinary_tract (36 cases),skin (30 cases),ovary (17 cases),pancreas (15 cases),haematopoietic_and_lymphoid_tissue (12 cases),upper_aerodigestive_tract (12 cases),endometrium (11 cases),kidney (10 cases),oesophagus (8 cases),biliary_tract (8 cases),central_nervous_system (7 cases),small_intestine (7 cases),liver (6 cases),prostate (6 cases),bone (1 cases),NS (1 cases),soft_tissue (1 cases),thyroid (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	3	0	209	2.60287	0.245018	853	99	307	274	COLUMN NOT FOUND	89	211	1	12	0	0	1.00727	0	-1	18	0.0853081	2	1	1	0	0	20	0	0.248235294117647	0.751764705882353	0.248235294117647	2.01421800947867	chr17.fa:37855841-37855841_G_A	chr17_37855841_37855841			chr17.fa:37855841-37855841_G_A	0.0288634739913387					chr17.fa:37855841-37855841_G_A							56	56	270	0.43	0.0121	G/A	NOBIAS	BIAS	COLUMN NOT FOUND		0.247971	60	0	27.9085	13.8065	60	0	47	54	12	0	1	SBS	0	20	12	0.465347	213.387	851	211	0.247944	2.04438	0.406412	0.452847	39.8364	0.279085	0.138065	60	60	0	1.00727	0	209	2.60287	0.245018	853	211.158	792	199	0.251263	1.82558	0.411387	0.459201	39.8538	0.278237	0.137033	41.9524	41.8797	0	1.00769	0.0727	199	2.61307	0.251263	792	0	ENSG00000141736	ENSG00000141736	CCDS32642.1																						
chr13.fa:32913837-32913837_A_	0	0.839	1292	0	315	0	0	586	23308	35	40	39.7747	153	140	557	271	246	0.441652	DEL	chr13.fa	32913837	32913837	A		chr13.fa:32913837-32913837_A_	ENSG00000139618	BRCA2	CCDS9344.1	-		1782	1782	-		frameshift_variant	10	COLUMN NOT FOUND	COLUMN NOT FOUND	breast cancer 2, early onset	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr13.fa:32913837-32913837_A_	chr13:31811837-31811837	chr13:32913837-32913837	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr13.fa:32913837-32913837_A_	stomach (1 cases)		endometrium (2 cases)	large_intestine (127 cases),lung (52 cases),skin (50 cases),endometrium (39 cases),stomach (31 cases),ovary (30 cases),breast (29 cases),urinary_tract (21 cases),liver (20 cases),oesophagus (17 cases),kidney (16 cases),pancreas (16 cases),central_nervous_system (15 cases),haematopoietic_and_lymphoid_tissue (11 cases),upper_aerodigestive_tract (8 cases),prostate (7 cases),thyroid (3 cases),bone (2 cases),NS (2 cases),cervix (2 cases),salivary_gland (1 cases),peritoneum (1 cases),pituitary (1 cases)	1	BRCA2	breast cancer 2, early onset	BRCA2 is involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. 	BRCC2;BROVCA2;FACD;FAD;FAD1;FANCB;FANCD;FANCD1;GLM3;PNCA2	DNA repair	BRCA2 mutations are associated with better survival in ovarian cancer.  Triple negative breast cancer patients with BRCA mutations have been shown to have a lower risk of relapse in some studies, but others have found no association between BRCA mutation status and prognosis in triple-negative cases	JAMA. 2011 Oct 12;306(14):1557-65, Clin Cancer Res. 2011 Mar 1;17(5):1082-9, Breast Cancer Res Treat. 2011 Nov;130(1):145-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Prognostic1##J :\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Prognostic2	Survival of ovarian cancer patients with BRCA mutations##Recurrence free survival in breast cancer patients by BRCA mutation status	JAMA. 2011 Oct 12;306(14):1557-65##Clin Cancer Res. 2011 Mar 1;17(5):1082-9	BRCA2 dysfunction sensitizes cells to PARP inhibition.  Clinical studies have also demonstrated the efficacy of PARP inhibitors such as olaparib and BSI-201 in BRCA mutation carriers.  Ovarian cancer patients with BRCA2 mutations are more sensitive to platimun based chemotherapy.  	Nature. 2005 Apr 14;434(7035):917-21, Curr Drug Targets. 2011 Jul 21, N Engl J Med. 2009 Jul 9;361(2):123-34, JAMA. 2011 Oct 12;306(14):1557-65	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Therapeutic2	Reduction in viability of BRCA2 deficient cells after PARP1-specific siRNA silencing##Duration of treatment and best response of BRCA mutated tumors of various types	Nature. 2005 Apr 14;434(7035):917-21##N Engl J Med. 2009 Jul 9;361(2):123-34	BRCA2	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	BRCA2	HUMAN|ENSEMBL=ENSG00000139618|UniProtKB=P51587		PTHR11289:SF0	BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN BRCA2	SUBFAMILY NOT NAMED	damaged DNA binding#GO:0003684;nucleic acid binding#GO:0003676;binding#GO:0005488;DNA binding#GO:0003677	DNA repair#GO:0006281;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;primary metabolic process#GO:0044238;DNA metabolic process#GO:0006259;metabolic process#GO:0008152		damaged DNA-binding protein#PC00086;DNA binding protein#PC00009;nucleic acid binding#PC00171							chr13.fa:32913837-32913837_A_	13:32913837	ENSG00000139618	CCDS9344.1	frameshift_variant,feature_truncation	5345	5345	1782	1	-	-	5345delA	N1784Tfs*7	chr13.fa:32913837-32913837_A_	ENSG00000139618	ENSG00000139618	CCDS9344.1	-	-	1782	1782	-	-	FRAME_SHIFT	10	SEQCTRLPS10_PS_Seq2_BWA	SNP:chr13_32913836_32913837_rs80359506_CA_-																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	BRCA2	breast cancer 2, early onset	CCDS9344.1	chr13.fa:32913837-32913837_A_	5345delA	N1784Tfs*7	10	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.431373	0.0409840435157844	561	242	COLUMN NOT FOUND	ENSG00000139618	damaged DNA binding#GO:0003684;nucleic acid binding#GO:0003676;binding#GO:0005488;DNA binding#GO:0003677	DNA repair#GO:0006281;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;primary metabolic process#GO:0044238;DNA metabolic process#GO:0006259;metabolic process#GO:0008152	-	stomach (1 cases)	-	endometrium (2 cases)	large_intestine (127 cases),lung (52 cases),skin (50 cases),endometrium (39 cases),stomach (31 cases),ovary (30 cases),breast (29 cases),urinary_tract (21 cases),liver (20 cases),oesophagus (17 cases),kidney (16 cases),pancreas (16 cases),central_nervous_system (15 cases),haematopoietic_and_lymphoid_tissue (11 cases),upper_aerodigestive_tract (8 cases),prostate (7 cases),thyroid (3 cases),bone (2 cases),NS (2 cases),cervix (2 cases),salivary_gland (1 cases),peritoneum (1 cases),pituitary (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	246	1	0	0	246	2	1	242	2.38843	0.431373	561	90	366	301	COLUMN NOT FOUND	87	246	1	16	0	0	1	0	-1	1	0.00406504	0	3	2	7	0	0						chr13.fa:32913837-32913837_A_	chr13_32913837_32913837			chr13.fa:32913837-32913837_A_	0.0409840435157844					chr13.fa:32913837-32913837_A_	chr13.fa:32913837-32913837_A_	Keep					48	48	293	0.48	0.2417	A/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.45356	60	0	27.8259	12.486	60	0	28	73	-101	0	1	DEL	1	0	-101	0.277228	219.134	557	246	0.441652	0.695894	0.456313	0.499318	39.7747	0.278259	0.12486	60	60	0	1	0	242	2.38843	0.431373	561	219.37	542	248	0.457565	1.01428	0.446381	0.489212	39.7593	0.269899	0.126437	41.9938	41.9868	0	1.00678	0.007	246	2.38211	0.452206	544	0	ENSG00000139618	ENSG00000139618	CCDS9344.1																						
chr10.fa:89720640-89720640_T_C	0	0.464	282	0	50	0	77	104	4102	34	40	39.4423	48	4	127	52	50	0.393701	SBS	chr10.fa	89720640	89720640	T	C	chr10.fa:89720640-89720640_T_C	ENSG00000171862	PTEN	CCDS31238.1	-				-		intron_variant	7	COLUMN NOT FOUND	COLUMN NOT FOUND	phosphatase and tensin homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr10.fa:89720640-89720640_T_C	chr10:89710620-89710620	chr10:89720640-89720640	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr10.fa:89720640-89720640_T_C				endometrium (845 cases),central_nervous_system (560 cases),large_intestine (337 cases),haematopoietic_and_lymphoid_tissue (131 cases),skin (101 cases),breast (99 cases),lung (75 cases),prostate (59 cases),kidney (45 cases),ovary (44 cases),stomach (42 cases),thyroid (28 cases),liver (24 cases),upper_aerodigestive_tract (18 cases),cervix (13 cases),oesophagus (12 cases),soft_tissue (11 cases),urinary_tract (11 cases),vulva (9 cases),pancreas (9 cases),NS (8 cases),biliary_tract (5 cases),eye (4 cases),salivary_gland (3 cases),bone (2 cases),genital_tract (2 cases),meninges (2 cases),autonomic_ganglia (1 cases)		PTEN	phosphatase and tensin homolog	The protein encoded this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. 	10q23del;BZS;DEC;GLM2;MGC11227;MHAM;MMAC1;PTEN1;TEP1	Phosphatidylinositol signaling	Loss of PTEN is associated with worse prognosis in salivary gland cancer.  Homozygous PTEN deletion or mutation correlates with shorter survival in GBM patients.  Reduced PTEN expression leads to a worse prognosis in GIST patients.  PTEN mutations are associated with reduced survival in pediatric T-ALL patients	Br J Cancer. 2012 Feb 14;106(4):719-26, Neuropathology. 2011 Aug;31(4):376-83, Anticancer Res. 2010 Mar;30(3):981-5, J Huazhong Univ Sci Technolog Med Sci. 2010 Apr;30(2):165-9, Leukemia. 2010 Jan;24(1):239-42	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic3	Survival of salivary gland patients with tumors positive and negative for PTEN expression## PTEN deletion is associated with reduced survival in GBM patients##PTEN mutation and survival of pediatric T-ALL patients	Br J Cancer. 2012 Feb 14;106(4):719-26##Neuropathology. 2011 Aug;31(4):376-83##Leukemia. 2010 Jan;24(1):239-42	The combination of PTEN loss, low CEN7 copy number and PIK3CA gain is associated with poor response to gefitinib in NSCLC.  Activation of the PI3K pathway through loss of PTEN (or mutation of PIK3CA) may lead to resistance to lapatinib and trastuzumab in breast cancer. Loss of PTEN may confer sensitivity to PARP inhibitors in endometrial cancer and only colorectal cell lines with high PTEN expression are sensitive to 5-FU and oxiplatin treatment in vitro.  Over-expression of PTEN results in increased radioresistance in head and neck cancer.  Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in CRC	Br J Cancer. 2011 Dec 6;105(12):1920-6, BMC Cancer. 2011 Jun 15;11:11:248, Nat Rev Clin Oncol. 2011 May;8(5):302-6, Eur J Surg Oncol. 2011 Feb;37(2):140-7, Br J Cancer. 2010 Jun 8;102(12):1778-85, Br J Cancer. 2010 Mar 2;102(5):940	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Therapeutic2	Survival in NSCLC patients with PTEN loss when treated with gefitinib##Overall response rate and clinical benefit rate in breast cancer patients treated with lapatinib according to PI3K pathway activation	Br J Cancer. 2011 Dec 6;105(12):1920-6## BMC Cancer. 2011 Jun 15;11:11:248	PTEN	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	PTEN	HUMAN|ENSEMBL=ENSG00000171862|UniProtKB=P60484		PTHR12305:SF14	PHOSPHATASE WITH HOMOLOGY TO TENSIN	PTEN	hydrolase activity#GO:0016787;hydrolase activity, acting on ester bonds#GO:0016788;catalytic activity#GO:0003824;phosphoprotein phosphatase activity#GO:0004721;phosphoric monoester hydrolase activity#GO:0016791	apoptosis#GO:0006915;lipid metabolic process#GO:0006629;induction of apoptosis#GO:0006917;immune system process#GO:0002376;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;cell communication#GO:0007154;cell adhesion#GO:0007155;cellular process#GO:0009987;protein metabolic process#GO:0019538;phospholipid metabolic process#GO:0006644;protein modification process#GO:0006464;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein phosphatase#PC00195;phosphatase#PC00181;hydrolase#PC00121	p53 pathway#P00059>PTEN#G01579;p53 pathway feedback loops 2#P04398>PTEN#G04714;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#G04675;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#P00905;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PTEN#P00849;p53 pathway#P00059>PTEN#P01480;Hypoxia response via HIF activation#P00030>PTEN#P00824;PI3 kinase pathway#P00048>PTEN#P01189;p53 pathway feedback loops 2#P04398>PTEN#P04658						chr10.fa:89720640-89720640_T_C	10:89720640	ENSG00000171862	CCDS31238.1	intron_variant	-	-	-	1	-	-	802-11T>C	N/A	chr10.fa:89720640-89720640_T_C	ENSG00000171862	ENSG00000171862	CCDS31238.1							INTRON		SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	PTEN	phosphatase and tensin homolog	CCDS31238.1	chr10.fa:89720640-89720640_T_C	802-11T>C	N/A	7	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.393701	0.0849729810685795	127	50	COLUMN NOT FOUND	ENSG00000171862	hydrolase activity#GO:0016787;hydrolase activity, acting on ester bonds#GO:0016788;catalytic activity#GO:0003824;phosphoprotein phosphatase activity#GO:0004721;phosphoric monoester hydrolase activity#GO:0016791	apoptosis#GO:0006915;lipid metabolic process#GO:0006629;induction of apoptosis#GO:0006917;immune system process#GO:0002376;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;cell communication#GO:0007154;cell adhesion#GO:0007155;cellular process#GO:0009987;protein metabolic process#GO:0019538;phospholipid metabolic process#GO:0006644;protein modification process#GO:0006464;primary metabolic process#GO:0044238;metabolic process#GO:0008152	p53 pathway#P00059>PTEN#G01579;p53 pathway feedback loops 2#P04398>PTEN#G04714;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#G04675;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#P00905;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PTEN#P00849;p53 pathway#P00059>PTEN#P01480;Hypoxia response via HIF activation#P00030>PTEN#P00824;PI3 kinase pathway#P00048>PTEN#P01189;p53 pathway feedback loops 2#P04398>PTEN#P04658	-	-	-	endometrium (845 cases),central_nervous_system (560 cases),large_intestine (337 cases),haematopoietic_and_lymphoid_tissue (131 cases),skin (101 cases),breast (99 cases),lung (75 cases),prostate (59 cases),kidney (45 cases),ovary (44 cases),stomach (42 cases),thyroid (28 cases),liver (24 cases),upper_aerodigestive_tract (18 cases),cervix (13 cases),oesophagus (12 cases),soft_tissue (11 cases),urinary_tract (11 cases),vulva (9 cases),pancreas (9 cases),NS (8 cases),biliary_tract (5 cases),eye (4 cases),salivary_gland (3 cases),bone (2 cases),genital_tract (2 cases),meninges (2 cases),autonomic_ganglia (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	50	2.08	0.393701	127	92	152	204	COLUMN NOT FOUND	78	50	1	170	0	0	1.92308	0	-1	2	0.04	15	7	5	0	63	19	0	0.393700787401575	0.606299212598425	0.393700787401575	1.27	chr10.fa:89720640-89720640_T_C	chr10_89720640_89720640			chr10.fa:89720640-89720640_T_C	0.0849729810685795					chr10.fa:89720640-89720640_T_C							41	41	52	0.08	0	T/C	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.368794	59.909	0	25.9818	14.6399	59.7529	0	21	80	9	0	1	SBS	0	19	9	0.207921	155.08	127	50	0.393701	5.98321	0.0292287	0.124617	39.4423	0.259818	0.146399	59.909	59.7529	0	1.92308	0.1561	50	2.08	0.393701	127	153.416	120	48	0.4	6.09682	0.0113222	0.108678	39.42	0.259623	0.147743	40.3699	39.7301	0	1.98	0.6398	48	2.08333	0.4	120	63	ENSG00000171862	ENSG00000171862	CCDS31238.1																						
chr15.fa:90631918-90631918_C_	0	0.802	2950	0	0	0	955	588	23312	37	40	39.6463	134	160	1190	252	247	0.207563	DEL	chr15.fa	90631918	90631918	C		chr15.fa:90631918-90631918_C_	ENSG00000182054	IDH2	CCDS10359.1	-		145	145	-		frameshift_variant	4	COLUMN NOT FOUND	COLUMN NOT FOUND	isocitrate dehydrogenase 2 (NADP+), mitochondrial	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr15.fa:90631918-90631918_C_	chr15:88432922-88432922	chr15:90631918-90631918	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr15.fa:90631918-90631918_C_	large_intestine (1 cases),stomach (1 cases)		haematopoietic_and_lymphoid_tissue (506 cases),large_intestine (5 cases),central_nervous_system (1 cases)	haematopoietic_and_lymphoid_tissue (656 cases),central_nervous_system (111 cases),large_intestine (32 cases),bone (26 cases),biliary_tract (24 cases),skin (9 cases),endometrium (5 cases),urinary_tract (4 cases),lung (4 cases),liver (3 cases),stomach (2 cases),soft_tissue (2 cases),kidney (2 cases),ovary (1 cases),breast (1 cases),pancreas (1 cases),oesophagus (1 cases),autonomic_ganglia (1 cases)	2	IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial	Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. 	D2HGA2;ICD-M;IDH;IDHM;IDP;IDPM;mNADP-IDH	TCA cycle and NADPH production	IDH2 mutations are associated with a better outcome in glioma patients. 	N Engl J Med. 2009 Feb 19;360(8):765-73	S:\Sample reports\Automated Report Info\Figures for gene slide subset\IDH2_Prognostic1	Glioma patients with IDH1 mutations have a better prognosis. 	N Engl J Med. 2009 Feb 19;360(8):765-73	IDH2 mutation may confer sensitivity to temozolomide in patients with gliomas	Neurology. 2010 Oct 26;75(17):1560-6	NA	NA	NA	IDH2	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	IDH2	HUMAN|ENSEMBL=ENSG00000182054|UniProtKB=P48735		PTHR11822:SF1	NADP-SPECIFIC ISOCITRATE DEHYDROGENASE	ISOCITRATE DEHYDROGENASE [NADP], MITOCHONDRIAL	oxidoreductase activity#GO:0016491;catalytic activity#GO:0003824	carbohydrate metabolic process#GO:0005975;tricarboxylic acid cycle#GO:0006099;primary metabolic process#GO:0044238;generation of precursor metabolites and energy#GO:0006091;metabolic process#GO:0008152		dehydrogenase#PC00092;oxidoreductase#PC00176	TCA cycle#P00051>Isocitrate Dehydrogenase#P01265						chr15.fa:90631918-90631918_C_	15:90631918	ENSG00000182054	CCDS10359.1	frameshift_variant,feature_truncation	435	435	145	-1	-	-	435delG	T146Lfs*15	chr15.fa:90631918-90631918_C_	ENSG00000182054	ENSG00000182054	CCDS10359.1	-	-	145	145	-	-	FRAME_SHIFT	4	SEQCTRLPS10_PS_Seq2_BWA	SNP:chr15_90631917_90631918_rs200758694_C_A																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial	CCDS10359.1	chr15.fa:90631918-90631918_C_	435delG	T146Lfs*15	4	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.194514	0.0223680151170909	1203	234	COLUMN NOT FOUND	ENSG00000182054	oxidoreductase activity#GO:0016491;catalytic activity#GO:0003824	carbohydrate metabolic process#GO:0005975;tricarboxylic acid cycle#GO:0006099;primary metabolic process#GO:0044238;generation of precursor metabolites and energy#GO:0006091;metabolic process#GO:0008152	TCA cycle#P00051>Isocitrate Dehydrogenase#P01265	large_intestine (1 cases),stomach (1 cases)	-	haematopoietic_and_lymphoid_tissue (506 cases),large_intestine (5 cases),central_nervous_system (1 cases)	haematopoietic_and_lymphoid_tissue (656 cases),central_nervous_system (111 cases),large_intestine (32 cases),bone (26 cases),biliary_tract (24 cases),skin (9 cases),endometrium (5 cases),urinary_tract (4 cases),lung (4 cases),liver (3 cases),stomach (2 cases),soft_tissue (2 cases),kidney (2 cases),ovary (1 cases),breast (1 cases),pancreas (1 cases),oesophagus (1 cases),autonomic_ganglia (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	243	0.983806	0	0	248	3	2	234	2.40171	0.194514	1203	93	276	227	COLUMN NOT FOUND	86	247	1	30	0	0	1.02041	0	-1	10	0.0404858	0	3	2	7	0	0						chr15.fa:90631918-90631918_C_	chr15_90631918_90631918			chr15.fa:90631918-90631918_C_	0.0223680151170909	chr15.fa:90631918-90631918_C_	Yes	chr15.fa:90631918-90631918_C_	SMExclude	chr15.fa:90631918-90631918_C_	chr15.fa:90631918-90631918_C_	Keep					53	53	294	0.46	0.0724	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.199322	60	0	28	13.5948	60	0	54	47	-101	0	1	DEL	1	0	-101	0.534653	218.587	1190	247	0.207563	1.38987	0.434324	0.477241	39.6463	0.28	0.135948	60	60	0	1.02041	0	234	2.40171	0.194514	1203	215.752	1123	230	0.204809	1.36875	0.432636	0.477111	39.6426	0.267276	0.141055	41.9741	42	0	1.02166	-0.0259	219	2.42922	0.193122	1134	0	ENSG00000182054	ENSG00000182054	CCDS10359.1																						
chr10.fa:43607629-43607629_C_T	0	0.934	4122	0	1335	0	294	732	29108	35	40	39.765	172	194	1627	306	294	0.180701	SBS	chr10.fa	43607629	43607629	C	T	chr10.fa:43607629-43607629_C_T	ENSG00000165731	RET	CCDS7200.1	ggC	ggT	535	535	G	G	synonymous_variant	8	COLUMN NOT FOUND	COLUMN NOT FOUND	ret proto-oncogene	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr10.fa:43607629-43607629_C_T	chr10:42927635-42927635	chr10:43607629-43607629	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr10.fa:43607629-43607629_C_T	large_intestine (1 cases)		lung (2 cases)	thyroid (372 cases),large_intestine (82 cases),lung (46 cases),skin (45 cases),adrenal_gland (39 cases),stomach (22 cases),endometrium (17 cases),breast (15 cases),urinary_tract (13 cases),haematopoietic_and_lymphoid_tissue (12 cases),oesophagus (10 cases),kidney (9 cases),central_nervous_system (9 cases),ovary (8 cases),pancreas (8 cases),liver (7 cases),upper_aerodigestive_tract (6 cases),prostate (4 cases),bone (2 cases),NS (2 cases),thymus (2 cases),biliary_tract (1 cases)	1	RET	ret proto-oncogene	This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. 	CDHF12;CDHR16;HSCR1;MEN2A;MEN2B;MTC1;PTC;RET-ELE1;RET51	MAP kinase signaling	Sporadic medullary thyroid cancer patients with RET mutations such as M918T may have a worse prognosis	Curr Opin Oncol. 2009 Jan;21(1):5-10, J Clin Endocrinol Metab. 2008 Mar;93(3):682-7	S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Prognostic1	Thyroid cancer patients with sporadic RET mutations have a worse prognosis	 J Clin Endocrinol Metab. 2008 Mar;93(3):682-7	Vandetanib is a small molecule inhibitor of RET that has demonstrated clinical benefits in patients with medullary thyroid cancer and XL184 has shown similar promising results in clinical trials.  Some RET mutations, such as V804M confer resistance to vandetanib treatment	Clin Pharmacol Ther. 2012 Jan;91(1):71-80, J Clin Oncol. 2011 Jul 1;29(19):2660-6, Curr Opin Oncol. 2012 Feb 15, Endocr Relat Cancer. 2010 Nov 30;18(1):1-11	S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\RET_Therapeutic2	Summary of completed studies of vandetanib in thyroid cancer##Clinical trials involving drugs that target RET in thyroid cancer	Clin Pharmacol Ther. 2012 Jan;91(1):71-80##Curr Opin Oncol. 2012 Feb 15	RET	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	RET	HUMAN|ENSEMBL=ENSG00000165731|UniProtKB=P07949		PTHR24416:SF97	TYROSINE-PROTEIN KINASE RECEPTOR	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr10.fa:43607629-43607629_C_T	10:43607629	ENSG00000165731	CCDS7200.1	synonymous_variant	1605	1605	535	1	G	ggC/ggT	1605C>T	%3D)	chr10.fa:43607629-43607629_C_T	ENSG00000165731	ENSG00000165731	CCDS7200.1	ggC	ggT	535	535	G	G	SYNONYMOUS_CODING	8	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	RET	ret proto-oncogene	CCDS7200.1	chr10.fa:43607629-43607629_C_T	1605C>T	%3D)	8	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.179251	0.0186265136173019	1629	292	COLUMN NOT FOUND	ENSG00000165731	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	large_intestine (1 cases)	-	lung (2 cases)	thyroid (372 cases),large_intestine (82 cases),lung (46 cases),skin (45 cases),adrenal_gland (39 cases),stomach (22 cases),endometrium (17 cases),breast (15 cases),urinary_tract (13 cases),haematopoietic_and_lymphoid_tissue (12 cases),oesophagus (10 cases),kidney (9 cases),central_nervous_system (9 cases),ovary (8 cases),pancreas (8 cases),liver (7 cases),upper_aerodigestive_tract (6 cases),prostate (4 cases),bone (2 cases),NS (2 cases),thymus (2 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	292	2.49315	0.179251	1629	99	307	275	COLUMN NOT FOUND	90	294	1	34	0	0	1.01093	0	-1	37	0.12585	0	1	1	1	0	0	0	0.180700676090965	0.819299323909035	0.180700676090965	2.76700680272109	chr10.fa:43607629-43607629_C_T	chr10_43607629_43607629			chr10.fa:43607629-43607629_C_T	0.0186265136173019					chr10.fa:43607629-43607629_C_T							39	39	366	0.47	0.1362	C/T	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.177584	60	0	26.8196	14.192	60	0	62	39	-101	0	1	SBS	0	0	-101	0.613861	226.143	1627	294	0.180701	1.03066	0.450277	0.489614	39.765	0.268196	0.14192	60	60	0	1.01093	0	292	2.49315	0.179251	1629	222.776	1536	270	0.175781	1.06952	0.446931	0.48798	39.7663	0.267883	0.143306	41.999	42	0	1.01183	-0.001	268	2.50746	0.174252	1538	0	ENSG00000165731	ENSG00000165731	CCDS7200.1																						
chr4.fa:55598220-55598220_T_G	0	0.167	666	3	0	6	160	12	500	16	40	31.25	6	0	304	5	6	0.0197368	SBS	chr4.fa	55598220	55598220	T	G	chr4.fa:55598220-55598220_T_G	ENSG00000157404	KIT	CCDS3496.1	-				-		intron_variant	16	COLUMN NOT FOUND	COLUMN NOT FOUND	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr4.fa:55598220-55598220_T_G	chr4:55292977-55292977	chr4:55598220-55598220	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr4.fa:55598220-55598220_T_G				haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)		KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	C-Kit;CD117;PBT;SCFR	Tyrosine kinase signaling	Patients with exon 17 KIT mutations have a poorer prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Prognostic1	KIT mutations lead to poor prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic2	Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11##Mol Cancer Ther. 2011 Oct;10(10):1897-908.	KIT	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	HUMAN|ENSEMBL=ENSG00000157404|UniProtKB=P10721		PTHR24416:SF46	TYROSINE-PROTEIN KINASE RECEPTOR	MAST/STEM CELL GROWTH FACTOR RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr4.fa:55598220-55598220_T_G	4:55598220	ENSG00000157404	CCDS3496.1	intron_variant	-	-	-	1	-	-	2361+56T>G	N/A	chr4.fa:55598220-55598220_T_G	ENSG00000157404	ENSG00000157404	CCDS3496.1							INTRON		SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	CCDS3496.1	chr4.fa:55598220-55598220_T_G	2361+56T>G	N/A	16	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0346821	0.0272659590065913	173	6	COLUMN NOT FOUND	ENSG00000157404	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	-	haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	4	6	3	6	2	0.0346821	173	88	3	78	COLUMN NOT FOUND	3	6	1	432	0	0	2.125	0	-1	1	0.166667	18	9	7	0	78	20	0	0.0199335548172757	0.980066445182724	0.0199335548172757	25.0833333333333	chr4.fa:55598220-55598220_T_G	chr4_55598220_55598220			chr4.fa:55598220-55598220_T_G	0.0272659590065913					chr4.fa:55598220-55598220_T_G							18	18	6	0	0.0156	T/G	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.018018	60	0	7.375	3.22159	60	0	25	76	17	0	1	SBS	0	20	17	0.247525	60.8097	304	6	0.0197368	2.44949	0	0.137682	31.25	0.07375	0.0322159	60	60	0	2.125	0	6	2	0.0346821	173	52.0384	203	4	0.0197044	2	0	0.168625	32.3333	0.0678947	0.0555605	34.7679	39.5727	0	2.33333	-4.8048	4	2	0.0506329	79	78	ENSG00000157404	ENSG00000157404	CCDS3496.1																						
chr7.fa:92462639-92462639_C_T	0	0.91	2548	0	835	0	191	482	19114	35	40	39.6556	82	159	1024	208	191	0.186523	SBS	chr7.fa	92462639	92462639	C	T	chr7.fa:92462639-92462639_C_T	ENSG00000105810	CDK6	CCDS5628.1	-				-		upstream_gene_variant	25	COLUMN NOT FOUND	COLUMN NOT FOUND	cyclin-dependent kinase 6	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr7.fa:92462639-92462639_C_T	chr7:92300575-92300575	chr7:92462639-92462639	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:92462639-92462639_C_T				large_intestine (12 cases),skin (7 cases),stomach (7 cases),lung (6 cases),endometrium (5 cases),breast (3 cases),urinary_tract (2 cases),pancreas (2 cases),ovary (1 cases),kidney (1 cases),oesophagus (1 cases),central_nervous_system (1 cases)		CDK6	cyclin-dependent kinase 6	The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Expression of this gene is up-regulated in some types of cancer. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]	MGC59692;PLSTIRE	Cell cycle progression	Overexpression of CDK9 is a negative prognostic marker in medulloblastoma	J Clin Oncol. 2005 Dec 1;23(34):8853-62	S:\Sample reports\Automated Report Info\Figures for gene slide subset\CDK6_Prognostic1	Amplification of chromosomal region 17q23 containing CDK6 correlates with poor prognosis	J Clin Oncol. 2005 Dec 1;23(34):8853-62	PD-0332991 is a CDK4/6 inhibitor that reduces proliferation of ovarian cancer cells in vitro and is most effective in Rb-proficient lines with low p16 expression.  This compound has also been shown to be highly effective in suppressing the growth of xenograft tumors in a GBM model, particularly in combination with radiation.	Clin Cancer Res. 2011 Mar 15;17(6):1591-602, Cancer Res. 2010 Apr 15;70(8):3228-38	S:\Sample reports\Automated Report Info\Figures for gene slide subset\CDK4_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\CDK4_Therapeutic2	Growth inhibitory effects of PD-0332991 in a panel of ovarian cancer cell lines##Increased survival in a GBM mouse model treated with the CDK6 inhibitor PD-0332991 and radiation therapy (RT)  	Clin Cancer Res. 2011 Mar 15;17(6):1591-602##Cancer Res. 2010 Apr 15;70(8):3228-38	CDK6	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	CDK6	HUMAN|ENSEMBL=ENSG00000105810|UniProtKB=Q00534		PTHR24056:SF130	CELL DIVISION PROTEIN KINASE	CELL DIVISION PROTEIN KINASE 6	transferase activity#GO:0016740;non-membrane spanning protein tyrosine kinase activity#GO:0004715;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;ectoderm development#GO:0007398;signal transduction#GO:0007165;glycogen metabolic process#GO:0005977;developmental process#GO:0032502;cell communication#GO:0007154;cellular process#GO:0009987;nervous system development#GO:0007399;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;mesoderm development#GO:0007498;polysaccharide metabolic process#GO:0005976;system development#GO:0048731;protein amino acid phosphorylation#GO:0006468;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;segment specification#GO:0007379;mitosis#GO:0007067;protein metabolic process#GO:0019538;pattern specification process#GO:0007389;carbohydrate metabolic process#GO:0005975;protein modification process#GO:0006464;metabolic process#GO:0008152		non-receptor serine/threonine protein kinase#PC00167;protein kinase#PC00193;non-receptor tyrosine protein kinase#PC00168;transferase#PC00220;kinase#PC00137							chr7.fa:92462639-92462639_C_T	7:92462639	ENSG00000105810	CCDS5628.1	upstream_gene_variant	-		-	-1	-	-	-2G>A	N/A	chr7.fa:92462639-92462639_C_T	ENSG00000105810	ENSG00000105810	CCDS5628.1							UPSTREAM: 2 bases		SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	CDK6	cyclin-dependent kinase 6	CCDS5628.1	chr7.fa:92462639-92462639_C_T	-2G>A	N/A	25	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.184211	0.0237207633758115	1026	189	COLUMN NOT FOUND	ENSG00000105810	transferase activity#GO:0016740;non-membrane spanning protein tyrosine kinase activity#GO:0004715;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;ectoderm development#GO:0007398;signal transduction#GO:0007165;glycogen metabolic process#GO:0005977;developmental process#GO:0032502;cell communication#GO:0007154;cellular process#GO:0009987;nervous system development#GO:0007399;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;mesoderm development#GO:0007498;polysaccharide metabolic process#GO:0005976;system development#GO:0048731;protein amino acid phosphorylation#GO:0006468;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;segment specification#GO:0007379;mitosis#GO:0007067;protein metabolic process#GO:0019538;pattern specification process#GO:0007389;carbohydrate metabolic process#GO:0005975;protein modification process#GO:0006464;metabolic process#GO:0008152	-	-	-	-	large_intestine (12 cases),skin (7 cases),stomach (7 cases),lung (6 cases),endometrium (5 cases),breast (3 cases),urinary_tract (2 cases),pancreas (2 cases),ovary (1 cases),kidney (1 cases),oesophagus (1 cases),central_nervous_system (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	189	2.50794	0.184211	1026	98	332	261	COLUMN NOT FOUND	89	191	1	38	0	0	1.41079	0	-1	24	0.125654	2	1	2	0	30	1	0	0.1865234375	0.8134765625	0.1865234375	2.68062827225131	chr7.fa:92462639-92462639_C_T	chr7_92462639_92462639			chr7.fa:92462639-92462639_C_T	0.0237207633758115					chr7.fa:92462639-92462639_C_T							28	28	241	0.34	0	C/T	NOBIAS	BIAS	COLUMN NOT FOUND		0.189168	60	0	25.4195	14.3583	60	0	79	22	-9	0	1	SBS	0	1	-9	0.782178	208.489	1024	191	0.186523	4.41561	0.315846	0.364652	39.6556	0.254195	0.143583	60	60	0	1.41079	0	189	2.50794	0.184211	1026	205.601	990	178	0.179798	4.40804	0.309524	0.36008	39.6348	0.25698	0.145544	41.9746	41.864	0	1.44783	0.1106	177	2.57627	0.178607	991	30	ENSG00000105810	ENSG00000105810	CCDS5628.1																						
chr3.fa:138413710-138413710_G_	0	0.35	2342	0	950	0	1	16	640	40	40	40	7	1	958	8	8	0.00835073	DEL	chr3.fa	138413710	138413710	G		chr3.fa:138413710-138413710_G_	ENSG00000051382	PIK3CB	CCDS3104.1	-		604	604	-		frameshift_variant	12	COLUMN NOT FOUND	COLUMN NOT FOUND	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr3.fa:138413710-138413710_G_	chr3:139896400-139896400	chr3:138413710-138413710	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr3.fa:138413710-138413710_G_	large_intestine (1 cases)		breast (1 cases)	large_intestine (27 cases),skin (25 cases),lung (18 cases),endometrium (14 cases),liver (12 cases),breast (11 cases),stomach (10 cases),central_nervous_system (10 cases),kidney (8 cases),upper_aerodigestive_tract (6 cases),ovary (4 cases),haematopoietic_and_lymphoid_tissue (4 cases),pancreas (4 cases),urinary_tract (3 cases),oesophagus (3 cases),autonomic_ganglia (3 cases),bone (2 cases),prostate (2 cases),thyroid (2 cases),NS (1 cases),soft_tissue (1 cases)	1	PIK3CB	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K). These kinases are important in signaling pathways involving receptors on the outer membrane of eukaryotic cells and are named for their catalytic subunit. The encoded protein is the catalytic subunit for PI3Kbeta (PI3KB).	PI3K; PIK3C1; P110BETA; PI3KBETA	Phosphatidylinositol signaling	None described	NA	NA	NA	NA	None described?	NA	NA	NA	NA	PIK3CB	YES								COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	PIK3CB	HUMAN|ENSEMBL=ENSG00000051382|UniProtKB=P42338		PTHR10048:SF33	PHOSPHATIDYLINOSITOL KINASE	PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT BETA ISOFORM	transferase activity#GO:0016740;catalytic activity#GO:0003824;kinase activity#GO:0016301	lipid metabolic process#GO:0006629;signal transduction#GO:0007165;transport#GO:0006810;endocytosis#GO:0006897;protein targeting#GO:0006605;vesicle-mediated transport#GO:0016192;cell communication#GO:0007154;cellular process#GO:0009987;phospholipid metabolic process#GO:0006644;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;protein transport#GO:0015031;intracellular signaling cascade#GO:0007242;negative regulation of apoptosis#GO:0043066;intracellular protein transport#GO:0006886;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;metabolic process#GO:0008152		transferase#PC00220;kinase#PC00137	PDGF signaling pathway#P00047>PI3K#P01168;Apoptosis signaling pathway#P00006>PI3K#P00310;T cell activation#P00053>PI3K#P01322;Hypoxia response via HIF activation#P00030>PI3K#P00823;Axon guidance mediated by netrin#P00009>PI3K#P00363;PI3 kinase pathway#P00048>p110#P01192;EGF receptor signaling pathway#P00018>PI3K#P00557;VEGF signaling pathway#P00056>PI3K#P01413;FGF signaling pathway#P00021>PI3K#P00640;p53 pathway feedback loops 2#P04398>PI3K#P04661;Endothelin signaling pathway#P00019>PI3K#P00577;Integrin signalling pathway#P00034>PI3K#P00936;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PI3K#P00868;B cell activation#P00010>PI3K#P00391;Angiogenesis#P00005>PI3K#P00236;Ras Pathway#P04393>PI3K#P04567;p53 pathway#P00059>PI3K#P04609;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PI3K#P00900;Interleukin signaling pathway#P00036>PI3K#P00990;PI3 kinase pathway#P00048>P110ACT#P01177						chr3.fa:138413710-138413710_G_	3:138413710	ENSG00000051382	CCDS3104.1	frameshift_variant,feature_truncation	1810	1810	604	-1	-	-	1810delC	R604Gfs*4	chr3.fa:138413710-138413710_G_	ENSG00000051382	ENSG00000051382	CCDS3104.1	-	-	604	604	-	-	FRAME_SHIFT	12	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	PIK3CB	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	CCDS3104.1	chr3.fa:138413710-138413710_G_	1810delC	R604Gfs*4	12	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00729167	0.00538201237636339	960	7	COLUMN NOT FOUND	ENSG00000051382	transferase activity#GO:0016740;catalytic activity#GO:0003824;kinase activity#GO:0016301	lipid metabolic process#GO:0006629;signal transduction#GO:0007165;transport#GO:0006810;endocytosis#GO:0006897;protein targeting#GO:0006605;vesicle-mediated transport#GO:0016192;cell communication#GO:0007154;cellular process#GO:0009987;phospholipid metabolic process#GO:0006644;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;protein transport#GO:0015031;intracellular signaling cascade#GO:0007242;negative regulation of apoptosis#GO:0043066;intracellular protein transport#GO:0006886;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;metabolic process#GO:0008152	PDGF signaling pathway#P00047>PI3K#P01168;Apoptosis signaling pathway#P00006>PI3K#P00310;T cell activation#P00053>PI3K#P01322;Hypoxia response via HIF activation#P00030>PI3K#P00823;Axon guidance mediated by netrin#P00009>PI3K#P00363;PI3 kinase pathway#P00048>p110#P01192;EGF receptor signaling pathway#P00018>PI3K#P00557;VEGF signaling pathway#P00056>PI3K#P01413;FGF signaling pathway#P00021>PI3K#P00640;p53 pathway feedback loops 2#P04398>PI3K#P04661;Endothelin signaling pathway#P00019>PI3K#P00577;Integrin signalling pathway#P00034>PI3K#P00936;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PI3K#P00868;B cell activation#P00010>PI3K#P00391;Angiogenesis#P00005>PI3K#P00236;Ras Pathway#P04393>PI3K#P04567;p53 pathway#P00059>PI3K#P04609;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PI3K#P00900;Interleukin signaling pathway#P00036>PI3K#P00990;PI3 kinase pathway#P00048>P110ACT#P01177	large_intestine (1 cases)	-	breast (1 cases)	large_intestine (27 cases),skin (25 cases),lung (18 cases),endometrium (14 cases),liver (12 cases),breast (11 cases),stomach (10 cases),central_nervous_system (10 cases),kidney (8 cases),upper_aerodigestive_tract (6 cases),ovary (4 cases),haematopoietic_and_lymphoid_tissue (4 cases),pancreas (4 cases),urinary_tract (3 cases),oesophagus (3 cases),autonomic_ganglia (3 cases),bone (2 cases),prostate (2 cases),thyroid (2 cases),NS (1 cases),soft_tissue (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	8	1	0	0	9	4	2	7	2	0.00729167	960	41	101	179	COLUMN NOT FOUND	41	8	1	12	0	0	1	0	-1	0	0	3	3	2	7	0	0						chr3.fa:138413710-138413710_G_	chr3_138413710_138413710			chr3.fa:138413710-138413710_G_	0.00538201237636339			chr3.fa:138413710-138413710_G_	SMExclude	chr3.fa:138413710-138413710_G_	chr3.fa:138413710-138413710_G_	Keep					12	12	8	0.12	0.0352	G/	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.00683177	60	0	22.5	16.0498	60	0	53	48	-101	0	1	DEL	1	0	-101	0.524752	87.889	958	8	0.00835073	2.12132	0.005764	0.244236	40	0.225	0.160498	60	60	0	1	0	7	2	0.00729167	960	87.889	908	8	0.00881057	2.12132	0.005764	0.244236	40	0.225	0.160498	42	42	0	1	0	7	2	0.00769231	910	0	ENSG00000051382	ENSG00000051382	CCDS3104.1																						
chr4.fa:55598221-55598221_T_A	0	0.2	660	7	0	1	195	14	618	16	40	34.3333	6	1	298	6	7	0.0234899	SBS	chr4.fa	55598221	55598221	T	A	chr4.fa:55598221-55598221_T_A	ENSG00000157404	KIT	CCDS3496.1	-				-		intron_variant	16	COLUMN NOT FOUND	COLUMN NOT FOUND	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr4.fa:55598221-55598221_T_A	chr4:55292978-55292978	chr4:55598221-55598221	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr4.fa:55598221-55598221_T_A				haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)		KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	C-Kit;CD117;PBT;SCFR	Tyrosine kinase signaling	Patients with exon 17 KIT mutations have a poorer prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Prognostic1	KIT mutations lead to poor prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic2	Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11##Mol Cancer Ther. 2011 Oct;10(10):1897-908.	KIT	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	HUMAN|ENSEMBL=ENSG00000157404|UniProtKB=P10721		PTHR24416:SF46	TYROSINE-PROTEIN KINASE RECEPTOR	MAST/STEM CELL GROWTH FACTOR RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr4.fa:55598221-55598221_T_A	4:55598221	ENSG00000157404	CCDS3496.1	intron_variant	-	-	-	1	-	-	2361+57T>A	N/A	chr4.fa:55598221-55598221_T_A	ENSG00000157404	ENSG00000157404	CCDS3496.1							INTRON		SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	CCDS3496.1	chr4.fa:55598221-55598221_T_A	2361+57T>A	N/A	16	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0294118	0.0231856374473249	204	6	COLUMN NOT FOUND	ENSG00000157404	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	-	haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	1	4	1	6	2	0.0294118	204	86	3	78	COLUMN NOT FOUND	3	7	1	454	0	0	2	0	-1	1	0.142857	19	10	7	0	78	20	0	0.0235690235690236	0.976430976430976	0.0235690235690236	21.2142857142857	chr4.fa:55598221-55598221_T_A	chr4_55598221_55598221			chr4.fa:55598221-55598221_T_A	0.0231856374473249					chr4.fa:55598221-55598221_T_A							19	19	7	0.14	0.0625	T/A	BIAS	NOBIAS	COLUMN NOT FOUND		0.0212121	60	0	8.44444	3.03276	60	0	26	75	16	0	1	SBS	0	20	16	0.257426	71.3941	298	7	0.0234899	1.88982	0.0153881	0.270326	34.3333	0.0844444	0.0303276	60	60	0	2	0	6	2	0.0294118	204	74.9497	198	8	0.040404	2.12132	0.005764	0.244236	34.1111	0.0778947	0.0555605	34.5826	40.398	0	2.22222	-5.8154	7	2	0.0707071	99	78	ENSG00000157404	ENSG00000157404	CCDS3496.1																						
chr17.fa:56435161-56435161_C_	0	0.872	2972	322	0	0	0	2188	86768	33	40	39.6563	549	544	1187	727	886	0.74642	DEL	chr17.fa	56435161	56435161	C		chr17.fa:56435161-56435161_C_	ENSG00000108375	RNF43	CCDS11607.1	-		659	659	-		frameshift_variant	8	COLUMN NOT FOUND	COLUMN NOT FOUND	ring finger protein 43	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr17.fa:56435161-56435161_C_	chr17:53790160-53790160	chr17:56435161-56435161	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr17.fa:56435161-56435161_C_	large_intestine (40 cases),stomach (4 cases),oesophagus (3 cases)		large_intestine (3 cases),pancreas (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (101 cases),pancreas (46 cases),stomach (27 cases),skin (22 cases),endometrium (16 cases),lung (15 cases),ovary (13 cases),oesophagus (8 cases),central_nervous_system (7 cases),biliary_tract (7 cases),breast (5 cases),urinary_tract (4 cases),liver (4 cases),prostate (3 cases),haematopoietic_and_lymphoid_tissue (2 cases),kidney (2 cases),autonomic_ganglia (2 cases),bone (1 cases),NS (1 cases),adrenal_gland (1 cases)	47	RNF43	ring finger protein 43	RNF43 is a HAP95 (AKAP8L; MIM 609475) binding ubiquitin ligase that promotes cell growth and is upregulated in colon cancer	URCC; RNF124	Ubiquitin dependent proteolysis	None described	NA	NA	NA	NA	None described	NA	NA	NA	NA	RNF43	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	RNF43	HUMAN|ENSEMBL=ENSG00000108375|UniProtKB=Q68DV7		PTHR16200:SF0	RING ZINC FINGER	SUBFAMILY NOT NAMED											chr17.fa:56435161-56435161_C_	17:56435161	ENSG00000108375	CCDS11607.1	frameshift_variant,feature_truncation	1976	1976	659	-1	-	-	1976delG	G659Vfs*41	chr17.fa:56435161-56435161_C_	ENSG00000108375	ENSG00000108375	CCDS11607.1	-	-	659	659	-	-	FRAME_SHIFT	8	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	RNF43	ring finger protein 43	CCDS11607.1	chr17.fa:56435161-56435161_C_	1976delG	G659Vfs*41	8	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.71606	0.0254279169130567	1208	865	COLUMN NOT FOUND	ENSG00000108375	-	-	-	large_intestine (40 cases),stomach (4 cases),oesophagus (3 cases)	-	large_intestine (3 cases),pancreas (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (101 cases),pancreas (46 cases),stomach (27 cases),skin (22 cases),endometrium (16 cases),lung (15 cases),ovary (13 cases),oesophagus (8 cases),central_nervous_system (7 cases),biliary_tract (7 cases),breast (5 cases),urinary_tract (4 cases),liver (4 cases),prostate (3 cases),haematopoietic_and_lymphoid_tissue (2 cases),kidney (2 cases),autonomic_ganglia (2 cases),bone (1 cases),NS (1 cases),adrenal_gland (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	883	0.996614	0	0	886	2	1	865	2.48092	0.71606	1208	93	310	266	COLUMN NOT FOUND	87	886	1	58	0	0	1.00457	0	-1	22	0.0248307	0	3	2	7	0	0						chr17.fa:56435161-56435161_C_	chr17_56435161_56435161			chr17.fa:56435161-56435161_C_	0.0254279169130567					chr17.fa:56435161-56435161_C_	chr17.fa:56435161-56435161_C_	Keep					58	58	1093	0.5	0.4519	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.736205	60	0	28.1305	13.3126	60	0	67	34	-101	0	1	DEL	1	0	-101	0.663366	269.181	1187	886	0.74642	0.136165	0.486383	0.509043	39.6563	0.281305	0.133126	60	60	0	1.00457	0	865	2.48092	0.71606	1208	268.004	1139	859	0.75417	0.221198	0.48472	0.507733	39.6635	0.276731	0.137264	41.9986	41.9982	0	1.00471	0.0004	844	2.47867	0.731369	1154	0	ENSG00000108375	ENSG00000108375	CCDS11607.1																						
chrX.fa:66765158-66765158_T_A	0	0.162	1996	7	0	0	726	14	558	39	40	39.8571	1	6	841	5	7	0.00832342	SBS	chrX.fa	66765158	66765158	T	A	chrX.fa:66765158-66765158_T_A	ENSG00000169083	AR	CCDS14387.1	cTg	cAg	57	57	L	Q	missense_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66765158-66765158_T_A	chrX:66681883-66681883	chrX:66765158-66765158	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66765158-66765158_T_A	large_intestine (7 cases),liver (1 cases),central_nervous_system (1 cases),lung (1 cases)		upper_aerodigestive_tract (19 cases),large_intestine (16 cases),skin (5 cases),liver (3 cases),kidney (2 cases),stomach (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	10	AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES	chrX.fa:66765158-66765158_T_A	NM_000044.3_L57Q	0.192	0.0012	0.05	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66765158-66765158_T_A	X:66765158	ENSG00000169083	CCDS14387.1	missense_variant	170	170	57	1	L/Q	cTg/cAg	170T>A	L57Q	chrX.fa:66765158-66765158_T_A	ENSG00000169083	ENSG00000169083	CCDS14387.1	cTg	cAg	57	57	L	Q	NON_SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA		rs78686797_T_A	chrX	66765157	66765158	rs78686797	+	T	A/T	single	by-cluster	0	0	missense	1		EXOME_CHIP,SEATTLESEQ,																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	9	rs78686797	SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66765158-66765158_T_A	170T>A	L57Q	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00560538	0.00489954331977069	892	5	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	large_intestine (7 cases),liver (1 cases),central_nervous_system (1 cases),lung (1 cases)	-	upper_aerodigestive_tract (19 cases),large_intestine (16 cases),skin (5 cases),liver (3 cases),kidney (2 cases),stomach (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	0.192	0.0012	0.05	T	A/T	single	by-cluster	0	0	missense	1	-	EXOME_CHIP,SEATTLESEQ,	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	159	9	7	5	2	0.00560538	892	97	135	59	COLUMN NOT FOUND	5	7	1	494	0	0	1.57143	0	-1	0	0	0	1	4	0	81	9	0	0.00832342449464923	0.991676575505351	0.00832342449464923	60.0714285714286	chrX.fa:66765158-66765158_T_A	chrX_66765158_66765158		chrX.fa:66765158-66765158_T_A	chrX.fa:66765158-66765158_T_A	0.00489954331977069					chrX.fa:66765158-66765158_T_A							62	62	7	0.14	0.0625	T/A	BIAS	NOBIAS	COLUMN NOT FOUND		0.00701403	59.9756	0	5.6	3.78317	60	0	71	30	-1	0	1	SBS	0	9	-1	0.70297	82.8805	841	7	0.00832342	1.88982	0.0153881	0.270326	39.8571	0.056	0.0378317	59.9756	60	0	1.57143	-0.0244	5	2	0.00560538	892	83.1777	789	7	0.00887199	1.88982	0.0153881	0.270326	40	0.0606667	0.0425781	41.3904	41.7202	0	2	-0.3298	4	2	0.00475624	841	81	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr5.fa:1294835-1294835_C_	0	0.843	3062	0	0	0	915	800	31690	37	40	39.6125	199	200	1227	336	311	0.253464	DEL	chr5.fa	1294835	1294835	C		chr5.fa:1294835-1294835_C_	ENSG00000164362	TERT	CCDS3861.2	-				-				COLUMN NOT FOUND	COLUMN NOT FOUND	telomerase reverse transcriptase	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr5.fa:1294835-1294835_C_	chr5:1347835-1347835	chr5:1294835-1294835	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr5.fa:1294835-1294835_C_				"central_nervous_system (2863 cases), urinary_tract (1834 case), thyroid (740 cases), skin (569 cases), liver (491 cases), ns (118 cases), large_intestine (47 cases), lung (28 case), kidney (12 cases), stomach (12 cases), upper_aerodigestive_tract (11 case), endometrium (10 cases), eye (9 cases), oesophagus (5 cases), soft_tissue (5 cases), breast (4 cases), pancreas (4 cases), ovary (2 cases), haematopoietic_and_lymphoid_tissue (1 cases), prostate (1 cases)"		TERT	telomerase reverse transcriptase	Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence and chromosomal repair and deregulation of telomerase expression in somatic cells may be involved in oncogenesis. 	DKCA2;DKCB4;EST2;TCS1;TP2;TRT;hEST2;hTRT	Telomere maintenance	High levels are TERT expression are associated with a reduced overall survival in AML patients.  Increased TERT expression correlates with improved survival in resected NSCLC.  High TERT levels are associated with a poor clinical outcome in breast cancer and may predict oral cancer progression and prognosis	Exp Hematol. 2011 Feb;39(2):195-202.e2, Anticancer Res. 2009 Apr;29(4):1157-62, Anticancer Res. 2006 Nov-Dec;26(6C):4901-4, Oral Oncol. 2007 Feb;43(2):122-9	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TERT_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TERT_Prognostic2	Survival of AML patients treated with chemotherapy according to TERT expression## Kaplan Meier curves for NSCLC patients with differing levels of TERT expression in their tumors	Exp Hematol. 2011 Feb;39(2):195-202.e2##Anticancer Res. 2009 Apr;29(4):1157-62	TERT expression has a predictive value in defining bladder cancer patients that will fail adjuvant BCG immunotherapy.  A broad spectrum of therapeutic strategies from direct targeting to immune targeting  of telomerase expressing cell to focusing on the telomeres themselves have been developed.  Combined siTERT gene therapy and TERT-specific I-131 treatment reduced tumor growth in a hepatoma mouse model.  Inhibition of telomerase activity with BIBR1532 in combination with carboplatin demonstrated positive results on ovarian cancer cells in vitro	J Cancer Res Clin Oncol. 2009 Sep;135(9):1169-75,Clin Adv Hematol Oncol. 2011 Jun;9(6):442-55, Cancer Gene Ther. 2012 Feb, Gynecol Oncol. 2012 Mar;124(3):598-605 	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TERT_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TERT_Therapeutic2	Post-BCG HERT positive patients had a worse survival than HERT negative cases##Therapeutic effects of I-131 and/or siTERT in a mouse model	J Cancer Res Clin Oncol. 2009 Sep;135(9):1169-75##Cancer Gene Ther. 2012 Feb	TERT	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TERT	HUMAN|ENSEMBL=ENSG00000164362|UniProtKB=O14746		PTHR12066:SF0	TELOMERASE REVERSE TRANSCRIPTASE	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transferase activity#GO:0016740;RNA-directed DNA polymerase activity#GO:0003964;binding#GO:0005488;catalytic activity#GO:0003824	transcription, RNA-dependent#GO:0006410;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;primary metabolic process#GO:0044238;metabolic process#GO:0008152		RNA binding protein#PC00031;reverse transcriptase#PC00200;nucleic acid binding#PC00171							chr5.fa:1294835-1294835_C_	5:1294835	ENSG00000164362	CCDS3861.2	intron_variant,feature_truncation	-		-	-1	-	-	219+51delG	N/A	chr5.fa:1294835-1294835_C_	ENSG00000164362	ENSG00000164362	CCDS3861.2							INTRON		SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	TERT	telomerase reverse transcriptase	CCDS3861.2	chr5.fa:1294835-1294835_C_	219+51delG	N/A	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.250407	0.0242124770999939	1230	308	COLUMN NOT FOUND	ENSG00000164362	nucleic acid binding#GO:0003676;transferase activity#GO:0016740;RNA-directed DNA polymerase activity#GO:0003964;binding#GO:0005488;catalytic activity#GO:0003824	transcription, RNA-dependent#GO:0006410;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	-	"central_nervous_system (2863 cases), urinary_tract (1834 case), thyroid (740 cases), skin (569 cases), liver (491 cases), ns (118 cases), large_intestine (47 cases), lung (28 case), kidney (12 cases), stomach (12 cases), upper_aerodigestive_tract (11 case), endometrium (10 cases), eye (9 cases), oesophagus (5 cases), soft_tissue (5 cases), breast (4 cases), pancreas (4 cases), ovary (2 cases), haematopoietic_and_lymphoid_tissue (1 cases), prostate (1 cases)"	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	306	0.983923	0	0	315	4	3	308	2.57143	0.250407	1230	92	271	251	COLUMN NOT FOUND	86	311	1	42	0	0	1.0175	0	-1	21	0.0675241	2	3	2	6	0	0						chr5.fa:1294835-1294835_C_	chr5_1294835_1294835			chr5.fa:1294835-1294835_C_	0.0242124770999939					chr5.fa:1294835-1294835_C_	chr5.fa:1294835-1294835_C_,chr5.fa:1294835-1294835__C	Keep					21	21	399	0.5	0.5	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.261267	60	0	28.0931	12.2956	60	0	78	23	-64	0	1	DEL	1	0	-64	0.772277	227.495	1227	311	0.253464	0.0441985	0.479623	0.517871	39.6125	0.280931	0.122956	60	60	0	1.0175	0	308	2.57143	0.250407	1230	225.408	1146	295	0.257417	0.658909	0.461183	0.500454	39.6122	0.27235	0.127575	41.9892	41.9601	0	1.01276	0.0291	291	2.65979	0.253043	1150	0	ENSG00000164362	ENSG00000164362	CCDS3861.2																						
chr9.fa:135771988-135771990_GCT_	0	0.108	3120	0	1250	0	0	70	2760	33	40	39.4286	19	16	1265	34	34	0.0268775	DEL	chr9.fa	135771988	135771990	GCT		chr9.fa:135771988-135771990_GCT_	ENSG00000165699	TSC1	CCDS6956.1	AGC	-	1043	1043	S	-	inframe_deletion	21	COLUMN NOT FOUND	COLUMN NOT FOUND	tuberous sclerosis 1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr9.fa:135771988-135771990_GCT_	chr9:134761809-134761811	chr9:135771988-135771990	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr9.fa:135771988-135771990_GCT_	endometrium (1 cases)		large_intestine (3 cases),lung (1 cases)	large_intestine (51 cases),urinary_tract (25 cases),skin (25 cases),lung (22 cases),stomach (15 cases),endometrium (14 cases),liver (11 cases),kidney (10 cases),breast (9 cases),ovary (6 cases),upper_aerodigestive_tract (5 cases),central_nervous_system (5 cases),haematopoietic_and_lymphoid_tissue (4 cases),bone (2 cases),oesophagus (2 cases),autonomic_ganglia (2 cases),prostate (2 cases),salivary_gland (1 cases),NS (1 cases),soft_tissue (1 cases),pancreas (1 cases)	1	TSC1	tuberous sclerosis 1	This gene encodes a growth inhibitory protein thought to play a role in the stabilization of tuberin. 	KIAA0243;LAM;MGC86987;TSC	mTOR signaling and cell cycle arrest	None described	NA	NA	NA	NA	Renal angiomyolipomas caused by defects in TSC1 display regression on treatment with the mTOR inhibitor, sirolimus (rapamycin).  Everolimus treatment of astrocytomas in patients with germline TSC1 mutations leads to a reduction in tumor size	PLoS One. 2011;6(9):e23379, Clin Cancer Res. 2011 Jun 15;17(12):4071-8,  N Engl J Med. 2010 Nov 4;363(19):1801-11	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic1	Reduced tumor burden in Tuberous Sclerosis patients treated with sirolimus (rapamycin)	PLoS One. 2011;6(9):e23379	TSC1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC1	HUMAN|ENSEMBL=ENSG00000165699|UniProtKB=Q92574		PTHR15154:SF2	HAMARTIN	SUBFAMILY NOT NAMED		cell cycle#GO:0007049;cellular process#GO:0009987			Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC1#P04495;p53 pathway by glucose deprivation#P04397>TSC1#P04645						chr9.fa:135771988-135771990_GCT_	9:135771988-135771990	ENSG00000165699	CCDS6956.1	inframe_deletion	3127-3129	3127-3129	1043	-1	S/-	AGC/-	3127_3129delAGC	S1043del	chr9.fa:135771988-135771990_GCT_	ENSG00000165699	ENSG00000165699	CCDS6956.1	agc	-	1043	1043	S	-	CODON_DELETION	21	SEQCTRLPS10_PS_Seq2_BWA	SNP:chr9_135771987_135771987_rs118203743_-_GCTGCT,SNP:chr9_135771987_135771988_rs201192125_G_A,SNP:chr9_135771987_135771990_rs118203719_()1376BPDEL_)LEHPV6731(,SNP:chr9_135771987_135771990_rs118203719_()1376BPDEL_-,SNP:chr9_135771987_135771990_rs2234980_GCTGCTGCTGCTGCTGCT_6)GCT(,SNP:chr9_135771987_135771990_rs2234980_GCTGCTGCTGCTGCTGCT_7,SNP:chr9_135771987_135771990_rs2234980_GCTGCTGCTGCTGCTGCT_8,SNP:chr9_135771987_135771996_rs118203719_()1376BPDEL_)LEHPV6731(,SNP:chr9_135771987_135771996_rs118203719_()1376BPDEL_-,SNP:chr9_135771987_135771996_rs2234980_GCTGCTGCTGCTGCTGCT_6)GCT(,SNP:chr9_135771987_135771996_rs2234980_GCTGCTGCTGCTGCTGCT_7,SNP:chr9_135771987_135771996_rs2234980_GCTGCTGCTGCTGCTGCT_8	rs118203743_-_GCT	chr9	135771987	135771987	rs118203743	-	-	-/AGC/AGCAGC	insertion	by-cluster	0	0	cds-indel	1		TSC2DB,	0				clinically-assoc,submitted-by-lsdb		FLAGGED																														COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC1	tuberous sclerosis 1	CCDS6956.1	chr9.fa:135771988-135771990_GCT_	3127_3129delAGC	S1043del	21	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0108949	0.00567594492794144	1285	14	COLUMN NOT FOUND	ENSG00000165699	-	cell cycle#GO:0007049;cellular process#GO:0009987	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC1#P04495;p53 pathway by glucose deprivation#P04397>TSC1#P04645	endometrium (1 cases)	-	large_intestine (3 cases),lung (1 cases)	large_intestine (51 cases),urinary_tract (25 cases),skin (25 cases),lung (22 cases),stomach (15 cases),endometrium (14 cases),liver (11 cases),kidney (10 cases),breast (9 cases),ovary (6 cases),upper_aerodigestive_tract (5 cases),central_nervous_system (5 cases),haematopoietic_and_lymphoid_tissue (4 cases),bone (2 cases),oesophagus (2 cases),autonomic_ganglia (2 cases),prostate (2 cases),salivary_gland (1 cases),NS (1 cases),soft_tissue (1 cases),pancreas (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-/AGC/AGCAGC	insertion	by-cluster	0	0	cds-indel	1	-	TSC2DB,	0	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	34	1	0	0	35	3	2	14	2.14286	0.0108949	1285	76	220	55	COLUMN NOT FOUND	55	34	1	34	0	0	1	0	-1	0	0	0	1	4	6	20	9						chr9.fa:135771988-135771990_GCT_	chr9_135771988_135771990			chr9.fa:135771988-135771990_GCT_	0.00567594492794144			chr9.fa:135771988-135771990_GCT_	SMExclude	chr9.fa:135771988-135771990_GCT_	chr9.fa:135771988-135771990_GCT_	Keep					37	37	35	0.46	0.3679	GCT/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0224359	60	0	30.3143	11.501	60	0	64	37	-1	0	1	DEL	3	9	-1	0.633663	140.182	1265	34	0.0268775	0.499796	0.399305	0.514981	39.4286	0.303143	0.11501	60	60	0	1	0	14	2.14286	0.0108949	1285	138.801	1216	32	0.0263158	0.17142	0.425231	0.544466	39.697	0.317879	0.100909	41.9909	41.7031	0	1	0.2878	14	2.14286	0.0113452	1234	20	ENSG00000165699	ENSG00000165699	CCDS6956.1																						
chrX.fa:66766368-66766368_C_T	0	0.401	144	0	59	0	10	20	782	34	40	39.1	8	2	69	9	10	0.144928	SBS	chrX.fa	66766368	66766368	C	T	chrX.fa:66766368-66766368_C_T	ENSG00000169083	AR	CCDS14387.1	ggC	ggT	460	460	G	G	synonymous_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66766368-66766368_C_T	chrX:66683093-66683093	chrX:66766368-66766368	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66766368-66766368_C_T			peritoneum (1 cases),liver (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)		AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66766368-66766368_C_T	X:66766368	ENSG00000169083	CCDS14387.1	synonymous_variant	1380	1380	460	1	G	ggC/ggT	1380C>T	%3D)	chrX.fa:66766368-66766368_C_T	ENSG00000169083	ENSG00000169083	CCDS14387.1	ggC	ggT	460	460	G	G	SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66766368-66766368_C_T	1380C>T	%3D)	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.144928	0.0830631584643892	69	10	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	-	-	peritoneum (1 cases),liver (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	10	2	0.144928	69	94	84	171	COLUMN NOT FOUND	24	10	1	40	0	0	2	0	-1	0	0	0	1	8	0	108	20	0	0.144927536231884	0.855072463768116	0.144927536231884	3.45	chrX.fa:66766368-66766368_C_T	chrX_66766368_66766368			chrX.fa:66766368-66766368_C_T	0.0830631584643892					chrX.fa:66766368-66766368_C_T							70	70	10	0.2	0.0547	C/T	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.138889	60	0	23.5	12.126	60	0	85	16	30	0	1	SBS	0	20	30	0.841584	93.7577	69	10	0.144928	1.89737	0.093352	0.306648	39.1	0.235	0.12126	60	60	0	2	0	10	2	0.144928	69	81.0982	59	7	0.118644	1.88982	0.0153881	0.270326	39	0.19	0.126388	40.9129	32.9415	0	2.42857	7.9714	7	2	0.118644	59	108	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr17.fa:7578561-7578561_G_A	0	0.933	2680	236	0	852	0	578	22956	34	40	39.7163	124	165	1086	253	236	0.217311	SBS	chr17.fa	7578561	7578561	G	A	chr17.fa:7578561-7578561_G_A	ENSG00000141510	TP53	CCDS11118.1	-				-		intron_variant	40	COLUMN NOT FOUND	COLUMN NOT FOUND	tumor protein p53	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr17.fa:7578561-7578561_G_A	chr17:7519286-7519286	chr17:7578561-7578561	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr17.fa:7578561-7578561_G_A				large_intestine (2857 cases),lung (1950 cases),breast (1840 cases),upper_aerodigestive_tract (1518 cases),oesophagus (1478 cases),ovary (1326 cases),central_nervous_system (1152 cases),haematopoietic_and_lymphoid_tissue (1148 cases),stomach (938 cases),liver (933 cases),urinary_tract (926 cases),pancreas (594 cases),skin (585 cases),prostate (222 cases),endometrium (215 cases),biliary_tract (207 cases),soft_tissue (177 cases),vulva (110 cases),bone (103 cases),kidney (98 cases),adrenal_gland (63 cases),thyroid (62 cases),cervix (59 cases),small_intestine (43 cases),salivary_gland (38 cases),peritoneum (23 cases),eye (22 cases),pleura (18 cases),thymus (16 cases),genital_tract (15 cases),NS (13 cases),penis (9 cases),testis (6 cases),autonomic_ganglia (5 cases),meninges (3 cases),fallopian_tube (2 cases),pituitary (2 cases),placenta (1 cases),gastrointestinal_tract_(site_indeterminate) (1 cases),vagina (1 cases)		TP53	Tumor protein p53	This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. 	FLJ92943;LFS1;P53;TRP53	DNA repair and apoptosis	TP53 mutations are associated with lymphatic invasion in proximal colorectal tumors and poor prognosis in breast cancer and NSCLC	J Clin Oncol.2005 Oct 20;23(30):7518-28; Oncogene. 2007 Apr 2;26(15):2157-65; Clin Cancer Res. 2006 Feb 15;12(4):1157-67; Eur Respir J. 2001 Oct;18(4):705-19; Br J Cancer. 1997;76(1):44-51	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TP53 breast prognosis##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TP53 lung prognosis	TP53 mutation status is correlated with survival in breast cancer.  Patients without mutation in TP53 and a positive PR status (blue), without mutation in TP53 and negative PR status (red), with mutation in TP53 and positive PR status (green) and with TP53 mutation and negative PR status (black)## Radically resected NSCLC patients with TP53 mutations, especially those in exon 5, have a worse prognosis	Clin Cancer Res. 2006 Feb 15;12(4):1157-67##Br J Cancer. 1997;76(1):44-51	TP53 mutations confer resistance to the MDM2 inhibitor nutlin-3a in vitro	Nature. 2012 Mar 28;483(7391):570-5	NA	NA	NA	TP53	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TP53	HUMAN|ENSEMBL=ENSG00000141510|UniProtKB=P04637		PTHR11447:SF6	CELLULAR TUMOR ANTIGEN P53	CELLULAR TUMOR ANTIGEN P53	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;DNA repair#GO:0006281;induction of apoptosis#GO:0006917;regulation of transcription from RNA polymerase II promoter#GO:0006357;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;DNA metabolic process#GO:0006259;primary metabolic process#GO:0044238;metabolic process#GO:0008152		transcription factor#PC00218	p53 pathway feedback loops 2#P04398>p53#P04668;p53 pathway by glucose deprivation#P04397>p53#P04640;p53 pathway#P00059>p53#P01485;P53 pathway feedback loops 1#P04392>p53#P04539;Apoptosis signaling pathway#P00006>p53#P00273;Huntington disease#P00029>p53#P00797;p53 pathway#P00059>p53#G04702;Wnt signaling pathway#P00057>p53#P01430						chr17.fa:7578561-7578561_G_A	17:7578561	ENSG00000141510	CCDS11118.1	splice_region_variant,intron_variant	-		-	-1	-	-	376-7C>T	N/A	chr17.fa:7578561-7578561_G_A	ENSG00000141510	ENSG00000141510	CCDS11118.1							INTRON		SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	TP53	tumor protein p53	CCDS11118.1	chr17.fa:7578561-7578561_G_A	376-7C>T	N/A	40	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.215074	0.0244145988199284	1088	234	COLUMN NOT FOUND	ENSG00000141510	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;DNA repair#GO:0006281;induction of apoptosis#GO:0006917;regulation of transcription from RNA polymerase II promoter#GO:0006357;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;DNA metabolic process#GO:0006259;primary metabolic process#GO:0044238;metabolic process#GO:0008152	p53 pathway feedback loops 2#P04398>p53#P04668;p53 pathway by glucose deprivation#P04397>p53#P04640;p53 pathway#P00059>p53#P01485;P53 pathway feedback loops 1#P04392>p53#P04539;Apoptosis signaling pathway#P00006>p53#P00273;Huntington disease#P00029>p53#P00797;p53 pathway#P00059>p53#G04702;Wnt signaling pathway#P00057>p53#P01430	-	-	-	large_intestine (2857 cases),lung (1950 cases),breast (1840 cases),upper_aerodigestive_tract (1518 cases),oesophagus (1478 cases),ovary (1326 cases),central_nervous_system (1152 cases),haematopoietic_and_lymphoid_tissue (1148 cases),stomach (938 cases),liver (933 cases),urinary_tract (926 cases),pancreas (594 cases),skin (585 cases),prostate (222 cases),endometrium (215 cases),biliary_tract (207 cases),soft_tissue (177 cases),vulva (110 cases),bone (103 cases),kidney (98 cases),adrenal_gland (63 cases),thyroid (62 cases),cervix (59 cases),small_intestine (43 cases),salivary_gland (38 cases),peritoneum (23 cases),eye (22 cases),pleura (18 cases),thymus (16 cases),genital_tract (15 cases),NS (13 cases),penis (9 cases),testis (6 cases),autonomic_ganglia (5 cases),meninges (3 cases),fallopian_tube (2 cases),pituitary (2 cases),placenta (1 cases),gastrointestinal_tract_(site_indeterminate) (1 cases),vagina (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	234	2.45299	0.215074	1088	98	271	332	COLUMN NOT FOUND	90	236	1	190	0	0	1.07266	0	-1	7	0.029661	2	1	1	2	0	0	0	0.21731123388582	0.78268876611418	0.21731123388582	2.30084745762712	chr17.fa:7578561-7578561_G_A	chr17_7578561_7578561			chr17.fa:7578561-7578561_G_A	0.0244145988199284					chr17.fa:7578561-7578561_G_A							55	55	289	0.43	0.0092	G/A	NOBIAS	BIAS	COLUMN NOT FOUND		0.215672	60	0	26.5503	14.6559	60	0	49	52	-101	0	1	SBS	0	0	-101	0.485149	217.171	1086	236	0.217311	2.17943	0.407113	0.451019	39.7163	0.265503	0.146559	60	60	0	1.07266	0	234	2.45299	0.215074	1088	215.549	1039	226	0.217517	2.22514	0.403559	0.448426	39.7329	0.262451	0.146399	41.9553	41.9065	0	1.07581	0.0488	226	2.45133	0.217517	1039	0	ENSG00000141510	ENSG00000141510	CCDS11118.1																						
chr4.fa:55604693-55604693_C_A	0	0.928	2680	222	858	0	0	540	21308	35	40	39.4593	138	132	1080	240	222	0.205556	SBS	chr4.fa	55604693	55604693	C	A	chr4.fa:55604693-55604693_C_A	ENSG00000157404	KIT	CCDS3496.1	tcC	tcA	967	967	S	S	synonymous_variant	21	COLUMN NOT FOUND	COLUMN NOT FOUND	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr4.fa:55604693-55604693_C_A	chr4:55299450-55299450	chr4:55604693-55604693	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr4.fa:55604693-55604693_C_A	large_intestine (1 cases)		central_nervous_system (1 cases),endometrium (1 cases)	haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)	1	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	C-Kit;CD117;PBT;SCFR	Tyrosine kinase signaling	Patients with exon 17 KIT mutations have a poorer prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Prognostic1	KIT mutations lead to poor prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic2	Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11##Mol Cancer Ther. 2011 Oct;10(10):1897-908.	KIT	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	HUMAN|ENSEMBL=ENSG00000157404|UniProtKB=P10721		PTHR24416:SF46	TYROSINE-PROTEIN KINASE RECEPTOR	MAST/STEM CELL GROWTH FACTOR RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr4.fa:55604693-55604693_C_A	4:55604693	ENSG00000157404	CCDS3496.1	synonymous_variant	2901	2901	967	1	S	tcC/tcA	2901C>A	%3D)	chr4.fa:55604693-55604693_C_A	ENSG00000157404	ENSG00000157404	CCDS3496.1	tcC	tcA	967	967	S	S	SYNONYMOUS_CODING	21	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	CCDS3496.1	chr4.fa:55604693-55604693_C_A	2901C>A	%3D)	21	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.205556	0.0241013055861222	1080	222	COLUMN NOT FOUND	ENSG00000157404	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	large_intestine (1 cases)	-	central_nervous_system (1 cases),endometrium (1 cases)	haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	222	2.43243	0.205556	1080	99	257	254	COLUMN NOT FOUND	90	222	1	50	0	0	1.0037	0	-1	9	0.0405405	3	1	1	0	0	0	0	0.205555555555556	0.794444444444445	0.205555555555556	2.43243243243243	chr4.fa:55604693-55604693_C_A	chr4_55604693_55604693			chr4.fa:55604693-55604693_C_A	0.0241013055861222					chr4.fa:55604693-55604693_C_A							20	20	270	0.49	0.3805	C/A	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.201493	60	0	25.3707	14.1109	60	0	56	45	-101	0	1	SBS	0	0	-101	0.554455	213.363	1080	222	0.205556	0.331104	0.466254	0.511524	39.4593	0.253707	0.141109	60	60	0	1.0037	0	222	2.43243	0.205556	1080	211.708	1036	213	0.205598	0.449062	0.461507	0.507723	39.4538	0.247759	0.142471	42	42	0	1.00385	0	213	2.44131	0.205598	1036	0	ENSG00000157404	ENSG00000157404	CCDS3496.1																						
chr10.fa:89623901-89623901_G_C	0	0.79	2344	0	929	0	0	2344	93004	32	40	39.6775	580	591	929	739	929	1	Homo-SBS	chr10.fa	89623901	89623901	G	C	chr10.fa:89623901-89623901_G_C	ENSG00000171862	PTEN	CCDS31238.1	-				-		upstream_gene_variant	13	COLUMN NOT FOUND	COLUMN NOT FOUND	phosphatase and tensin homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr10.fa:89623901-89623901_G_C	chr10:89613881-89613881	chr10:89623901-89623901	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr10.fa:89623901-89623901_G_C				endometrium (845 cases),central_nervous_system (560 cases),large_intestine (337 cases),haematopoietic_and_lymphoid_tissue (131 cases),skin (101 cases),breast (99 cases),lung (75 cases),prostate (59 cases),kidney (45 cases),ovary (44 cases),stomach (42 cases),thyroid (28 cases),liver (24 cases),upper_aerodigestive_tract (18 cases),cervix (13 cases),oesophagus (12 cases),soft_tissue (11 cases),urinary_tract (11 cases),vulva (9 cases),pancreas (9 cases),NS (8 cases),biliary_tract (5 cases),eye (4 cases),salivary_gland (3 cases),bone (2 cases),genital_tract (2 cases),meninges (2 cases),autonomic_ganglia (1 cases)		PTEN	phosphatase and tensin homolog	The protein encoded this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. 	10q23del;BZS;DEC;GLM2;MGC11227;MHAM;MMAC1;PTEN1;TEP1	Phosphatidylinositol signaling	Loss of PTEN is associated with worse prognosis in salivary gland cancer.  Homozygous PTEN deletion or mutation correlates with shorter survival in GBM patients.  Reduced PTEN expression leads to a worse prognosis in GIST patients.  PTEN mutations are associated with reduced survival in pediatric T-ALL patients	Br J Cancer. 2012 Feb 14;106(4):719-26, Neuropathology. 2011 Aug;31(4):376-83, Anticancer Res. 2010 Mar;30(3):981-5, J Huazhong Univ Sci Technolog Med Sci. 2010 Apr;30(2):165-9, Leukemia. 2010 Jan;24(1):239-42	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Prognostic3	Survival of salivary gland patients with tumors positive and negative for PTEN expression## PTEN deletion is associated with reduced survival in GBM patients##PTEN mutation and survival of pediatric T-ALL patients	Br J Cancer. 2012 Feb 14;106(4):719-26##Neuropathology. 2011 Aug;31(4):376-83##Leukemia. 2010 Jan;24(1):239-42	The combination of PTEN loss, low CEN7 copy number and PIK3CA gain is associated with poor response to gefitinib in NSCLC.  Activation of the PI3K pathway through loss of PTEN (or mutation of PIK3CA) may lead to resistance to lapatinib and trastuzumab in breast cancer. Loss of PTEN may confer sensitivity to PARP inhibitors in endometrial cancer and only colorectal cell lines with high PTEN expression are sensitive to 5-FU and oxiplatin treatment in vitro.  Over-expression of PTEN results in increased radioresistance in head and neck cancer.  Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in CRC	Br J Cancer. 2011 Dec 6;105(12):1920-6, BMC Cancer. 2011 Jun 15;11:11:248, Nat Rev Clin Oncol. 2011 May;8(5):302-6, Eur J Surg Oncol. 2011 Feb;37(2):140-7, Br J Cancer. 2010 Jun 8;102(12):1778-85, Br J Cancer. 2010 Mar 2;102(5):940	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTEN_Therapeutic2	Survival in NSCLC patients with PTEN loss when treated with gefitinib##Overall response rate and clinical benefit rate in breast cancer patients treated with lapatinib according to PI3K pathway activation	Br J Cancer. 2011 Dec 6;105(12):1920-6## BMC Cancer. 2011 Jun 15;11:11:248	PTEN	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	PTEN	HUMAN|ENSEMBL=ENSG00000171862|UniProtKB=P60484		PTHR12305:SF14	PHOSPHATASE WITH HOMOLOGY TO TENSIN	PTEN	hydrolase activity#GO:0016787;hydrolase activity, acting on ester bonds#GO:0016788;catalytic activity#GO:0003824;phosphoprotein phosphatase activity#GO:0004721;phosphoric monoester hydrolase activity#GO:0016791	apoptosis#GO:0006915;lipid metabolic process#GO:0006629;induction of apoptosis#GO:0006917;immune system process#GO:0002376;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;cell communication#GO:0007154;cell adhesion#GO:0007155;cellular process#GO:0009987;protein metabolic process#GO:0019538;phospholipid metabolic process#GO:0006644;protein modification process#GO:0006464;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein phosphatase#PC00195;phosphatase#PC00181;hydrolase#PC00121	p53 pathway#P00059>PTEN#G01579;p53 pathway feedback loops 2#P04398>PTEN#G04714;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#G04675;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#P00905;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PTEN#P00849;p53 pathway#P00059>PTEN#P01480;Hypoxia response via HIF activation#P00030>PTEN#P00824;PI3 kinase pathway#P00048>PTEN#P01189;p53 pathway feedback loops 2#P04398>PTEN#P04658						chr10.fa:89623901-89623901_G_C	10:89623901	ENSG00000171862	CCDS31238.1	upstream_gene_variant	-		-	1	-	-	-326G>C	N/A													SEQCTRLPS10_PS_Seq2_BWA		rs2943772_G_C	chr10	89623900	89623901	rs2943772	-	G	C/G	single	by-cluster,by-hapmap	0	0	near-gene-5,untranslated-5	1	SingleAlleleFreq	BCM-HGSC-SUB,BL,BUSHMAN,COMPLETE_GENOMICS,CSHL-HAPMAP,ENSEMBL,HUMANGENOME_JCVI,PJP,SC_JCM,SSMP,	1	G,	9.000000,																																		COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	41	rs2943772	SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	PTEN	phosphatase and tensin homolog	CCDS31238.1	chr10.fa:89623901-89623901_G_C	-326G>C	N/A	13	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	1	N/A	929	929	COLUMN NOT FOUND	ENSG00000171862	hydrolase activity#GO:0016787;hydrolase activity, acting on ester bonds#GO:0016788;catalytic activity#GO:0003824;phosphoprotein phosphatase activity#GO:0004721;phosphoric monoester hydrolase activity#GO:0016791	apoptosis#GO:0006915;lipid metabolic process#GO:0006629;induction of apoptosis#GO:0006917;immune system process#GO:0002376;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell cycle#GO:0007049;cell communication#GO:0007154;cell adhesion#GO:0007155;cellular process#GO:0009987;protein metabolic process#GO:0019538;phospholipid metabolic process#GO:0006644;protein modification process#GO:0006464;primary metabolic process#GO:0044238;metabolic process#GO:0008152	p53 pathway#P00059>PTEN#G01579;p53 pathway feedback loops 2#P04398>PTEN#G04714;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#G04675;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PTEN#P00905;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>PTEN#P00849;p53 pathway#P00059>PTEN#P01480;Hypoxia response via HIF activation#P00030>PTEN#P00824;PI3 kinase pathway#P00048>PTEN#P01189;p53 pathway feedback loops 2#P04398>PTEN#P04658	-	-	-	endometrium (845 cases),central_nervous_system (560 cases),large_intestine (337 cases),haematopoietic_and_lymphoid_tissue (131 cases),skin (101 cases),breast (99 cases),lung (75 cases),prostate (59 cases),kidney (45 cases),ovary (44 cases),stomach (42 cases),thyroid (28 cases),liver (24 cases),upper_aerodigestive_tract (18 cases),cervix (13 cases),oesophagus (12 cases),soft_tissue (11 cases),urinary_tract (11 cases),vulva (9 cases),pancreas (9 cases),NS (8 cases),biliary_tract (5 cases),eye (4 cases),salivary_gland (3 cases),bone (2 cases),genital_tract (2 cases),meninges (2 cases),autonomic_ganglia (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	G	C/G	single	by-cluster,by-hapmap	0	0	near-gene-5,untranslated-5	1	SingleAlleleFreq	BCM-HGSC-SUB,BL,BUSHMAN,COMPLETE_GENOMICS,CSHL-HAPMAP,ENSEMBL,HUMANGENOME_JCVI,PJP,SC_JCM,SSMP,	1	G,	9.000000,	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	1	0	929	2.52314	1	929	99	331	302	COLUMN NOT FOUND	92	929	1	4	0	0	1.61945	0	-1	51	0.0548977	0	2	4	1	0	10	0	1	0	0	0	chr10.fa:89623901-89623901_G_C	chr10_89623901_89623901		chr10.fa:89623901-89623901_G_C	chr10.fa:89623901-89623901_G_C	N/A					chr10.fa:89623901-89623901_G_C							40	40	1171	0.5	0.3851	G/C	NOBIAS	NOBIAS	COLUMN NOT FOUND		1	58.9069	0	26.2163	14.7459	58.9069	0	81	20	1	0	1	SBS	0	10	1	0.80198	271.203	929	929	1	0.286315	0.484238	0.506368	39.6775	0.262163	0.147459	58.9069	58.9069	0	1.61945	0	929	2.52314	1	929	269.778	895	895	1	0.239332	0.484727	0.507273	39.6853	0.261102	0.14896	16.7687	16.7687	0	1.65511	0	895	2.51397	1	895	0	ENSG00000171862	ENSG00000171862	CCDS31238.1																						
chrX.fa:66766359-66766359_C_T	0	0.51	172	0	51	0	16	34	1392	27	40	38.6667	8	9	80	17	16	0.2	SBS	chrX.fa	66766359	66766359	C	T	chrX.fa:66766359-66766359_C_T	ENSG00000169083	AR	CCDS14387.1	ggC	ggT	457	457	G	G	synonymous_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66766359-66766359_C_T	chrX:66683084-66683084	chrX:66766359-66766359	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66766359-66766359_C_T			liver (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)		AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66766359-66766359_C_T	X:66766359	ENSG00000169083	CCDS14387.1	synonymous_variant	1371	1371	457	1	G	ggC/ggT	1371C>T	%3D)	chrX.fa:66766359-66766359_C_T	ENSG00000169083	ENSG00000169083	CCDS14387.1	ggC	ggT	457	457	G	G	SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	9	.	SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66766359-66766359_C_T	1371C>T	%3D)	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.223881	0.0998139330188187	67	15	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	-	-	liver (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	15	2.13333	0.223881	67	94	215	183	COLUMN NOT FOUND	45	16	1	52	0	0	1	0	-1	2	0.125	0	1	5	0	122	20	0	0.2	0.8	0.2	2.5	chrX.fa:66766359-66766359_C_T	chrX_66766359_66766359		chrX.fa:66766359-66766359_C_T	chrX.fa:66766359-66766359_C_T	0.0998139330188187					chrX.fa:66766359-66766359_C_T							69	69	17	0.47	0.5	C/T	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.197674	60	0	16.44	15.6467	60	0	82	19	21	0	1	SBS	0	20	21	0.811881	109.551	80	16	0.2	0.235294	0.386276	0.554901	38.6667	0.1644	0.156467	60	60	0	1	0	15	2.13333	0.223881	67	104.26	67	14	0.208955	0.249444	0.376533	0.556801	38.5	0.15087	0.151052	40.9102	40.8565	0	1.25	0.0537	13	2.15385	0.213115	61	122	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr9.fa:98211549-98211549_G_	0	0.839	3268	0	0	0	1039	658	26010	35	40	39.5289	145	184	1312	295	277	0.211128	DEL	chr9.fa	98211549	98211549	G		chr9.fa:98211549-98211549_G_	ENSG00000185920	PTCH1	CCDS6714.1	-		1202	1202	-		frameshift_variant	22	COLUMN NOT FOUND	COLUMN NOT FOUND	patched 1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr9.fa:98211549-98211549_G_	chr9:97251370-97251370	chr9:98211549-98211549	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr9.fa:98211549-98211549_G_	large_intestine (6 cases),stomach (2 cases)		skin (3 cases),kidney (1 cases)	skin (205 cases),large_intestine (166 cases),central_nervous_system (67 cases),bone (41 cases),lung (36 cases),stomach (28 cases),breast (21 cases),endometrium (21 cases),urinary_tract (17 cases),oesophagus (17 cases),kidney (16 cases),haematopoietic_and_lymphoid_tissue (9 cases),upper_aerodigestive_tract (9 cases),ovary (8 cases),liver (7 cases),pancreas (5 cases),prostate (4 cases),NS (3 cases),thyroid (3 cases),soft_tissue (2 cases),biliary_tract (2 cases),genital_tract (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),meninges (1 cases),cervix (1 cases)	8	PTCH1	patched 1	This gene encodes a member of the patched gene family. The encoded protein is the receptor for sonic hedgehog, a secreted molecule implicated in the formation of embryonic structures and in tumorigenesis, as well as the desert hedgehog and indian hedgehog proteins. 	BCNS;FLJ26746;FLJ42602;HPE7;NBCCS;PTC;PTC1;PTCH;PTCH11	Hedgehog signaling	High PTCH1 expression is associated with large tumor size and lack of chemotherapy response in esophageal carcinomas.  Overall survival in bladder cancer patients is associated with PTCH1 expression levels.	Jpn J Clin Oncol. 2011 Mar;41(3):386-93; Pathol Oncol Res.2011 Aug 24	S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTCH1_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\PTCH1_Prognostic2	Progression free survival in esophageal cancer patients with different PTCH1 expression levels## Overall survival in bladder cancer patients with different PTCH1 expression levels	Jpn J Clin Oncol. 2011 Mar;41(3):386-93## Pathol Oncol Res.2011 Aug 24	The hedgehog pathway inhibitor, GDC-0449 has been shown to be effective against medulloblastoma cancer with a somatic PTCH1 mutation.	N Engl J Med. 2009 Sep 17;361(12):1173-8	NA	NA	NA	PTCH1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	PTCH1	HUMAN|ENSEMBL=ENSG00000185920|UniProtKB=Q13635		PTHR10796:SF61	PATCHED-RELATED	PROTEIN PATCHED HOMOLOG 1	receptor activity#GO:0004872	cell surface receptor linked signal transduction#GO:0007166;lipid metabolic process#GO:0006629;signal transduction#GO:0007165;exocytosis#GO:0006887;protein transport#GO:0015031;transport#GO:0006810;vesicle-mediated transport#GO:0016192;intracellular protein transport#GO:0006886;cell communication#GO:0007154;cellular process#GO:0009987;lipid transport#GO:0006869;primary metabolic process#GO:0044238;metabolic process#GO:0008152		receptor#PC00197	Hedgehog signaling pathway#P00025>Patched#P00689						chr9.fa:98211549-98211549_G_	9:98211549	ENSG00000185920	CCDS6714.1	frameshift_variant,feature_truncation	3606	3606	1202	-1	-	-	3606delC	S1203Afs*52	chr9.fa:98211549-98211549_G_	ENSG00000185920	ENSG00000185920	CCDS6714.1	-	-	1202	1202	-	-	FRAME_SHIFT	22	SEQCTRLPS10_PS_Seq2_BWA	SNP:chr9_98211548_98211549_rs138240178_G_A																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	PTCH1	patched 1	CCDS6714.1	chr9.fa:98211549-98211549_G_	3606delC	S1203Afs*52	22	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.207447	0.0219076460258407	1316	273	COLUMN NOT FOUND	ENSG00000185920	receptor activity#GO:0004872	cell surface receptor linked signal transduction#GO:0007166;lipid metabolic process#GO:0006629;signal transduction#GO:0007165;exocytosis#GO:0006887;protein transport#GO:0015031;transport#GO:0006810;vesicle-mediated transport#GO:0016192;intracellular protein transport#GO:0006886;cell communication#GO:0007154;cellular process#GO:0009987;lipid transport#GO:0006869;primary metabolic process#GO:0044238;metabolic process#GO:0008152	Hedgehog signaling pathway#P00025>Patched#P00689	large_intestine (6 cases),stomach (2 cases)	-	skin (3 cases),kidney (1 cases)	skin (205 cases),large_intestine (166 cases),central_nervous_system (67 cases),bone (41 cases),lung (36 cases),stomach (28 cases),breast (21 cases),endometrium (21 cases),urinary_tract (17 cases),oesophagus (17 cases),kidney (16 cases),haematopoietic_and_lymphoid_tissue (9 cases),upper_aerodigestive_tract (9 cases),ovary (8 cases),liver (7 cases),pancreas (5 cases),prostate (4 cases),NS (3 cases),thyroid (3 cases),soft_tissue (2 cases),biliary_tract (2 cases),genital_tract (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),meninges (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	273	0.98556	0	0	277	2	1	273	2.38095	0.207447	1316	93	295	278	COLUMN NOT FOUND	88	277	1	24	0	0	1.01824	0	-1	7	0.0252708	0	3	2	6	0	0						chr9.fa:98211549-98211549_G_	chr9_98211549_98211549			chr9.fa:98211549-98211549_G_	0.0219076460258407					chr9.fa:98211549-98211549_G_	chr9.fa:98211549-98211549_G_	Keep					36	36	329	0.44	0.018	G/	NOBIAS	BIAS	COLUMN NOT FOUND		0.201346	60	0	29.3114	12.451	60	0	72	29	-101	0	1	DEL	1	0	-101	0.712871	222.454	1312	277	0.211128	1.97292	0.420466	0.460993	39.5289	0.293114	0.12451	60	60	0	1.01824	0	273	2.38095	0.207447	1316	220.567	1246	264	0.211878	1.89646	0.420884	0.462397	39.53	0.290526	0.125811	41.9975	41.9877	0	1.01893	0.0098	263	2.40304	0.210906	1247	0	ENSG00000185920	ENSG00000185920	CCDS6714.1																						
chrX.fa:66765161-66765161_A_T	0	0.26	1994	729	0	0	28	58	2256	34	40	38.8966	15	14	840	25	28	0.0333333	SBS	chrX.fa	66765161	66765161	A	T	chrX.fa:66765161-66765161_A_T	ENSG00000169083	AR	CCDS14387.1	cAg	cTg	58	58	Q	L	missense_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66765161-66765161_A_T	chrX:66681886-66681886	chrX:66765161-66765161	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66765161-66765161_A_T	large_intestine (8 cases),liver (2 cases),kidney (2 cases),stomach (1 cases)		upper_aerodigestive_tract (19 cases),large_intestine (15 cases),skin (5 cases),liver (2 cases),central_nervous_system (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	13	AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES	chrX.fa:66765161-66765161_A_T	NM_000044.3_Q58L	0.090	0.0000	0.05	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66765161-66765161_A_T	X:66765161	ENSG00000169083	CCDS14387.1	missense_variant	173	173	58	1	Q/L	cAg/cTg	173A>T	Q58L	chrX.fa:66765161-66765161_A_T	ENSG00000169083	ENSG00000169083	CCDS14387.1	cAg	cTg	58	58	Q	L	NON_SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA	SNP:chrX_66765160_66765161_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765160_66765161_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765164_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765167_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765169_rs5902610_AGCAGCAGC_-	rs200185441_A_T	chrX	66765160	66765161	rs200185441	+	A	A/T	single	unknown	0	0	missense	1		EXOME_CHIP,																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	2	.	SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66765161-66765161_A_T	173A>T	Q58L	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0264201	0.011425125883169	757	20	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	large_intestine (8 cases),liver (2 cases),kidney (2 cases),stomach (1 cases)	-	upper_aerodigestive_tract (19 cases),large_intestine (15 cases),skin (5 cases),liver (2 cases),central_nervous_system (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	0.090	0.0000	0.05	A	A/T	single	unknown	0	0	missense	1	-	EXOME_CHIP,	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	20	2.1	0.0264201	757	94	219	277	COLUMN NOT FOUND	89	28	1	768	0	0	1.68966	0	-1	0	0	0	1	5	0	100	12	0	0.0333333333333333	0.966666666666667	0.0333333333333333	15	chrX.fa:66765161-66765161_A_T	chrX_66765161_66765161		chrX.fa:66765161-66765161_A_T	chrX.fa:66765161-66765161_A_T	0.011425125883169					chrX.fa:66765161-66765161_A_T							64	64	29	0.48	0.5	A/T	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0290873	59.9756	0	10.1212	8.46599	60	0	71	30	3	0	1	SBS	0	12	3	0.70297	130.976	840	28	0.0333333	0.182466	0.419024	0.546493	38.8966	0.101212	0.0846599	59.9756	60	0	1.68966	-0.0244	20	2.1	0.0264201	757	136.788	782	32	0.0409207	1.19994	0.334321	0.453557	39.1212	0.0927083	0.072653	41.3851	40.5717	0	1.9697	0.8134	23	2.08696	0.0326241	705	100	ENSG00000169083	ENSG00000169083	CCDS14387.1	1	2.073e-05	48232	4235	-1.059e+00	-4.900e-02	1271926	0.000	7.51	11.09	59.36	0	0.537	57235	25.08	0.146	4.68	InbreedingCoeff	.	A:0	AG:0	AGC:21
chrX.fa:66765159-66765164_GCAGCA_	0	0.119	1996	7	0	0	726	164	6510	38	40	39.6951	34	48	841	70	82	0.097503	DEL	chrX.fa	66765159	66765164	GCAGCA		chrX.fa:66765159-66765164_GCAGCA_	ENSG00000169083	AR	CCDS14387.1	ctGCAGCAg	ctg	57	57	LQQ	L	inframe_deletion	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66765159-66765164_GCAGCA_	chrX:66681884-66681889	chrX:66765159-66765164	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66765159-66765164_GCAGCA_	skin (1 cases)		large_intestine (24 cases),upper_aerodigestive_tract (19 cases),skin (4 cases),liver (4 cases),kidney (2 cases),central_nervous_system (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	1	AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66765159-66765164_GCAGCA_	X:66765159-66765164	ENSG00000169083	CCDS14387.1	inframe_deletion	171-176	171-176	57-59	1	LQQ/L	ctGCAGCAg/ctg	171_176delGCAGCA	Q60_Q61del	chrX.fa:66765159-66765164_GCAGCA_	ENSG00000169083	ENSG00000169083	CCDS14387.1	ctgcagcag	ctg	57	57	LQQ	L	CODON_DELETION	1	SEQCTRLPS10_PS_Seq2_BWA	SNP:chrX_66765159_66765164_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765159_66765167_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765159_66765170_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765160_66765161_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765160_66765161_rs200185441_A_T,SNP:chrX_66765160_66765161_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765164_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765167_rs5902610_AGCAGCAGC_-,SNP:chrX_66765160_66765169_rs5902610_AGCAGCAGC_-,SNP:chrX_66765163_66765164_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765163_66765164_rs5902610_AGCAGCAGC_-																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66765159-66765164_GCAGCA_	171_176delGCAGCA	Q60_Q61del	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0616592	0.0157853008524269	892	55	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	skin (1 cases)	-	large_intestine (24 cases),upper_aerodigestive_tract (19 cases),skin (4 cases),liver (4 cases),kidney (2 cases),central_nervous_system (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	67	0.817073	0	0	159	9	7	55	2	0.0616592	892	77	216	224	COLUMN NOT FOUND	19	82	1	494	0	0	1.18293	0	-1	0	0	0	1	4	10	81	9						chrX.fa:66765159-66765164_GCAGCA_	chrX_66765159_66765164			chrX.fa:66765159-66765164_GCAGCA_	0.0157853008524269			chrX.fa:66765159-66765164_GCAGCA_	SMExclude	chrX.fa:66765159-66765164_GCAGCA_	chrX.fa:66765159-66765159__GCA,chrX.fa:66765159-66765164_GCAGCA_,chrX.fa:66765159-66765159__GCAGCA,chrX.fa:66765159-66765170_GCAGCAGCAGCA_,chrX.fa:66765159-66765167_GCAGCAGCA_	Keep					63	63	82	0.41	0.0753	GCAGCA/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0821643	59.9756	0	19.3049	5.16358	60	0	71	30	-1	0	1	DEL	6	9	-1	0.70297	175.406	841	82	0.097503	1.54604	0.377391	0.451877	39.6951	0.193049	0.0516358	59.9756	60	0	1.18293	-0.0244	55	2	0.0616592	892	173.894	789	79	0.100127	0.787562	0.417753	0.49364	39.6835	0.215316	0.0539084	41.3904	40.3234	0	1.21519	1.067	54	2	0.0642093	841	81	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr4.fa:55598212-55598222_TTTTTTTTTTT_	0	0.192	874	261	0	0	2	104	3818	27	40	36.7115	19	33	403	52	51	0.126551	DEL	chr4.fa	55598212	55598222	TTTTTTTTTTT		chr4.fa:55598212-55598222_TTTTTTTTTTT_	ENSG00000157404	KIT	CCDS3496.1	-				-		intron_variant	16	COLUMN NOT FOUND	COLUMN NOT FOUND	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr4.fa:55598212-55598222_TTTTTTTTTTT_	chr4:55292969-55292979	chr4:55598212-55598222	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr4.fa:55598212-55598222_TTTTTTTTTTT_				haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)		KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	This gene encodes the human homolog of the proto-oncogene c-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). 	C-Kit;CD117;PBT;SCFR	Tyrosine kinase signaling	Patients with exon 17 KIT mutations have a poorer prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Prognostic1	KIT mutations lead to poor prognosis in AML	Leuk Res. 2011 Oct;35(10):1376-83	Tumors containing kit mutations may be sensitive to Imatinib, Sunitinib and Vatalanib and inhibition of the heat shock protein HSP10 by IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11, Sarcoma. 2010;2010:458156, N Engl J Med. 2002 Aug 15;347(7):472-80, J Clin Oncol. 2011 Jul 20;29(21):2904-9, Br J Cancer. 2011 May 24;104(11):1686-90, Mol Cancer Ther. 2011 Oct;10(10):1897-908.	S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\KIT_Therapeutic2	Effect of KIT mutations on Imatinib response in GIST patients##Reduction in tumor volume in mice carrying KIT mutations on treatment with Imatinib, Sunitinib and IPI-504	N Engl J Med. 2005 Aug 18;353(7):701-11##Mol Cancer Ther. 2011 Oct;10(10):1897-908.	KIT	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	HUMAN|ENSEMBL=ENSG00000157404|UniProtKB=P10721		PTHR24416:SF46	TYROSINE-PROTEIN KINASE RECEPTOR	MAST/STEM CELL GROWTH FACTOR RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr4.fa:55598212-55598222_TTTTTTTTTTT_	4:55598212-55598222	ENSG00000157404	CCDS3496.1	intron_variant,feature_truncation	-	-	-	1	-	-	2361+48_2361+58delTTTTTTTTTTT	N/A	chr4.fa:55598212-55598222_TTTTTTTTTTT_	ENSG00000157404	ENSG00000157404	CCDS3496.1							INTRON		SEQCTRLPS10_PS_Seq2_BWA	SNP:chr4_55598211_55598211_rs71662297_-_TT,SNP:chr4_55598211_55598212_rs5858293_TT_-,SNP:chr4_55598211_55598212_rs5858293_TT_T,SNP:chr4_55598211_55598213_rs5858293_TT_-,SNP:chr4_55598211_55598213_rs5858293_TT_T																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	CCDS3496.1	chr4.fa:55598212-55598222_TTTTTTTTTTT_	2361+48_2361+58delTTTTTTTTTTT	N/A	16	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.091314	0.0266445610383431	449	41	COLUMN NOT FOUND	ENSG00000157404	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;system development#GO:0048731;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;angiogenesis#GO:0001525;developmental process#GO:0032502;negative regulation of apoptosis#GO:0043066;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	-	haematopoietic_and_lymphoid_tissue (1127 cases),soft_tissue (980 cases),skin (203 cases),large_intestine (165 cases),testis (50 cases),genital_tract (41 cases),lung (36 cases),ovary (25 cases),breast (25 cases),endometrium (21 cases),liver (19 cases),stomach (16 cases),thymus (14 cases),central_nervous_system (14 cases),eye (10 cases),salivary_gland (9 cases),pancreas (8 cases),oesophagus (7 cases),NS (6 cases),urinary_tract (6 cases),kidney (5 cases),bone (4 cases),prostate (4 cases),upper_aerodigestive_tract (3 cases),autonomic_ganglia (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	51	1	0	0	186	9	7	41	2.04878	0.091314	449	69	247	221	COLUMN NOT FOUND	58	51	1	46	0	0	1	0	-1	0	0	0	5	4	2	83	20						chr4.fa:55598212-55598222_TTTTTTTTTTT_	chr4_55598212_55598222			chr4.fa:55598212-55598222_TTTTTTTTTTT_	0.0266445610383431					chr4.fa:55598212-55598222_TTTTTTTTTTT_	chr4.fa:55598212-55598221_TTTTTTTTTT_,chr4.fa:55598212-55598222_TTTTTTTTTTT_,chr4.fa:55598212-55598218_TTTTTTT_,chr4.fa:55598212-55598219_TTTTTTTT_,chr4.fa:55598212-55598223_TTTTTTTTTTTT_,chr4.fa:55598212-55598220_TTTTTTTTT_	Keep					17	17	52	0.37	0.0352	TTTTTTTTTTT/	NOBIAS	BIAS	COLUMN NOT FOUND		0.118993	60	0	32.4231	9.97322	60	0	26	75	14	0	1	DEL	11	20	14	0.257426	145.056	403	51	0.126551	1.92269	0.31816	0.412609	36.7115	0.324231	0.0997322	60	60	0	1	0	41	2.04878	0.091314	449	140.981	303	46	0.151815	2.16457	0.290701	0.39015	36.617	0.341277	0.0822403	37.3293	22.9935	0	1	14.3358	38	2.05263	0.117284	324	83	ENSG00000157404	ENSG00000157404	CCDS3496.1																						
chr13.fa:32913559-32913559_A_	0	0.78	1374	0	449	0	0	300	11932	37	40	39.7733	62	88	574	148	127	0.221254	DEL	chr13.fa	32913559	32913559	A		chr13.fa:32913559-32913559_A_	ENSG00000139618	BRCA2	CCDS9344.1	-		1689	1689	-		frameshift_variant	10	COLUMN NOT FOUND	COLUMN NOT FOUND	breast cancer 2, early onset	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr13.fa:32913559-32913559_A_	chr13:31811559-31811559	chr13:32913559-32913559	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr13.fa:32913559-32913559_A_	large_intestine (1 cases)			large_intestine (127 cases),lung (52 cases),skin (50 cases),endometrium (39 cases),stomach (31 cases),ovary (30 cases),breast (29 cases),urinary_tract (21 cases),liver (20 cases),oesophagus (17 cases),kidney (16 cases),pancreas (16 cases),central_nervous_system (15 cases),haematopoietic_and_lymphoid_tissue (11 cases),upper_aerodigestive_tract (8 cases),prostate (7 cases),thyroid (3 cases),bone (2 cases),NS (2 cases),cervix (2 cases),salivary_gland (1 cases),peritoneum (1 cases),pituitary (1 cases)	1	BRCA2	breast cancer 2, early onset	BRCA2 is involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. 	BRCC2;BROVCA2;FACD;FAD;FAD1;FANCB;FANCD;FANCD1;GLM3;PNCA2	DNA repair	BRCA2 mutations are associated with better survival in ovarian cancer.  Triple negative breast cancer patients with BRCA mutations have been shown to have a lower risk of relapse in some studies, but others have found no association between BRCA mutation status and prognosis in triple-negative cases	JAMA. 2011 Oct 12;306(14):1557-65, Clin Cancer Res. 2011 Mar 1;17(5):1082-9, Breast Cancer Res Treat. 2011 Nov;130(1):145-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Prognostic1##J :\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Prognostic2	Survival of ovarian cancer patients with BRCA mutations##Recurrence free survival in breast cancer patients by BRCA mutation status	JAMA. 2011 Oct 12;306(14):1557-65##Clin Cancer Res. 2011 Mar 1;17(5):1082-9	BRCA2 dysfunction sensitizes cells to PARP inhibition.  Clinical studies have also demonstrated the efficacy of PARP inhibitors such as olaparib and BSI-201 in BRCA mutation carriers.  Ovarian cancer patients with BRCA2 mutations are more sensitive to platimun based chemotherapy.  	Nature. 2005 Apr 14;434(7035):917-21, Curr Drug Targets. 2011 Jul 21, N Engl J Med. 2009 Jul 9;361(2):123-34, JAMA. 2011 Oct 12;306(14):1557-65	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRCA2_Therapeutic2	Reduction in viability of BRCA2 deficient cells after PARP1-specific siRNA silencing##Duration of treatment and best response of BRCA mutated tumors of various types	Nature. 2005 Apr 14;434(7035):917-21##N Engl J Med. 2009 Jul 9;361(2):123-34	BRCA2	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	BRCA2	HUMAN|ENSEMBL=ENSG00000139618|UniProtKB=P51587		PTHR11289:SF0	BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN BRCA2	SUBFAMILY NOT NAMED	damaged DNA binding#GO:0003684;nucleic acid binding#GO:0003676;binding#GO:0005488;DNA binding#GO:0003677	DNA repair#GO:0006281;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;primary metabolic process#GO:0044238;DNA metabolic process#GO:0006259;metabolic process#GO:0008152		damaged DNA-binding protein#PC00086;DNA binding protein#PC00009;nucleic acid binding#PC00171							chr13.fa:32913559-32913559_A_	13:32913559	ENSG00000139618	CCDS9344.1	frameshift_variant,feature_truncation	5067	5067	1689	1	-	-	5067delA	K1691Nfs*15	chr13.fa:32913559-32913559_A_	ENSG00000139618	ENSG00000139618	CCDS9344.1	-	-	1689	1689	-	-	FRAME_SHIFT	10	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	BRCA2	breast cancer 2, early onset	CCDS9344.1	chr13.fa:32913559-32913559_A_	5067delA	K1691Nfs*15	10	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.217014	0.0336639926770026	576	125	COLUMN NOT FOUND	ENSG00000139618	damaged DNA binding#GO:0003684;nucleic acid binding#GO:0003676;binding#GO:0005488;DNA binding#GO:0003677	DNA repair#GO:0006281;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;primary metabolic process#GO:0044238;DNA metabolic process#GO:0006259;metabolic process#GO:0008152	-	large_intestine (1 cases)	-	-	large_intestine (127 cases),lung (52 cases),skin (50 cases),endometrium (39 cases),stomach (31 cases),ovary (30 cases),breast (29 cases),urinary_tract (21 cases),liver (20 cases),oesophagus (17 cases),kidney (16 cases),pancreas (16 cases),central_nervous_system (15 cases),haematopoietic_and_lymphoid_tissue (11 cases),upper_aerodigestive_tract (8 cases),prostate (7 cases),thyroid (3 cases),bone (2 cases),NS (2 cases),cervix (2 cases),salivary_gland (1 cases),peritoneum (1 cases),pituitary (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	126	0.992126	0	0	127	2	1	125	2.368	0.217014	576	90	311	303	COLUMN NOT FOUND	86	127	1	22	0	0	1.00667	0	-1	0	0	0	3	2	7	0	0						chr13.fa:32913559-32913559_A_	chr13_32913559_32913559			chr13.fa:32913559-32913559_A_	0.0336639926770026			chr13.fa:32913559-32913559_A_	SMExclude	chr13.fa:32913559-32913559_A_	chr13.fa:32913559-32913559_A_	Keep					47	47	150	0.41	0.0204	A/	NOBIAS	BIAS	COLUMN NOT FOUND		0.218341	60	0	29.3355	13.0824	60	0	34	67	-101	0	1	DEL	1	0	-101	0.336634	192.981	574	127	0.221254	1.95337	0.383407	0.443259	39.7733	0.293355	0.130824	60	60	0	1.00667	0	125	2.368	0.217014	576	192.974	567	127	0.223986	2.04211	0.37947	0.439322	39.7718	0.28817	0.133988	42	42	0	1.00671	0	125	2.352	0.219684	569	0	ENSG00000139618	ENSG00000139618	CCDS9344.1																						
chr1.fa:156843543-156843543_T_C	0	0.947	2418	0	234	0	776	538	21442	35	40	39.855	171	98	1010	241	234	0.231683	SBS	chr1.fa	156843543	156843543	T	C	chr1.fa:156843543-156843543_T_C	ENSG00000198400	NTRK1	CCDS1161.1	aaT	aaC	323	323	N	N	synonymous_variant	8	COLUMN NOT FOUND	COLUMN NOT FOUND	neurotrophic tyrosine kinase, receptor, type 1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr1.fa:156843543-156843543_T_C	chr1:155110167-155110167	chr1:156843543-156843543	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr1.fa:156843543-156843543_T_C	liver (2 cases),large_intestine (1 cases)		skin (2 cases),lung (2 cases),liver (1 cases),oesophagus (1 cases),stomach (1 cases),endometrium (1 cases)	large_intestine (49 cases),lung (43 cases),skin (41 cases),endometrium (18 cases),kidney (14 cases),stomach (11 cases),breast (10 cases),ovary (9 cases),urinary_tract (9 cases),pancreas (7 cases),liver (7 cases),central_nervous_system (6 cases),oesophagus (5 cases),NS (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),prostate (3 cases),parathyroid (1 cases),meninges (1 cases),upper_aerodigestive_tract (1 cases)	3	NTRK1	neurotrophic tyrosine kinase, receptor, type 1	This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, mental retardation and cancer. 	DKFZp781I14186;MTC;TRK;TRK1;TRKA;Trk-A;p140-TrkA	MAP kinase signaling	Neuroblastoma patients with tumors expressing NTRK1 have a more favorable prognosis.  Expression of activated NTRK1 in melanomas correlates with poor outcome	Pediatr Blood Cancer. 2011 May;56(5):749-56, Am J Clin Pathol. 2004 Sep;122(3):412-20	S:\Sample reports\Automated Report Info\Figures for gene slide subset\NTRK1_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\NTRK1_Prognostic2	Within the intermediate neuroblastoma risk group, expression of NTRK1 (TrkA) is associated with better clinical outcome##Kaplan-Meier curves showing the relationship between NTRK1 (TrkA) expression and overall survival	Pediatr Blood Cancer. 2011 May;56(5):749-56## Am J Clin Pathol. 2004 Sep;122(3):412-20	Lestaurtinib is an NTRK1 inhibitor that has been effective in neuroblastoma models and is now in clinical trials.	Clin Cancer Res. 2009 May 15;15(10):3244-50	NA	NA	NA	NTRK1	YES	YES	YES	chr1.fa:156843543-156843543_T_C	ENST00000497019_M249T	0.692	0.5915	0.65	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	NTRK1	HUMAN|ENSEMBL=ENSG00000198400|UniProtKB=P04629		PTHR24416:SF133	TYROSINE-PROTEIN KINASE RECEPTOR	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;MAPKKK cascade#GO:0000165;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;nervous system development#GO:0007399;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr1.fa:156843543-156843543_T_C	1:156843543	ENSG00000198400	CCDS1161.1	synonymous_variant	969	969	323	1	N	aaT/aaC	969T>C	%3D)	chr1.fa:156843543-156843543_T_C	ENSG00000198400	ENSG00000198400	CCDS1161.1	aaT	aaC	323	323	N	N	SYNONYMOUS_CODING	8	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	NTRK1	neurotrophic tyrosine kinase, receptor, type 1	CCDS1161.1	chr1.fa:156843543-156843543_T_C	969T>C	%3D)	8	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.231683	0.026020329991836	1010	234	COLUMN NOT FOUND	ENSG00000198400	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;MAPKKK cascade#GO:0000165;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;nervous system development#GO:0007399;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	liver (2 cases),large_intestine (1 cases)	-	skin (2 cases),lung (2 cases),liver (1 cases),oesophagus (1 cases),stomach (1 cases),endometrium (1 cases)	large_intestine (49 cases),lung (43 cases),skin (41 cases),endometrium (18 cases),kidney (14 cases),stomach (11 cases),breast (10 cases),ovary (9 cases),urinary_tract (9 cases),pancreas (7 cases),liver (7 cases),central_nervous_system (6 cases),oesophagus (5 cases),NS (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),prostate (3 cases),parathyroid (1 cases),meninges (1 cases),upper_aerodigestive_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	0.692	0.5915	0.65	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	234	2.29915	0.231683	1010	99	234	325	COLUMN NOT FOUND	91	234	1	30	0	0	1.01487	0	-1	22	0.0940171	0	2	1	0	0	0	0	0.231683168316832	0.768316831683168	0.231683168316832	2.15811965811966	chr1.fa:156843543-156843543_T_C	chr1_156843543_156843543			chr1.fa:156843543-156843543_T_C	0.026020329991836					chr1.fa:156843543-156843543_T_C							4	4	269	0.36	0	T/C	NOBIAS	BIAS	COLUMN NOT FOUND		0.222498	60	0	25.4718	13.9307	60	0	61	40	-101	0	1	SBS	0	0	-101	0.60396	217.592	1010	234	0.231683	4.15125	0.342266	0.386359	39.855	0.254718	0.139307	60	60	0	1.01487	0	234	2.29915	0.231683	1010	214.197	942	215	0.228238	4.14767	0.335565	0.381566	39.8486	0.250335	0.139618	41.9738	42	0	1.01594	-0.0262	215	2.33488	0.228238	942	0	ENSG00000198400	ENSG00000198400	CCDS1161.1	4	3.295e-05	121398	109396	0.646	-7.550e-01	1287504	2.439	52.41	18.87	59.29	0	1.77	57	10.57	0.827	-1.231e-01	MQ	.	T:0	TG:0	TGA:0
chr7.fa:140434422-140434422_C_	0	0.345	3838	0	0	0	1502	10	398	39	40	39.8	3	2	1507	5	5	0.00331785	DEL	chr7.fa	140434422	140434422	C		chr7.fa:140434422-140434422_C_	ENSG00000157764	BRAF	CCDS5863.1	-		759	759	-		frameshift_variant	18	COLUMN NOT FOUND	COLUMN NOT FOUND	v-raf murine sarcoma viral oncogene homolog B	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr7.fa:140434422-140434422_C_	chr7:140080891-140080891	chr7:140434422-140434422	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:140434422-140434422_C_			stomach (2 cases),skin (1 cases),lung (1 cases)	thyroid (12133 cases),skin (5148 cases),large_intestine (4462 cases),NS (860 cases),haematopoietic_and_lymphoid_tissue (515 cases),central_nervous_system (322 cases),ovary (261 cases),lung (170 cases),eye (67 cases),pituitary (57 cases),endometrium (37 cases),soft_tissue (36 cases),biliary_tract (33 cases),stomach (29 cases),breast (27 cases),prostate (27 cases),liver (24 cases),upper_aerodigestive_tract (22 cases),urinary_tract (21 cases),pancreas (18 cases),small_intestine (16 cases),bone (15 cases),testis (8 cases),cervix (6 cases),kidney (6 cases),oesophagus (5 cases),genital_tract (4 cases),adrenal_gland (4 cases),salivary_gland (2 cases),meninges (2 cases),autonomic_ganglia (2 cases),pleura (1 cases)		BRAF	v-raf murine sarcoma viral oncogene homolog B1	This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. 	B-RAF1;BRAF1;FLJ95109;MGC126806;MGC138284;NS7;RAFB1	MAP kinase signaling	BRAF V600E mutations in NSCLC are associated with a more aggressive histotype and shorter survival.  BRAF mutations in colorectal cancer are indicative of poorer survival and a high rate of peritoneal and lymph node metastases.  BRAF mutation is predictive of aggressive clinicopathological characteristics in thyroid cancer.	J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Prognostic2	Overall survival of lung cancer patients with and without V600E mutation in BRAF##Patients with BRAF mutations (Black line) have a worse prognosis than those with wild type BRAF (Grey line)	J Clin Oncol. 2011 Sep 10;29(26):3574-9##Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086	Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885	Lancet Oncol. 2010 Aug;11(8):753-62; Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61; Sci Transl Med 2010 Jun 9;2(35):35ra41;  Ann Oncol. 2009 Aug;20 Suppl 6:vi35-40; Cancer Res. 2006 Dec 1;66(23):11100-5; N Engl J Med. 2011 Jun 30;364(26):2507-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic3	Reduced tumor volume in mouse models with mutant BRAF tumors after treatment with Sorafenib and PLX4720##SB590885 is effective in reducing tumor size in mouse models##Vemurafenib (PLX4032) resulted in improved survival in a Phase 3 trial in metastatic melanoma patients with BRAF mutations.	Sci Transl Med 2010 Jun 9;2(35):35ra41##Cancer Res. 2006 Dec 1;66(23):11100-5##N Engl J Med. 2011 Jun 30;364(26):2507-16	BRAF	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	BRAF	HUMAN|ENSEMBL=ENSG00000157764|UniProtKB=P15056		PTHR23257:SF41	SERINE-THREONINE PROTEIN KINASE	B-RAF	transmembrane receptor protein serine/threonine kinase activity#GO:0004675;non-membrane spanning protein tyrosine kinase activity#GO:0004715;transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;transmembrane receptor protein kinase activity#GO:0019199;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;female gamete generation#GO:0007292;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;gamete generation#GO:0007276;developmental process#GO:0032502;cell adhesion#GO:0007155;cell communication#GO:0007154;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;I-kappaB kinase/NF-kappaB cascade#GO:0007249;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;immune system process#GO:0002376;response to stimulus#GO:0050896;response to stress#GO:0006950;reproduction#GO:0000003;anatomical structure morphogenesis#GO:0009653;protein amino acid phosphorylation#GO:0006468;transmembrane receptor protein serine/threonine kinase signaling pathway#GO:0007178;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;cellular structure morphogenesis#GO:0032989;JNK cascade#GO:0007254;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152		protein kinase receptor#PC00194;non-receptor serine/threonine protein kinase#PC00167;serine/threonine protein kinase receptor#PC00205;tyrosine protein kinase receptor#PC00233;protein kinase#PC00193;non-receptor tyrosine protein kinase#PC00168;transferase#PC00220;kinase#PC00137;receptor#PC00197	VEGF signaling pathway#P00056>Raf#P01417;Integrin signalling pathway#P00034>Raf#P00924;EGF receptor signaling pathway#P00018>Raf-1#P00560;PDGF signaling pathway#P00047>Raf#P01161;Angiogenesis#P00005>Raf#P00243;Interleukin signaling pathway#P00036>Raf#P00983;Integrin signalling pathway#P00034>B-Raf#P00911;Ras Pathway#P04393>Raf#P04556;B cell activation#P00010>Raf#P00381;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>Raf-1#P00843;T cell activation#P00053>Raf#P01311						chr7.fa:140434422-140434422_C_	7:140434422	ENSG00000157764	CCDS5863.1	frameshift_variant,feature_truncation	2276	2276	759	-1	-	-	2276delG	G759Dfs*?	chr7.fa:140434422-140434422_C_	ENSG00000157764	ENSG00000157764	CCDS5863.1	-	-	759	759	-	-	FRAME_SHIFT	18	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	BRAF	v-raf murine sarcoma viral oncogene homolog B	CCDS5863.1	chr7.fa:140434422-140434422_C_	2276delG	G759Dfs*?	18	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00331785	0.00290339524603108	1507	5	COLUMN NOT FOUND	ENSG00000157764	transmembrane receptor protein serine/threonine kinase activity#GO:0004675;non-membrane spanning protein tyrosine kinase activity#GO:0004715;transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;transmembrane receptor protein kinase activity#GO:0019199;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;female gamete generation#GO:0007292;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;gamete generation#GO:0007276;developmental process#GO:0032502;cell adhesion#GO:0007155;cell communication#GO:0007154;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;I-kappaB kinase/NF-kappaB cascade#GO:0007249;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;immune system process#GO:0002376;response to stimulus#GO:0050896;response to stress#GO:0006950;reproduction#GO:0000003;anatomical structure morphogenesis#GO:0009653;protein amino acid phosphorylation#GO:0006468;transmembrane receptor protein serine/threonine kinase signaling pathway#GO:0007178;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;cellular structure morphogenesis#GO:0032989;JNK cascade#GO:0007254;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152	VEGF signaling pathway#P00056>Raf#P01417;Integrin signalling pathway#P00034>Raf#P00924;EGF receptor signaling pathway#P00018>Raf-1#P00560;PDGF signaling pathway#P00047>Raf#P01161;Angiogenesis#P00005>Raf#P00243;Interleukin signaling pathway#P00036>Raf#P00983;Integrin signalling pathway#P00034>B-Raf#P00911;Ras Pathway#P04393>Raf#P04556;B cell activation#P00010>Raf#P00381;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>Raf-1#P00843;T cell activation#P00053>Raf#P01311	-	-	stomach (2 cases),skin (1 cases),lung (1 cases)	thyroid (12133 cases),skin (5148 cases),large_intestine (4462 cases),NS (860 cases),haematopoietic_and_lymphoid_tissue (515 cases),central_nervous_system (322 cases),ovary (261 cases),lung (170 cases),eye (67 cases),pituitary (57 cases),endometrium (37 cases),soft_tissue (36 cases),biliary_tract (33 cases),stomach (29 cases),breast (27 cases),prostate (27 cases),liver (24 cases),upper_aerodigestive_tract (22 cases),urinary_tract (21 cases),pancreas (18 cases),small_intestine (16 cases),bone (15 cases),testis (8 cases),cervix (6 cases),kidney (6 cases),oesophagus (5 cases),genital_tract (4 cases),adrenal_gland (4 cases),salivary_gland (2 cases),meninges (2 cases),autonomic_ganglia (2 cases),pleura (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	5	1	0	0	5	2	1	5	2	0.00331785	1507	74	53	30	COLUMN NOT FOUND	53	5	1	30	0	0	1	0	-1	4	0.8	0	2	1	5	0	0						chr7.fa:140434422-140434422_C_	chr7_140434422_140434422			chr7.fa:140434422-140434422_C_	0.00290339524603108					chr7.fa:140434422-140434422_C_	chr7.fa:140434422-140434422_C_	Keep					29	29	5	0.4	0.5	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.00260552	59.9966	0	18.6	11.5585	60	0	47	54	-101	0	1	DEL	1	0	-101	0.465347	71.312	1507	5	0.00331785	0.447214	0.249177	0.550823	39.8	0.186	0.115585	59.9966	60	0	1	-0.0034	5	2	0.00331785	1507	27.7259	1412	1	0.000708215	1	0	0.33725	40	0.39	0	27.5285	25	0	1	2.5285	1	2	0.000708215	1412	0	ENSG00000157764	ENSG00000157764	CCDS5863.1																						
chr2.fa:16082314-16082314_C_	0	0.794	3280	1073	0	0	0	622	24504	31	40	39.3955	142	169	1329	280	266	0.20015	DEL	chr2.fa	16082314	16082314	C		chr2.fa:16082314-16082314_C_	ENSG00000134323	MYCN	CCDS1687.1	-		43	43	-		frameshift_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr2.fa:16082314-16082314_C_	chr2:15999765-15999765	chr2:16082314-16082314	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr2.fa:16082314-16082314_C_	large_intestine (4 cases),stomach (1 cases)		autonomic_ganglia (4 cases),endometrium (4 cases),large_intestine (3 cases),skin (2 cases),central_nervous_system (2 cases),pancreas (1 cases),stomach (1 cases),kidney (1 cases)	large_intestine (29 cases),skin (22 cases),lung (11 cases),central_nervous_system (7 cases),endometrium (7 cases),urinary_tract (5 cases),autonomic_ganglia (5 cases),stomach (4 cases),kidney (4 cases),liver (3 cases),oesophagus (3 cases),breast (2 cases),NS (2 cases),pancreas (2 cases),prostate (2 cases),salivary_gland (1 cases),ovary (1 cases),bone (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),adrenal_gland (1 cases),upper_aerodigestive_tract (1 cases),biliary_tract (1 cases)	5	MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived	This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. 	MODED;N-myc;NMYC;ODED;bHLHe37	Regulation of transcription	MYCN amplification in neuroblastoma is generally associated with a poor prognosis	Science. 1984 Jun 8;224(4653):1121-4, J Clin Oncol. 2009 Apr 1;27(10):1627-36	S:\Sample reports\Automated Report Info\Figures for gene slide subset\MYCN_Prognostic1	The overall survival of neuroblastoma patients with MYC/MYCN amplifications is reduced compared to those with wild type MYC status	 J Clin Oncol. 2009 Apr 1;27(10):1627-36	None described	NA	NA	NA	NA	MYCN	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	MYCN	HUMAN|ENSEMBL=ENSG00000134323|UniProtKB=P04198		PTHR11514:SF3	MYC	N-MYC PROTO-ONCOGENE PROTEIN	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;regulation of transcription from RNA polymerase II promoter#GO:0006357;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152		transcription factor#PC00218;nucleic acid binding#PC00171;basic helix-loop-helix transcription factor#PC00055	Wnt signaling pathway#P00057>Wnt Target Genes#G01558						chr2.fa:16082314-16082314_C_	2:16082314	ENSG00000134323	CCDS1687.1	frameshift_variant,feature_truncation	128	128	43	1	-	-	128delC	P45Rfs*86	chr2.fa:16082314-16082314_C_	ENSG00000134323	ENSG00000134323	CCDS1687.1	-	-	43	43	-	-	FRAME_SHIFT	1	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	MYCN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	CCDS1687.1	chr2.fa:16082314-16082314_C_	128delC	P45Rfs*86	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.190299	0.0210176343936032	1340	255	COLUMN NOT FOUND	ENSG00000134323	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;regulation of transcription from RNA polymerase II promoter#GO:0006357;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;transcription#GO:0006350;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;metabolic process#GO:0008152	Wnt signaling pathway#P00057>Wnt Target Genes#G01558	large_intestine (4 cases),stomach (1 cases)	-	autonomic_ganglia (4 cases),endometrium (4 cases),large_intestine (3 cases),skin (2 cases),central_nervous_system (2 cases),pancreas (1 cases),stomach (1 cases),kidney (1 cases)	large_intestine (29 cases),skin (22 cases),lung (11 cases),central_nervous_system (7 cases),endometrium (7 cases),urinary_tract (5 cases),autonomic_ganglia (5 cases),stomach (4 cases),kidney (4 cases),liver (3 cases),oesophagus (3 cases),breast (2 cases),NS (2 cases),pancreas (2 cases),prostate (2 cases),salivary_gland (1 cases),ovary (1 cases),bone (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),adrenal_gland (1 cases),upper_aerodigestive_tract (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	263	0.988722	0	0	267	3	2	255	2.35294	0.190299	1340	93	332	273	COLUMN NOT FOUND	83	266	1	50	0	0	1.01929	0	-1	22	0.0827068	0	3	2	7	0	0						chr2.fa:16082314-16082314_C_	chr2_16082314_16082314			chr2.fa:16082314-16082314_C_	0.0210176343936032			chr2.fa:16082314-16082314_C_	SMExclude	chr2.fa:16082314-16082314_C_	chr2.fa:16082314-16082314_C_	Keep					6	6	311	0.46	0.0701	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.189634	60	0	29.4635	12.4135	60	0	65	36	-101	0	1	DEL	1	0	-101	0.643564	220.112	1329	266	0.20015	1.41594	0.435914	0.47727	39.3955	0.294635	0.124135	60	60	0	1.01929	0	255	2.35294	0.190299	1340	217.757	1250	251	0.2008	1.46997	0.432321	0.474895	39.3814	0.292542	0.129288	41.9885	41.9396	0	1.02062	0.0489	242	2.33058	0.192216	1259	0	ENSG00000134323	ENSG00000134323	CCDS1687.1																						
chrX.fa:66766357-66766365_GGCGGCGGC_	0	0.172	208	0	0	0	84	20	766	36	40	38.3	8	2	97	9	10	0.103093	DEL	chrX.fa	66766357	66766365	GGCGGCGGC		chrX.fa:66766357-66766365_GGCGGCGGC_	ENSG00000169083	AR	CCDS14387.1	GGCGGCGGC	-	457	457	GGG	-	inframe_deletion	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66766357-66766365_GGCGGCGGC_	chrX:66683082-66683090	chrX:66766357-66766365	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66766357-66766365_GGCGGCGGC_			peritoneum (1 cases),liver (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)		AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66766357-66766365_GGCGGCGGC_	X:66766357-66766365	ENSG00000169083	CCDS14387.1	inframe_deletion	1369-1377	1369-1377	457-459	1	GGG/-	GGCGGCGGC/-	1369_1377delGGCGGCGGC	G460_G462del	chrX.fa:66766357-66766365_GGCGGCGGC_	ENSG00000169083	ENSG00000169083	CCDS14387.1	ggcggcggc	-	457	457	GGG	-	CODON_DELETION	1	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66766357-66766365_GGCGGCGGC_	1369_1377delGGCGGCGGC	G460_G462del	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0918367	0.0571785602748271	98	9	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	-	-	peritoneum (1 cases),liver (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	14	4	3	9	2	0.0918367	98	66	84	155	COLUMN NOT FOUND	24	10	1	52	0	0	2	0	-1	0	0	0	1	4	5	102	20						chrX.fa:66766357-66766365_GGCGGCGGC_	chrX_66766357_66766365			chrX.fa:66766357-66766365_GGCGGCGGC_	0.0571785602748271			chrX.fa:66766357-66766365_GGCGGCGGC_	SMExclude	chrX.fa:66766357-66766365_GGCGGCGGC_	chrX.fa:66766357-66766365_GGCGGCGGC_,chrX.fa:66766357-66766362_GGCGGC_	Keep					68	68	10	0.2	0.0547	GGCGGCGGC/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0961538	60	0	25.5	8.76872	60	0	81	20	18	0	1	DEL	9	20	18	0.80198	91.8394	97	10	0.103093	1.89737	0.093352	0.306648	38.3	0.255	0.0876872	60	60	0	2	0	9	2	0.0918367	98	61.561	85	4	0.0470588	1	0.081375	0.418625	38.25	0.35	0.0507064	41.147	24	0	2	17.147	3	2	0.0348837	86	102	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr7.fa:140482927-140482927_G_	0	0.305	3470	1385	0	0	0	42	1672	39	40	39.8095	8	13	1403	21	16	0.0114041	DEL	chr7.fa	140482927	140482927	G		chr7.fa:140482927-140482927_G_	ENSG00000157764	BRAF	CCDS5863.1	-		403	403	-		frameshift_variant	10	COLUMN NOT FOUND	COLUMN NOT FOUND	v-raf murine sarcoma viral oncogene homolog B	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr7.fa:140482927-140482927_G_	chr7:140129396-140129396	chr7:140482927-140482927	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:140482927-140482927_G_	large_intestine (2 cases)		large_intestine (2 cases),cervix (1 cases)	thyroid (12133 cases),skin (5148 cases),large_intestine (4462 cases),NS (860 cases),haematopoietic_and_lymphoid_tissue (515 cases),central_nervous_system (322 cases),ovary (261 cases),lung (170 cases),eye (67 cases),pituitary (57 cases),endometrium (37 cases),soft_tissue (36 cases),biliary_tract (33 cases),stomach (29 cases),breast (27 cases),prostate (27 cases),liver (24 cases),upper_aerodigestive_tract (22 cases),urinary_tract (21 cases),pancreas (18 cases),small_intestine (16 cases),bone (15 cases),testis (8 cases),cervix (6 cases),kidney (6 cases),oesophagus (5 cases),genital_tract (4 cases),adrenal_gland (4 cases),salivary_gland (2 cases),meninges (2 cases),autonomic_ganglia (2 cases),pleura (1 cases)	2	BRAF	v-raf murine sarcoma viral oncogene homolog B1	This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. 	B-RAF1;BRAF1;FLJ95109;MGC126806;MGC138284;NS7;RAFB1	MAP kinase signaling	BRAF V600E mutations in NSCLC are associated with a more aggressive histotype and shorter survival.  BRAF mutations in colorectal cancer are indicative of poorer survival and a high rate of peritoneal and lymph node metastases.  BRAF mutation is predictive of aggressive clinicopathological characteristics in thyroid cancer.	J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Prognostic2	Overall survival of lung cancer patients with and without V600E mutation in BRAF##Patients with BRAF mutations (Black line) have a worse prognosis than those with wild type BRAF (Grey line)	J Clin Oncol. 2011 Sep 10;29(26):3574-9##Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086	Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885	Lancet Oncol. 2010 Aug;11(8):753-62; Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61; Sci Transl Med 2010 Jun 9;2(35):35ra41;  Ann Oncol. 2009 Aug;20 Suppl 6:vi35-40; Cancer Res. 2006 Dec 1;66(23):11100-5; N Engl J Med. 2011 Jun 30;364(26):2507-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic3	Reduced tumor volume in mouse models with mutant BRAF tumors after treatment with Sorafenib and PLX4720##SB590885 is effective in reducing tumor size in mouse models##Vemurafenib (PLX4032) resulted in improved survival in a Phase 3 trial in metastatic melanoma patients with BRAF mutations.	Sci Transl Med 2010 Jun 9;2(35):35ra41##Cancer Res. 2006 Dec 1;66(23):11100-5##N Engl J Med. 2011 Jun 30;364(26):2507-16	BRAF	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	BRAF	HUMAN|ENSEMBL=ENSG00000157764|UniProtKB=P15056		PTHR23257:SF41	SERINE-THREONINE PROTEIN KINASE	B-RAF	transmembrane receptor protein serine/threonine kinase activity#GO:0004675;non-membrane spanning protein tyrosine kinase activity#GO:0004715;transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;transmembrane receptor protein kinase activity#GO:0019199;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;female gamete generation#GO:0007292;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;gamete generation#GO:0007276;developmental process#GO:0032502;cell adhesion#GO:0007155;cell communication#GO:0007154;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;I-kappaB kinase/NF-kappaB cascade#GO:0007249;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;immune system process#GO:0002376;response to stimulus#GO:0050896;response to stress#GO:0006950;reproduction#GO:0000003;anatomical structure morphogenesis#GO:0009653;protein amino acid phosphorylation#GO:0006468;transmembrane receptor protein serine/threonine kinase signaling pathway#GO:0007178;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;cellular structure morphogenesis#GO:0032989;JNK cascade#GO:0007254;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152		protein kinase receptor#PC00194;non-receptor serine/threonine protein kinase#PC00167;serine/threonine protein kinase receptor#PC00205;tyrosine protein kinase receptor#PC00233;protein kinase#PC00193;non-receptor tyrosine protein kinase#PC00168;transferase#PC00220;kinase#PC00137;receptor#PC00197	VEGF signaling pathway#P00056>Raf#P01417;Integrin signalling pathway#P00034>Raf#P00924;EGF receptor signaling pathway#P00018>Raf-1#P00560;PDGF signaling pathway#P00047>Raf#P01161;Angiogenesis#P00005>Raf#P00243;Interleukin signaling pathway#P00036>Raf#P00983;Integrin signalling pathway#P00034>B-Raf#P00911;Ras Pathway#P04393>Raf#P04556;B cell activation#P00010>Raf#P00381;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>Raf-1#P00843;T cell activation#P00053>Raf#P01311						chr7.fa:140482927-140482927_G_	7:140482927	ENSG00000157764	CCDS5863.1	frameshift_variant,feature_truncation	1208	1208	403	-1	-	-	1208delC	P403Lfs*8	chr7.fa:140482927-140482927_G_	ENSG00000157764	ENSG00000157764	CCDS5863.1	-	-	403	403	-	-	FRAME_SHIFT	10	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	BRAF	v-raf murine sarcoma viral oncogene homolog B	CCDS5863.1	chr7.fa:140482927-140482927_G_	1208delC	P403Lfs*8	10	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0114041	0.0055560709975556	1403	16	COLUMN NOT FOUND	ENSG00000157764	transmembrane receptor protein serine/threonine kinase activity#GO:0004675;non-membrane spanning protein tyrosine kinase activity#GO:0004715;transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;transmembrane receptor protein kinase activity#GO:0019199;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;female gamete generation#GO:0007292;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;gamete generation#GO:0007276;developmental process#GO:0032502;cell adhesion#GO:0007155;cell communication#GO:0007154;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;I-kappaB kinase/NF-kappaB cascade#GO:0007249;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;immune system process#GO:0002376;response to stimulus#GO:0050896;response to stress#GO:0006950;reproduction#GO:0000003;anatomical structure morphogenesis#GO:0009653;protein amino acid phosphorylation#GO:0006468;transmembrane receptor protein serine/threonine kinase signaling pathway#GO:0007178;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;cellular structure morphogenesis#GO:0032989;JNK cascade#GO:0007254;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152	VEGF signaling pathway#P00056>Raf#P01417;Integrin signalling pathway#P00034>Raf#P00924;EGF receptor signaling pathway#P00018>Raf-1#P00560;PDGF signaling pathway#P00047>Raf#P01161;Angiogenesis#P00005>Raf#P00243;Interleukin signaling pathway#P00036>Raf#P00983;Integrin signalling pathway#P00034>B-Raf#P00911;Ras Pathway#P04393>Raf#P04556;B cell activation#P00010>Raf#P00381;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>Raf-1#P00843;T cell activation#P00053>Raf#P01311	large_intestine (2 cases)	-	large_intestine (2 cases),cervix (1 cases)	thyroid (12133 cases),skin (5148 cases),large_intestine (4462 cases),NS (860 cases),haematopoietic_and_lymphoid_tissue (515 cases),central_nervous_system (322 cases),ovary (261 cases),lung (170 cases),eye (67 cases),pituitary (57 cases),endometrium (37 cases),soft_tissue (36 cases),biliary_tract (33 cases),stomach (29 cases),breast (27 cases),prostate (27 cases),liver (24 cases),upper_aerodigestive_tract (22 cases),urinary_tract (21 cases),pancreas (18 cases),small_intestine (16 cases),bone (15 cases),testis (8 cases),cervix (6 cases),kidney (6 cases),oesophagus (5 cases),genital_tract (4 cases),adrenal_gland (4 cases),salivary_gland (2 cases),meninges (2 cases),autonomic_ganglia (2 cases),pleura (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	16	1	0	0	18	3	2	16	2.625	0.0114041	1403	72	222	117	COLUMN NOT FOUND	70	16	1	46	0	0	1	0	-1	4	0.25	0	3	2	7	0	0						chr7.fa:140482927-140482927_G_	chr7_140482927_140482927			chr7.fa:140482927-140482927_G_	0.0055560709975556			chr7.fa:140482927-140482927_G_	SMExclude	chr7.fa:140482927-140482927_G_	chr7.fa:140482927-140482927_G_	Keep					33	33	21	0.38	0.1917	G/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0121037	60	0	30.8571	11.7088	60	0	45	56	-101	0	1	DEL	1	0	-101	0.445545	112.789	1403	16	0.0114041	0.952381	0.29664	0.465265	39.8095	0.308571	0.117088	60	60	0	1	0	16	2.625	0.0114041	1403	101.994	1309	12	0.0091673	1.01885	0.255585	0.450297	39.7647	0.272941	0.0988867	41.9239	42	0	1	-0.0761	12	2.83333	0.0091673	1309	0	ENSG00000157764	ENSG00000157764	CCDS5863.1																						
chrX.fa:66765164-66765164_A_T	0	0.199	1910	704	0	0	21	42	1668	38	40	39.7143	11	10	813	18	21	0.0258303	SBS	chrX.fa	66765164	66765164	A	T	chrX.fa:66765164-66765164_A_T	ENSG00000169083	AR	CCDS14387.1	cAg	cTg	59	59	Q	L	missense_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	androgen receptor	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chrX.fa:66765164-66765164_A_T	chrX:66681889-66681889	chrX:66765164-66765164	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chrX.fa:66765164-66765164_A_T	large_intestine (2 cases),skin (1 cases)		large_intestine (21 cases),upper_aerodigestive_tract (19 cases),skin (4 cases),liver (4 cases),kidney (2 cases),central_nervous_system (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	3	AR	androgen receptor	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. 	AIS;DHTR;HUMARA;HYSP1;KD;NR3C4;SBMA;SMAX1;TFM	Hormone activated regulation of transcription	Low AR expression, prior to hormonal therapy, is associated with tumor progression.	Int J Urol. 2002 Oct;9(10):545-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Prognostic1	Progression free survival according to AR expression.  Solid line high expression; dotted line low expression	Int J Urol. 2002 Oct;9(10):545-53	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.  Activating mutations in the AR gene lead to endocrine therapy resistance.  Hsp90 inhibitors result in the degradation of AR and inhibit tumor growth in mice.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8, Endocr Relat Cancer. 2005 Jun;12(2):229-44, Semin Oncol. 2003 Oct;30(5):709-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\AR_Therapeutic1	High AR levels are associated with improved survival in breast cancer patients after hormonal therapy.	Clin Cancer Res. 2009 Apr 1;15(7):2472-8	AR	YES	YES	YES	chrX.fa:66765164-66765164_A_T	NM_000044.3_Q59L	0.102	0.0000	0.05	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	HUMAN|ENSEMBL=ENSG00000169083|UniProtKB=P10275		PTHR24084:SF6	FAMILY NOT NAMED	SUBFAMILY NOT NAMED	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152		transcription factor#PC00218;nuclear hormone receptor#PC00169;receptor#PC00197;nucleic acid binding#PC00171	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774						chrX.fa:66765164-66765164_A_T	X:66765164	ENSG00000169083	CCDS14387.1	missense_variant	176	176	59	1	Q/L	cAg/cTg	176A>T	Q59L	chrX.fa:66765164-66765164_A_T	ENSG00000169083	ENSG00000169083	CCDS14387.1	cAg	cTg	59	59	Q	L	NON_SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA	SNP:chrX_66765163_66765164_rs193922933_CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG_(CAG(10_36)),SNP:chrX_66765163_66765164_rs5902610_AGCAGCAGC_-																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	AR	androgen receptor	CCDS14387.1	chrX.fa:66765164-66765164_A_T	176A>T	Q59L	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.022069	0.0106938027809528	725	16	COLUMN NOT FOUND	ENSG00000169083	nucleic acid binding#GO:0003676;transcription factor activity#GO:0003700;receptor activity#GO:0004872;ligand-dependent nuclear receptor activity#GO:0004879;binding#GO:0005488;transcription regulator activity#GO:0030528;DNA binding#GO:0003677	female gamete generation#GO:0007292;signal transduction#GO:0007165;gamete generation#GO:0007276;regulation of transcription from RNA polymerase II promoter#GO:0006357;system process#GO:0003008;neurological system process#GO:0050877;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process#GO:0006139;cell communication#GO:0007154;cellular process#GO:0009987;transcription from RNA polymerase II promoter#GO:0006366;primary metabolic process#GO:0044238;reproduction#GO:0000003;cell motility#GO:0006928;mitosis#GO:0007067;cell cycle#GO:0007049;transcription#GO:0006350;metabolic process#GO:0008152	Gonadotropin-releasing hormone receptor pathway#P06664>AR#P06774	large_intestine (2 cases),skin (1 cases)	-	large_intestine (21 cases),upper_aerodigestive_tract (19 cases),skin (4 cases),liver (4 cases),kidney (2 cases),central_nervous_system (1 cases),stomach (1 cases),lung (1 cases)	large_intestine (75 cases),lung (33 cases),stomach (30 cases),skin (26 cases),upper_aerodigestive_tract (25 cases),endometrium (14 cases),breast (12 cases),oesophagus (11 cases),liver (10 cases),prostate (10 cases),ovary (8 cases),central_nervous_system (5 cases),kidney (4 cases),urinary_tract (3 cases),pancreas (3 cases),biliary_tract (3 cases),bone (2 cases),pleura (1 cases),haematopoietic_and_lymphoid_tissue (1 cases),peritoneum (1 cases),autonomic_ganglia (1 cases),adrenal_gland (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	0.102	0.0000	0.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	16	2	0.022069	725	97	172	197	COLUMN NOT FOUND	4	21	1	768	0	0	2.04762	0	-1	0	0	0	1	6	0	103	15	0	0.025830258302583	0.974169741697417	0.025830258302583	19.3571428571429	chrX.fa:66765164-66765164_A_T	chrX_66765164_66765164			chrX.fa:66765164-66765164_A_T	0.0106938027809528			chrX.fa:66765164-66765164_A_T	SMExclude	chrX.fa:66765164-66765164_A_T							65	65	21	0.48	0.5	A/T	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0219895	59.9745	0	6.78788	3.38035	60	0	70	31	6	0	1	SBS	0	15	6	0.693069	122.759	813	21	0.0258303	0.218218	0.402596	0.549784	39.7143	0.0678788	0.0338035	59.9745	60	0	2.04762	-0.0255	16	2	0.022069	725	135.185	756	30	0.0396825	1.82574	0.27176	0.394906	39.3667	0.0805882	0.0343703	41.371	41.8696	0	2.36667	-0.4986	21	2	0.0310192	677	103	ENSG00000169083	ENSG00000169083	CCDS14387.1																						
chr1.fa:156846308-156846308_C_	0	0.896	3010	0	0	934	0	728	28948	37	40	39.7637	170	194	1237	316	305	0.246564	DEL	chr1.fa	156846308	156846308	C		chr1.fa:156846308-156846308_C_	ENSG00000198400	NTRK1	CCDS1161.1	-		583	583	-		frameshift_variant	14	COLUMN NOT FOUND	COLUMN NOT FOUND	neurotrophic tyrosine kinase, receptor, type 1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr1.fa:156846308-156846308_C_	chr1:155112932-155112932	chr1:156846308-156846308	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr1.fa:156846308-156846308_C_	large_intestine (1 cases)		skin (1 cases),lung (1 cases)	large_intestine (49 cases),lung (43 cases),skin (41 cases),endometrium (18 cases),kidney (14 cases),stomach (11 cases),breast (10 cases),ovary (9 cases),urinary_tract (9 cases),pancreas (7 cases),liver (7 cases),central_nervous_system (6 cases),oesophagus (5 cases),NS (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),prostate (3 cases),parathyroid (1 cases),meninges (1 cases),upper_aerodigestive_tract (1 cases)	1	NTRK1	neurotrophic tyrosine kinase, receptor, type 1	This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, mental retardation and cancer. 	DKFZp781I14186;MTC;TRK;TRK1;TRKA;Trk-A;p140-TrkA	MAP kinase signaling	Neuroblastoma patients with tumors expressing NTRK1 have a more favorable prognosis.  Expression of activated NTRK1 in melanomas correlates with poor outcome	Pediatr Blood Cancer. 2011 May;56(5):749-56, Am J Clin Pathol. 2004 Sep;122(3):412-20	S:\Sample reports\Automated Report Info\Figures for gene slide subset\NTRK1_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\NTRK1_Prognostic2	Within the intermediate neuroblastoma risk group, expression of NTRK1 (TrkA) is associated with better clinical outcome##Kaplan-Meier curves showing the relationship between NTRK1 (TrkA) expression and overall survival	Pediatr Blood Cancer. 2011 May;56(5):749-56## Am J Clin Pathol. 2004 Sep;122(3):412-20	Lestaurtinib is an NTRK1 inhibitor that has been effective in neuroblastoma models and is now in clinical trials.	Clin Cancer Res. 2009 May 15;15(10):3244-50	NA	NA	NA	NTRK1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	NTRK1	HUMAN|ENSEMBL=ENSG00000198400|UniProtKB=P04629		PTHR24416:SF133	TYROSINE-PROTEIN KINASE RECEPTOR	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;MAPKKK cascade#GO:0000165;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;nervous system development#GO:0007399;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr1.fa:156846308-156846308_C_	1:156846308	ENSG00000198400	CCDS1161.1	frameshift_variant,feature_truncation	1749	1749	583	1	-	-	1749delC	L585Cfs*73	chr1.fa:156846308-156846308_C_	ENSG00000198400	ENSG00000198400	CCDS1161.1	-	-	583	583	-	-	FRAME_SHIFT	14	SEQCTRLPS10_PS_Seq2_BWA	SNP:chr1_156846307_156846308_rs200008715_CC_-																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	NTRK1	neurotrophic tyrosine kinase, receptor, type 1	CCDS1161.1	chr1.fa:156846308-156846308_C_	1749delC	L585Cfs*73	14	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.244552	0.0239336177441156	1239	303	COLUMN NOT FOUND	ENSG00000198400	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;MAPKKK cascade#GO:0000165;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;nervous system development#GO:0007399;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	large_intestine (1 cases)	-	skin (1 cases),lung (1 cases)	large_intestine (49 cases),lung (43 cases),skin (41 cases),endometrium (18 cases),kidney (14 cases),stomach (11 cases),breast (10 cases),ovary (9 cases),urinary_tract (9 cases),pancreas (7 cases),liver (7 cases),central_nervous_system (6 cases),oesophagus (5 cases),NS (3 cases),haematopoietic_and_lymphoid_tissue (3 cases),prostate (3 cases),parathyroid (1 cases),meninges (1 cases),upper_aerodigestive_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	254	0.832787	0	0	305	2	1	303	2.38944	0.244552	1239	93	294	256	COLUMN NOT FOUND	88	305	1	358	0	0	1.18956	0	-1	10	0.0327869	0	2	2	5	0	0						chr1.fa:156846308-156846308_C_	chr1_156846308_156846308			chr1.fa:156846308-156846308_C_	0.0239336177441156					chr1.fa:156846308-156846308_C_	chr1.fa:156846308-156846308_C_	Keep					5	5	364	0.47	0.114	C/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.24186	60	0	26.9919	13.5969	60	0	65	36	-101	0	1	DEL	1	0	-101	0.643564	227.591	1237	305	0.246564	1.15149	0.447722	0.486344	39.7637	0.269919	0.135969	60	60	0	1.18956	0	303	2.38944	0.244552	1239	226.281	1171	295	0.251921	1.17775	0.446079	0.48535	39.7657	0.266205	0.139485	41.9835	41.933	0	1.19714	0.0505	293	2.37543	0.249787	1173	0	ENSG00000198400	ENSG00000198400	CCDS1161.1																						
chr7.fa:140434575-140434575_A_	0	0.201	542	0	192	0	0	154	5736	26	40	37.2468	2	75	265	45	77	0.290566	DEL	chr7.fa	140434575	140434575	A		chr7.fa:140434575-140434575_A_	ENSG00000157764	BRAF	CCDS5863.1	-				-		intron_variant	18	COLUMN NOT FOUND	COLUMN NOT FOUND	v-raf murine sarcoma viral oncogene homolog B	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr7.fa:140434575-140434575_A_	chr7:140081044-140081044	chr7:140434575-140434575	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr7.fa:140434575-140434575_A_	upper_aerodigestive_tract (1 cases)			thyroid (12133 cases),skin (5148 cases),large_intestine (4462 cases),NS (860 cases),haematopoietic_and_lymphoid_tissue (515 cases),central_nervous_system (322 cases),ovary (261 cases),lung (170 cases),eye (67 cases),pituitary (57 cases),endometrium (37 cases),soft_tissue (36 cases),biliary_tract (33 cases),stomach (29 cases),breast (27 cases),prostate (27 cases),liver (24 cases),upper_aerodigestive_tract (22 cases),urinary_tract (21 cases),pancreas (18 cases),small_intestine (16 cases),bone (15 cases),testis (8 cases),cervix (6 cases),kidney (6 cases),oesophagus (5 cases),genital_tract (4 cases),adrenal_gland (4 cases),salivary_gland (2 cases),meninges (2 cases),autonomic_ganglia (2 cases),pleura (1 cases)	1	BRAF	v-raf murine sarcoma viral oncogene homolog B1	This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. 	B-RAF1;BRAF1;FLJ95109;MGC126806;MGC138284;NS7;RAFB1	MAP kinase signaling	BRAF V600E mutations in NSCLC are associated with a more aggressive histotype and shorter survival.  BRAF mutations in colorectal cancer are indicative of poorer survival and a high rate of peritoneal and lymph node metastases.  BRAF mutation is predictive of aggressive clinicopathological characteristics in thyroid cancer.	J Clin Oncol. 2011 Sep 10;29(26):3574-9, Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086, Ann Surg Oncol. 2010 Dec;17(12):3294-300	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Prognostic2	Overall survival of lung cancer patients with and without V600E mutation in BRAF##Patients with BRAF mutations (Black line) have a worse prognosis than those with wild type BRAF (Grey line)	J Clin Oncol. 2011 Sep 10;29(26):3574-9##Cancer. 2011 Mar 31. doi: 10.1002/cncr.26086	Tumors with BRAF mutations are resistant to cetuximab and panitumumab, but sensitive to vemurafenib (PLX4032), sorafenib, PLX4720, RAF265, AZ268 and SB-590885	Lancet Oncol. 2010 Aug;11(8):753-62; Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61; Sci Transl Med 2010 Jun 9;2(35):35ra41;  Ann Oncol. 2009 Aug;20 Suppl 6:vi35-40; Cancer Res. 2006 Dec 1;66(23):11100-5; N Engl J Med. 2011 Jun 30;364(26):2507-16	S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\BRAF_Therapeutic3	Reduced tumor volume in mouse models with mutant BRAF tumors after treatment with Sorafenib and PLX4720##SB590885 is effective in reducing tumor size in mouse models##Vemurafenib (PLX4032) resulted in improved survival in a Phase 3 trial in metastatic melanoma patients with BRAF mutations.	Sci Transl Med 2010 Jun 9;2(35):35ra41##Cancer Res. 2006 Dec 1;66(23):11100-5##N Engl J Med. 2011 Jun 30;364(26):2507-16	BRAF	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	BRAF	HUMAN|ENSEMBL=ENSG00000157764|UniProtKB=P15056		PTHR23257:SF41	SERINE-THREONINE PROTEIN KINASE	B-RAF	transmembrane receptor protein serine/threonine kinase activity#GO:0004675;non-membrane spanning protein tyrosine kinase activity#GO:0004715;transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;transmembrane receptor protein kinase activity#GO:0019199;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;female gamete generation#GO:0007292;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;gamete generation#GO:0007276;developmental process#GO:0032502;cell adhesion#GO:0007155;cell communication#GO:0007154;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;I-kappaB kinase/NF-kappaB cascade#GO:0007249;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;immune system process#GO:0002376;response to stimulus#GO:0050896;response to stress#GO:0006950;reproduction#GO:0000003;anatomical structure morphogenesis#GO:0009653;protein amino acid phosphorylation#GO:0006468;transmembrane receptor protein serine/threonine kinase signaling pathway#GO:0007178;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;cellular structure morphogenesis#GO:0032989;JNK cascade#GO:0007254;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152		protein kinase receptor#PC00194;non-receptor serine/threonine protein kinase#PC00167;serine/threonine protein kinase receptor#PC00205;tyrosine protein kinase receptor#PC00233;protein kinase#PC00193;non-receptor tyrosine protein kinase#PC00168;transferase#PC00220;kinase#PC00137;receptor#PC00197	VEGF signaling pathway#P00056>Raf#P01417;Integrin signalling pathway#P00034>Raf#P00924;EGF receptor signaling pathway#P00018>Raf-1#P00560;PDGF signaling pathway#P00047>Raf#P01161;Angiogenesis#P00005>Raf#P00243;Interleukin signaling pathway#P00036>Raf#P00983;Integrin signalling pathway#P00034>B-Raf#P00911;Ras Pathway#P04393>Raf#P04556;B cell activation#P00010>Raf#P00381;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>Raf-1#P00843;T cell activation#P00053>Raf#P01311						chr7.fa:140434575-140434575_A_	7:140434575	ENSG00000157764	CCDS5863.1	splice_region_variant,intron_variant,feature_truncation	-	-	-	-1	-	-	2128-5delT	N/A	chr7.fa:140434575-140434575_A_	ENSG00000157764	ENSG00000157764	CCDS5863.1							INTRON		SEQCTRLPS10_PS_Seq2_BWA	SNP:chr7_140434574_140434574_rs373442098_CA_-,SNP:chr7_140434574_140434574_rs373442098_CA_A,SNP:chr7_140434574_140434575_rs151306633_A_C																																																					COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	BRAF	v-raf murine sarcoma viral oncogene homolog B	CCDS5863.1	chr7.fa:140434575-140434575_A_	2128-5delT	N/A	18	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.254545	0.0514852684028101	275	70	COLUMN NOT FOUND	ENSG00000157764	transmembrane receptor protein serine/threonine kinase activity#GO:0004675;non-membrane spanning protein tyrosine kinase activity#GO:0004715;transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;transmembrane receptor protein kinase activity#GO:0019199;catalytic activity#GO:0003824;kinase activity#GO:0016301;protein kinase activity#GO:0004672	embryonic development#GO:0009790;female gamete generation#GO:0007292;induction of apoptosis#GO:0006917;signal transduction#GO:0007165;gamete generation#GO:0007276;developmental process#GO:0032502;cell adhesion#GO:0007155;cell communication#GO:0007154;cellular component organization and biogenesis#GO:0016043;cellular process#GO:0009987;I-kappaB kinase/NF-kappaB cascade#GO:0007249;phosphate metabolic process#GO:0006796;primary metabolic process#GO:0044238;cell surface receptor linked signal transduction#GO:0007166;apoptosis#GO:0006915;MAPKKK cascade#GO:0000165;immune system process#GO:0002376;response to stimulus#GO:0050896;response to stress#GO:0006950;reproduction#GO:0000003;anatomical structure morphogenesis#GO:0009653;protein amino acid phosphorylation#GO:0006468;transmembrane receptor protein serine/threonine kinase signaling pathway#GO:0007178;intracellular signaling cascade#GO:0007242;cell cycle#GO:0007049;cellular structure morphogenesis#GO:0032989;JNK cascade#GO:0007254;protein metabolic process#GO:0019538;protein modification process#GO:0006464;metabolic process#GO:0008152	VEGF signaling pathway#P00056>Raf#P01417;Integrin signalling pathway#P00034>Raf#P00924;EGF receptor signaling pathway#P00018>Raf-1#P00560;PDGF signaling pathway#P00047>Raf#P01161;Angiogenesis#P00005>Raf#P00243;Interleukin signaling pathway#P00036>Raf#P00983;Integrin signalling pathway#P00034>B-Raf#P00911;Ras Pathway#P04393>Raf#P04556;B cell activation#P00010>Raf#P00381;Inflammation mediated by chemokine and cytokine signaling pathway#P00031>Raf-1#P00843;T cell activation#P00053>Raf#P01311	upper_aerodigestive_tract (1 cases)	-	-	thyroid (12133 cases),skin (5148 cases),large_intestine (4462 cases),NS (860 cases),haematopoietic_and_lymphoid_tissue (515 cases),central_nervous_system (322 cases),ovary (261 cases),lung (170 cases),eye (67 cases),pituitary (57 cases),endometrium (37 cases),soft_tissue (36 cases),biliary_tract (33 cases),stomach (29 cases),breast (27 cases),prostate (27 cases),liver (24 cases),upper_aerodigestive_tract (22 cases),urinary_tract (21 cases),pancreas (18 cases),small_intestine (16 cases),bone (15 cases),testis (8 cases),cervix (6 cases),kidney (6 cases),oesophagus (5 cases),genital_tract (4 cases),adrenal_gland (4 cases),salivary_gland (2 cases),meninges (2 cases),autonomic_ganglia (2 cases),pleura (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	75	0.974026	0	0	83	3	2	70	2	0.254545	275	64	237	209	COLUMN NOT FOUND	13	77	1	50	0	0	1.02597	0	-1	2	0.025974	0	5	3	11	92	9						chr7.fa:140434575-140434575_A_	chr7_140434575_140434575			chr7.fa:140434575-140434575_A_	0.0514852684028101			chr7.fa:140434575-140434575_A_	SMExclude	chr7.fa:140434575-140434575_A_	chr7.fa:140434575-140434575__A,chr7.fa:140434575-140434575_A_	Keep					30	30	77	0.03	0	A/	BIAS	BIAS	COLUMN NOT FOUND	BIAS	0.284133	60	0	17.0779	4.20577	60	0	30	71	-1	0	1	DEL	1	9	-1	0.29703	162.273	265	77	0.290566	8.31912	0	0.0644072	37.2468	0.170779	0.0420577	60	60	0	1.02597	0	70	2	0.254545	275	165.179	232	76	0.327586	8.25897	0	0.065001	38.0263	0.156184	0.0320925	41.7233	42	0	1.01316	-0.2767	72	2	0.302521	238	92	ENSG00000157764	ENSG00000157764	CCDS5863.1																						
chr8.fa:38271765-38271765_G_A	0	0.924	3058	314	0	917	0	770	30596	27	40	39.6321	191	194	1231	322	314	0.255077	SBS	chr8.fa	38271765	38271765	G	A	chr8.fa:38271765-38271765_G_A	ENSG00000077782	FGFR1	CCDS6107.2	ggC	ggT	697	697	G	G	synonymous_variant	15	COLUMN NOT FOUND	COLUMN NOT FOUND	fibroblast growth factor receptor 1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr8.fa:38271765-38271765_G_A	chr8:38390922-38390922	chr8:38271765-38271765	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr8.fa:38271765-38271765_G_A	oesophagus (1 cases),large_intestine (1 cases),lung (1 cases)	G697G lung (1 cases)	pancreas (1 cases),endometrium (1 cases)	large_intestine (55 cases),skin (23 cases),central_nervous_system (23 cases),stomach (22 cases),lung (17 cases),breast (13 cases),endometrium (12 cases),haematopoietic_and_lymphoid_tissue (7 cases),urinary_tract (7 cases),kidney (6 cases),pancreas (6 cases),liver (4 cases),oesophagus (3 cases),prostate (2 cases),biliary_tract (2 cases),ovary (1 cases),bone (1 cases),soft_tissue (1 cases),autonomic_ganglia (1 cases),thyroid (1 cases),upper_aerodigestive_tract (1 cases),eye (1 cases)	3	FGFR1	fibroblast growth factor receptor 1	The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, whose members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. 	BFGFR;CD331;CEK;FGFBR;FGFR-1;FLG;FLJ99988;FLT-2;FLT2;HBGFR;KAL2;N-SAM;OGD;bFGF-R-1	FGF signaling	None described	NA	NA	NA	NA	There are multiple small molecule inhibitors to FGFR1, such as Pazopanib.  Acenaphtho[1,2-b] pyrrole carboxylic esters are potent inhibitors of FGFR1 and lead to growth inhibition in vitro.	Pharmacol Ther. 2010 Jan;125(1):105-17, J Med Chem. 2011 Jun 9;54(11):3732-45	NA	NA	NA	FGFR1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	FGFR1	HUMAN|ENSEMBL=ENSG00000077782|UniProtKB=P11362		PTHR24416:SF131	TYROSINE-PROTEIN KINASE RECEPTOR	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197	FGF signaling pathway#P00021>FGFR1-4#P00636;Angiogenesis#P00005>FGFR-1#P00186						chr8.fa:38271765-38271765_G_A	8:38271765	ENSG00000077782	CCDS6107.2	synonymous_variant	2091	2091	697	-1	G	ggC/ggT	2091C>T	%3D)	chr8.fa:38271765-38271765_G_A	ENSG00000077782	ENSG00000077782	CCDS6107.2	ggC	ggT	697	697	G	G	SYNONYMOUS_CODING	15	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	FGFR1	fibroblast growth factor receptor 1	CCDS6107.2	chr8.fa:38271765-38271765_G_A	2091C>T	%3D)	15	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.255077	0.0243510943745068	1231	314	COLUMN NOT FOUND	ENSG00000077782	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	FGF signaling pathway#P00021>FGFR1-4#P00636;Angiogenesis#P00005>FGFR-1#P00186	oesophagus (1 cases),large_intestine (1 cases),lung (1 cases)	G697G lung (1 cases)	pancreas (1 cases),endometrium (1 cases)	large_intestine (55 cases),skin (23 cases),central_nervous_system (23 cases),stomach (22 cases),lung (17 cases),breast (13 cases),endometrium (12 cases),haematopoietic_and_lymphoid_tissue (7 cases),urinary_tract (7 cases),kidney (6 cases),pancreas (6 cases),liver (4 cases),oesophagus (3 cases),prostate (2 cases),biliary_tract (2 cases),ovary (1 cases),bone (1 cases),soft_tissue (1 cases),autonomic_ganglia (1 cases),thyroid (1 cases),upper_aerodigestive_tract (1 cases),eye (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	314	2.45223	0.255077	1231	98	226	321	COLUMN NOT FOUND	91	314	1	122	0	0	1.11399	0	-1	12	0.0382166	0	1	2	0	0	0	0	0.255077173030057	0.744922826969943	0.255077173030057	1.96019108280255	chr8.fa:38271765-38271765_G_A	chr8_38271765_38271765			chr8.fa:38271765-38271765_G_A	0.0243510943745068					chr8.fa:38271765-38271765_G_A							35	35	385	0.5	0.4594	G/A	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.251799	60	0	27.238	14.1356	60	0	58	43	-101	0	1	SBS	0	0	-101	0.574257	227.987	1231	314	0.255077	0.138078	0.477072	0.515136	39.6321	0.27238	0.141356	60	60	0	1.11399	0	314	2.45223	0.255077	1231	226.752	1150	304	0.264348	0.140989	0.476614	0.515299	39.6398	0.272114	0.142044	41.9945	41.9843	0	1.11828	0.0102	304	2.44079	0.264348	1150	0	ENSG00000077782	ENSG00000077782	CCDS6107.2	1	8.252e-06	121190	120656	-1.904e+00	-4.000e-02	1942391	3.878	69.51	18.69	59.76	0	0.397	318	13.39	-2.780e-01	1.01	FS	.	G:0	GC:0	GCC:0
chr11.fa:69465988-69465990_GAG_	0	0.13	3004	1198	0	0	0	28	1110	39	40	39.6429	8	6	1207	14	13	0.0107705	DEL	chr11.fa	69465988	69465990	GAG		chr11.fa:69465988-69465990_GAG_	ENSG00000110092	CCND1	CCDS8191.1	GAG	-	276	276	E	-	inframe_deletion	5	COLUMN NOT FOUND	COLUMN NOT FOUND	cyclin D1	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr11.fa:69465988-69465990_GAG_	chr11:69175169-69175171	chr11:69465988-69465990	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr11.fa:69465988-69465990_GAG_	large_intestine (2 cases),endometrium (1 cases)		large_intestine (2 cases),stomach (1 cases),endometrium (1 cases)	haematopoietic_and_lymphoid_tissue (39 cases),endometrium (19 cases),large_intestine (12 cases),lung (8 cases),skin (4 cases),stomach (3 cases),NS (2 cases),urinary_tract (2 cases),ovary (1 cases),breast (1 cases),prostate (1 cases),upper_aerodigestive_tract (1 cases),liver (1 cases),oesophagus (1 cases)	3	CCND1	cyclin D1	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. 	BCL1;D11S287E;PRAD1;U21B31	Cell cycle progression	CCND1 amplification is associated with a more aggressive phenotype in breast cancer and a poor prognosis in esophageal cancer	Breast Cancer Res Treat. 2011 Oct 16, Br J Cancer. 2010 Apr 27;102(9):1378-83	S:\Sample reports\Automated Report Info\Figures for gene slide subset\CCND1_Prognostic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\CCND1_Prognostic2	Kaplan-Meier analysis showing the differences in overall survival for breast cancer patients, stratified by CCND1 status##Survival curves according to CCND1 copy number in esophageal cancer patients 	Breast Cancer Res Treat. 2011 Oct 16##Br J Cancer. 2010 Apr 27;102(9):1378-83	CCND1 amplification is a predictor of disease recurrence in ER positive breast cancer patients after tamoxifen therapy.  Amplification of CCND1 correlates with sensitivity to EGFR inhibitors such as lapatinib in cancer cells.  Treatment of MLC cells expressing CCND1 with the CDK4/6 inhibitor PD0332991 results in reduced cell proliferation.	Cancer Res. 2005 Sep 1;65(17):8009-16, Nature. 2012 Mar 28;483(7391):570-5; Blood. 2006 Sep 1;108(5):1744-50	S:\Sample reports\Automated Report Info\Figures for gene slide subset\CCND1_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\CCND1_Therapeutic2	Effect of CCND1 amplification on outcome of tamoxifen treatment in breast cancer##Inhibition of CCND1 expressing MCL cell proliferation by the CDK4/6 inhibitor PD0332991	Cancer Res. 2005 Sep 1;65(17):8009-16##Blood. 2006 Sep 1;108(5):1744-50	CCND1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	CCND1	HUMAN|ENSEMBL=ENSG00000110092|UniProtKB=P24385		PTHR10177:SF67	CYCLINE	G1/S-SPECIFIC CYCLIN-D1	protein binding#GO:0005515;enzyme activator activity#GO:0008047;kinase regulator activity#GO:0019207;binding#GO:0005488;enzyme regulator activity#GO:0030234;kinase activator activity#GO:0019209	cell cycle#GO:0007049;mitosis#GO:0007067;gamete generation#GO:0007276;reproduction#GO:0000003;cellular process#GO:0009987;spermatogenesis#GO:0007283		kinase modulator#PC00140;enzyme modulator#PC00095;kinase activator#PC00138	Wnt signaling pathway#P00057>Wnt Target Genes#G01558;PI3 kinase pathway#P00048>Cyclin d#G01546;Cell cycle#P00013>Cyclin D#P00484						chr11.fa:69465988-69465990_GAG_	11:69465988-69465990	ENSG00000110092	CCDS8191.1	inframe_deletion	826-828	826-828	276	1	E/-	GAG/-	826_828delGAG	E276del	chr11.fa:69465988-69465990_GAG_	ENSG00000110092	ENSG00000110092	CCDS8191.1	gag	-	276	276	E	-	CODON_DELETION	5	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	CCND1	cyclin D1	CCDS8191.1	chr11.fa:69465988-69465990_GAG_	826_828delGAG	E276del	5	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.00743187	0.00483741498049803	1211	9	COLUMN NOT FOUND	ENSG00000110092	protein binding#GO:0005515;enzyme activator activity#GO:0008047;kinase regulator activity#GO:0019207;binding#GO:0005488;enzyme regulator activity#GO:0030234;kinase activator activity#GO:0019209	cell cycle#GO:0007049;mitosis#GO:0007067;gamete generation#GO:0007276;reproduction#GO:0000003;cellular process#GO:0009987;spermatogenesis#GO:0007283	Wnt signaling pathway#P00057>Wnt Target Genes#G01558;PI3 kinase pathway#P00048>Cyclin d#G01546;Cell cycle#P00013>Cyclin D#P00484	large_intestine (2 cases),endometrium (1 cases)	-	large_intestine (2 cases),stomach (1 cases),endometrium (1 cases)	haematopoietic_and_lymphoid_tissue (39 cases),endometrium (19 cases),large_intestine (12 cases),lung (8 cases),skin (4 cases),stomach (3 cases),NS (2 cases),urinary_tract (2 cases),ovary (1 cases),breast (1 cases),prostate (1 cases),upper_aerodigestive_tract (1 cases),liver (1 cases),oesophagus (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	13	1	0	0	13	2	1	9	2.22222	0.00743187	1211	81	133	85	COLUMN NOT FOUND	61	13	1	42	0	0	1	0	-1	2	0.153846	2	2	4	5	41	20						chr11.fa:69465988-69465990_GAG_	chr11_69465988_69465990			chr11.fa:69465988-69465990_GAG_	0.00483741498049803			chr11.fa:69465988-69465990_GAG_	SMExclude	chr11.fa:69465988-69465990_GAG_	chr11.fa:69465988-69465990_GAG_	Keep					43	43	14	0.43	0.3953	GAG/	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.00932091	60	0	31.2857	12.1436	60	0	69	32	12	0	1	DEL	3	20	12	0.683168	104.62	1207	13	0.0107705	0.515079	0.335035	0.522108	39.6429	0.312857	0.121436	60	60	0	1	0	9	2.22222	0.00743187	1211	98.568	1134	11	0.00970018	0.552771	0.314982	0.518352	39.6667	0.348333	0.0892293	41.9945	41.3441	0	1	0.6504	7	2.28571	0.00615114	1138	41	ENSG00000110092	ENSG00000110092	CCDS8191.1																						
chr2.fa:30143058-30143058_C_G	0	0.941	3368	0	1002	313	0	798	31798	35	40	39.8471	189	210	1324	332	313	0.236405	SBS	chr2.fa	30143058	30143058	C	G	chr2.fa:30143058-30143058_C_G	ENSG00000171094	ALK	CCDS33172.1	ggG	ggC	156	156	G	G	synonymous_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	anaplastic lymphoma receptor tyrosine kinase	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut;Amps	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr2.fa:30143058-30143058_C_G	chr2:29996562-29996562	chr2:30143058-30143058	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr2.fa:30143058-30143058_C_G				autonomic_ganglia (206 cases),large_intestine (115 cases),lung (79 cases),skin (75 cases),stomach (23 cases),endometrium (19 cases),breast (18 cases),haematopoietic_and_lymphoid_tissue (18 cases),oesophagus (17 cases),ovary (12 cases),liver (12 cases),upper_aerodigestive_tract (9 cases),kidney (8 cases),urinary_tract (6 cases),soft_tissue (6 cases),central_nervous_system (6 cases),pancreas (5 cases),prostate (5 cases),NS (4 cases),thyroid (4 cases),adrenal_gland (3 cases),pleura (1 cases),bone (1 cases),thymus (1 cases),biliary_tract (1 cases)		ALK	anaplastic lymphoma receptor tyrosine kinase	This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. 	CD246;NBLST3	Tyrosine kinase signaling	None described	NA	NA	NA	NA	CH542802 is a selective inhibitor that blocks EML4/ALK mutant driven cell growth in a NSCLC mouse xenograft model and several other drugs are under development.  Secondary mutations in this gene may also cause resistance to ALK inhibitors.  ALK rearrangements are associated with better response to premetrexed.  Patients with the EML4/ALK fusion do not respond to treatment with EGFR TKIs.	Cancer Cell. 2011 May 17;19(5):679-90, Mol Cancer Ther. 2011 Apr;10(4):569-79, Cancer Res. 2010 Dec 15;70(24):10038-43, J Thorac Oncol. 2011 Apr;6(4):774-80, J Clin Oncol. 2009 Sep 10;27(26):4247-53	S:\Sample reports\Automated Report Info\Figures for gene slide subset\ALK_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\ALK_Therapeutic2##S:\Sample reports\Automated Report Info\Figures for gene slide subset\ALK_Therapeutic3	Efficacy of CH5424802 in mouse model of EML4/ALK mutant driven tumors##Drugs against oncogenic ALK under development##Progression free survival on premetrexed	Cancer Cell. 2011 May 17;19(5):679-90##Mol Cancer Ther. 2011 Apr;10(4):569-79##J Thorac Oncol. 2011 Apr;6(4):774-80	ALK	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	ALK	HUMAN|ENSEMBL=ENSG00000171094|UniProtKB=Q9UM73		PTHR24416:SF139	TYROSINE-PROTEIN KINASE RECEPTOR	ALK TYROSINE KINASE RECEPTOR	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152		protein kinase receptor#PC00194;protein kinase#PC00193;transferase#PC00220;kinase#PC00137;tyrosine protein kinase receptor#PC00233;receptor#PC00197							chr2.fa:30143058-30143058_C_G	2:30143058	ENSG00000171094	CCDS33172.1	synonymous_variant	468	468	156	-1	G	ggG/ggC	468G>C	%3D)	chr2.fa:30143058-30143058_C_G	ENSG00000171094	ENSG00000171094	CCDS33172.1	ggG	ggC	156	156	G	G	SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA																										chr2	30143057	30143058	ESP6500chr2_30143057	dbSNP_131	1,8523	0,4354	1,12877	0.0117,0.0,0.0078	AA,AG,GG	0,1,4261	0,0,2177	0,1,6438	17	ALK	0.7	-0.7	G	unknown	no	unknown	NM_004304.4	missense	SER/PRO	157/1621	469	74	benign	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	ALK	anaplastic lymphoma receptor tyrosine kinase	CCDS33172.1	chr2.fa:30143058-30143058_C_G	468G>C	%3D)	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.236502	0.0229675406148152	1315	311	COLUMN NOT FOUND	ENSG00000171094	transferase activity#GO:0016740;receptor activity#GO:0004872;transmembrane receptor protein tyrosine kinase activity#GO:0004714;catalytic activity#GO:0003824;kinase activity#GO:0016301;transmembrane receptor protein kinase activity#GO:0019199;protein kinase activity#GO:0004672	cell surface receptor linked signal transduction#GO:0007166;signal transduction#GO:0007165;protein amino acid phosphorylation#GO:0006468;cell communication#GO:0007154;cellular process#GO:0009987;protein metabolic process#GO:0019538;protein modification process#GO:0006464;transmembrane receptor protein tyrosine kinase signaling pathway#GO:0007169;primary metabolic process#GO:0044238;metabolic process#GO:0008152	-	-	-	-	autonomic_ganglia (206 cases),large_intestine (115 cases),lung (79 cases),skin (75 cases),stomach (23 cases),endometrium (19 cases),breast (18 cases),haematopoietic_and_lymphoid_tissue (18 cases),oesophagus (17 cases),ovary (12 cases),liver (12 cases),upper_aerodigestive_tract (9 cases),kidney (8 cases),urinary_tract (6 cases),soft_tissue (6 cases),central_nervous_system (6 cases),pancreas (5 cases),prostate (5 cases),NS (4 cases),thyroid (4 cases),adrenal_gland (3 cases),pleura (1 cases),bone (1 cases),thymus (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	311	2.55305	0.236502	1315	99	259	315	COLUMN NOT FOUND	90	313	1	82	0	0	1.03258	0	-1	19	0.0607029	3	1	1	0	0	0	0	0.236404833836858	0.763595166163142	0.236404833836858	2.11501597444089	chr2.fa:30143058-30143058_C_G	chr2_30143058_30143058	chr2_30143058_30143058		chr2.fa:30143058-30143058_C_G	0.0229675406148152					chr2.fa:30143058-30143058_C_G							10	10	399	0.47	0.1584	C/G	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.236936	60	0	26.58	13.6298	60	0	69	32	-101	0	1	SBS	0	0	-101	0.683168	229.097	1324	313	0.236405	0.931148	0.454622	0.492747	39.8471	0.2658	0.136298	60	60	0	1.03258	0	311	2.55305	0.236502	1315	227.375	1262	300	0.237718	0.949688	0.453114	0.492056	39.8407	0.262602	0.136872	41.9964	41.9898	0	1.03394	0.0066	298	2.55705	0.237829	1253	0	ENSG00000171094	ENSG00000171094	CCDS33172.1	1	8.255e-06	121136	109858	-6.760e-01	-7.200e-02	1420479	4.218	53.21	18.57	60.00	0	0.031	292	10.17	0.486	0.750	MQ	.	C:2	CC:0	CCC:0
chr16.fa:2134450-2134450_G_A	0	0.942	3504	325	0	1071	0	830	33052	35	40	39.8217	206	207	1394	346	325	0.233142	SBS	chr16.fa	2134450	2134450	G	A	chr16.fa:2134450-2134450_G_A	ENSG00000103197	TSC2	CCDS10458.1	cgG	cgA	1409	1409	R	R	synonymous_variant	33	COLUMN NOT FOUND	COLUMN NOT FOUND	tuberous sclerosis 2	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr16.fa:2134450-2134450_G_A	chr16:2074451-2074451	chr16:2134450-2134450	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr16.fa:2134450-2134450_G_A	large_intestine (1 cases)		bone (1 cases),autonomic_ganglia (1 cases)	large_intestine (61 cases),lung (44 cases),liver (36 cases),skin (35 cases),kidney (33 cases),stomach (24 cases),endometrium (17 cases),pancreas (15 cases),upper_aerodigestive_tract (14 cases),breast (13 cases),central_nervous_system (11 cases),haematopoietic_and_lymphoid_tissue (8 cases),urinary_tract (7 cases),ovary (6 cases),prostate (6 cases),oesophagus (5 cases),bone (4 cases),NS (2 cases),soft_tissue (2 cases),autonomic_ganglia (2 cases),thyroid (2 cases),parathyroid (1 cases),adrenal_gland (1 cases),cervix (1 cases),biliary_tract (1 cases)	1	TSC2	tuberous sclerosis 2	This gene product is believed to be a tumor suppressor and is able to stimulate specific GTPases. The protein associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin. 	FLJ43106;LAM;TSC4	mTOR signaling and cell cycle arrest	None described	NA	NA	NA	NA	TSC2 deficient cells are sensitive to anti-EGFR antibodies, Renal angiomyolipomas caused by defects in TSC2 display regression on treatment with the mTOR inhibitor, sirolimus (rapamycin), Everolimus treatment of astrocytomas in patients with germline TSC2 mutations leads to a reduction in tumor size	PLoS One. 2008;3(10):e3558, Clin Cancer Res. 2011 Jun 15;17(12):4071-8, PLoS One. 2011;6(9):e23379, N Engl J Med. 2010 Nov 4;363(19):1801-11	S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic1##S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic2, S:\Sample reports\Automated Report Info\Figures for gene slide subset\TSC2_Therapeutic3	Anti-EGFR antibodies reduce proliferation of TSC2 deficient cells##Reduced tumor burden in Tuberous Sclerosis patients treated with sirolimus (rapamycin)##Everolimus treatment of astrocytomas in patients with germline TSC2 mutations leads to a reduction in tumor size 	PLoS One. 2008;3(10):e3558##PLoS One. 2011;6(9):e23379##N Engl J Med. 2010 Nov 4;363(19):1801-11	TSC2	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC2	HUMAN|ENSEMBL=ENSG00000103197|UniProtKB=P49815		PTHR10063:SF1	TUBERIN	TUBERIN	protein binding#GO:0005515;small GTPase regulator activity#GO:0005083;binding#GO:0005488;enzyme regulator activity#GO:0030234	cell cycle#GO:0007049;intracellular protein transport#GO:0006886;vesicle-mediated transport#GO:0016192;cellular process#GO:0009987;protein transport#GO:0015031;endocytosis#GO:0006897;transport#GO:0006810		G-protein modulator#PC00022;enzyme modulator#PC00095	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC2#P04494;p53 pathway by glucose deprivation#P04397>TSC2#P04644;p53 pathway by glucose deprivation#P04397>TSC2#G04706						chr16.fa:2134450-2134450_G_A	16:2134450	ENSG00000103197	CCDS10458.1	synonymous_variant	4227	4227	1409	1	R	cgG/cgA	4227G>A	%3D)	chr16.fa:2134450-2134450_G_A	ENSG00000103197	ENSG00000103197	CCDS10458.1	cgG	cgA	1409	1409	R	R	SYNONYMOUS_CODING	33	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	TSC2	tuberous sclerosis 2	CCDS10458.1	chr16.fa:2134450-2134450_G_A	4227G>A	%3D)	33	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.231375	0.0221222382925587	1396	323	COLUMN NOT FOUND	ENSG00000103197	protein binding#GO:0005515;small GTPase regulator activity#GO:0005083;binding#GO:0005488;enzyme regulator activity#GO:0030234	cell cycle#GO:0007049;intracellular protein transport#GO:0006886;vesicle-mediated transport#GO:0016192;cellular process#GO:0009987;protein transport#GO:0015031;endocytosis#GO:0006897;transport#GO:0006810	Insulin/IGF pathway-protein kinase B signaling cascade#P00033>TSC2#P04494;p53 pathway by glucose deprivation#P04397>TSC2#P04644;p53 pathway by glucose deprivation#P04397>TSC2#G04706	large_intestine (1 cases)	-	bone (1 cases),autonomic_ganglia (1 cases)	large_intestine (61 cases),lung (44 cases),liver (36 cases),skin (35 cases),kidney (33 cases),stomach (24 cases),endometrium (17 cases),pancreas (15 cases),upper_aerodigestive_tract (14 cases),breast (13 cases),central_nervous_system (11 cases),haematopoietic_and_lymphoid_tissue (8 cases),urinary_tract (7 cases),ovary (6 cases),prostate (6 cases),oesophagus (5 cases),bone (4 cases),NS (2 cases),soft_tissue (2 cases),autonomic_ganglia (2 cases),thyroid (2 cases),parathyroid (1 cases),adrenal_gland (1 cases),cervix (1 cases),biliary_tract (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	323	2.55728	0.231375	1396	99	219	285	COLUMN NOT FOUND	89	325	1	26	0	0	1.01928	0	-1	30	0.0923077	2	1	1	0	0	0	0	0.233142037302726	0.766857962697274	0.233142037302726	2.14461538461538	chr16.fa:2134450-2134450_G_A	chr16_2134450_2134450			chr16.fa:2134450-2134450_G_A	0.0221222382925587					chr16.fa:2134450-2134450_G_A							54	54	413	0.5	0.5	G/A	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.236872	60	0	25.7571	14.2822	60	0	69	32	-101	0	1	SBS	0	0	-101	0.683168	230.444	1394	325	0.233142	0.0436507	0.480082	0.517497	39.8217	0.257571	0.142822	60	60	0	1.01928	0	323	2.55728	0.231375	1396	227.017	1306	297	0.227412	0.136414	0.476473	0.515611	39.8478	0.254408	0.144988	41.9928	41.9795	0	1.021	0.0133	297	2.56566	0.227412	1306	0	ENSG00000103197	ENSG00000103197	CCDS10458.1																						
chr5.fa:67522653-67522653_T_C	0	0.85	2358	0	15	0	927	42	1672	39	40	39.8095	12	9	942	21	15	0.0159236	SBS	chr5.fa	67522653	67522653	T	C	chr5.fa:67522653-67522653_T_C	ENSG00000145675	PIK3R1	CCDS3993.1	ccT	ccC	50	50	P	P	synonymous_variant	1	COLUMN NOT FOUND	COLUMN NOT FOUND	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	0		0	0	0	0	0	0	0	0		0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0	0	0	0	0	0	0	COLUMN NOT FOUND	COLUMN NOT FOUND	SMut	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND				chr5.fa:67522653-67522653_T_C	chr5:67558409-67558409	chr5:67522653-67522653	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	chr5.fa:67522653-67522653_T_C			large_intestine (2 cases),endometrium (1 cases)	endometrium (108 cases),large_intestine (105 cases),central_nervous_system (50 cases),breast (43 cases),skin (17 cases),lung (16 cases),haematopoietic_and_lymphoid_tissue (15 cases),stomach (8 cases),oesophagus (8 cases),liver (7 cases),upper_aerodigestive_tract (7 cases),ovary (6 cases),kidney (5 cases),urinary_tract (4 cases),pancreas (2 cases),prostate (2 cases),bone (1 cases),thyroid (1 cases),meninges (1 cases),cervix (1 cases)		PIK3R1	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin.	GRB1;p85;p85-ALPHA	Phosphatidylinositol signaling	None described	NA	NA	NA	NA	Gene silencing of PIK3R1 leads to increased apoptosis in response to 5-FU tretament in colorectal cancer cells	Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1085-8	NA	NA	NA	PIK3R1	YES	YES	YES						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	PIK3R1	HUMAN|ENSEMBL=ENSG00000145675|UniProtKB=P27986		PTHR10155:SF3	PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT	PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT ALPHA	protein binding#GO:0005515;kinase regulator activity#GO:0019207;binding#GO:0005488;enzyme regulator activity#GO:0030234	intracellular signaling cascade#GO:0007242;cell communication#GO:0007154;signal transduction#GO:0007165;cellular process#GO:0009987		kinase modulator#PC00140;enzyme modulator#PC00095	PDGF signaling pathway#P00047>PI3K#P01168;PI3 kinase pathway#P00048>p85#P01202;T cell activation#P00053>PI3K#P01322;Axon guidance mediated by netrin#P00009>PI3K#P00363;Hypoxia response via HIF activation#P00030>PI3K#P00823;Angiogenesis#P00005>PI3K#P00236;VEGF signaling pathway#P00056>PI3K#P01413;p53 pathway feedback loops 2#P04398>PI3K#P04661;p53 pathway#P00059>PI3K#P04609;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PI3K#P00900;Endothelin signaling pathway#P00019>PI3K#P00577;Integrin signalling pathway#P00034>PI3K#P00936;Gonadotropin-releasing hormone receptor pathway#P06664>PI3K#P06766						chr5.fa:67522653-67522653_T_C	5:67522653	ENSG00000145675	CCDS3993.1	synonymous_variant	150	150	50	1	P	ccT/ccC	150T>C	%3D)	chr5.fa:67522653-67522653_T_C	ENSG00000145675	ENSG00000145675	CCDS3993.1	ccT	ccC	50	50	P	P	SYNONYMOUS_CODING	1	SEQCTRLPS10_PS_Seq2_BWA																																																						COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND			SEQCTRLPS10_PS_Seq2_BWA	COLUMN NOT FOUND	COLUMN NOT FOUND	PIK3R1	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	CCDS3993.1	chr5.fa:67522653-67522653_T_C	150T>C	%3D)	1	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	0.0159236	0.00799401969248318	942	15	COLUMN NOT FOUND	ENSG00000145675	protein binding#GO:0005515;kinase regulator activity#GO:0019207;binding#GO:0005488;enzyme regulator activity#GO:0030234	intracellular signaling cascade#GO:0007242;cell communication#GO:0007154;signal transduction#GO:0007165;cellular process#GO:0009987	PDGF signaling pathway#P00047>PI3K#P01168;PI3 kinase pathway#P00048>p85#P01202;T cell activation#P00053>PI3K#P01322;Axon guidance mediated by netrin#P00009>PI3K#P00363;Hypoxia response via HIF activation#P00030>PI3K#P00823;Angiogenesis#P00005>PI3K#P00236;VEGF signaling pathway#P00056>PI3K#P01413;p53 pathway feedback loops 2#P04398>PI3K#P04661;p53 pathway#P00059>PI3K#P04609;Insulin/IGF pathway-protein kinase B signaling cascade#P00033>PI3K#P00900;Endothelin signaling pathway#P00019>PI3K#P00577;Integrin signalling pathway#P00034>PI3K#P00936;Gonadotropin-releasing hormone receptor pathway#P06664>PI3K#P06766	-	-	large_intestine (2 cases),endometrium (1 cases)	endometrium (108 cases),large_intestine (105 cases),central_nervous_system (50 cases),breast (43 cases),skin (17 cases),lung (16 cases),haematopoietic_and_lymphoid_tissue (15 cases),stomach (8 cases),oesophagus (8 cases),liver (7 cases),upper_aerodigestive_tract (7 cases),ovary (6 cases),kidney (5 cases),urinary_tract (4 cases),pancreas (2 cases),prostate (2 cases),bone (1 cases),thyroid (1 cases),meninges (1 cases),cervix (1 cases)	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	COLUMN NOT FOUND	COLUMN NOT FOUND	COLUMN NOT FOUND	-	-	YES	0	0	0	0	0	2	0	15	2.8	0.0159236	942	88	92	277	COLUMN NOT FOUND	69	15	1	160	0	0	1	0	-1	2	0.133333	0	1	2	0	0	0	0	0.0159235668789809	0.984076433121019	0.0159235668789809	31.4	chr5.fa:67522653-67522653_T_C	chr5_67522653_67522653			chr5.fa:67522653-67522653_T_C	0.00799401969248318					chr5.fa:67522653-67522653_T_C							22	22	21	0.43	0.3318	T/C	NOBIAS	NOBIAS	COLUMN NOT FOUND		0.0178117	60	0	32.8182	13.6487	60	0	48	53	-101	0	1	SBS	0	0	-101	0.475248	110.375	942	15	0.0159236	0.553283	0.341494	0.515649	39.8095	0.328182	0.136487	60	60	0	1	0	15	2.8	0.0159236	942	105.007	916	13	0.0141921	0.569298	0.327516	0.514589	39.7895	0.3315	0.141357	41.9932	42	0	1	-0.0068	13	2.92308	0.0141921	916	0	ENSG00000145675	ENSG00000145675	CCDS3993.1																						
Changes Lost (In old file but not in new):
ChangeUID	IndexString	Coverage	ACount	CCount	GCount	TCount	MutCount	SumQualityScore	MinQualityScore	MaxQualityScore	AverageQualityScore	Forward	Reverse	DistinctCoverage	DistinctTags	DistinctPairs	MutPct	MutType	Chrom	Start	End	BaseFrom	BaseTo	LookupKey	ENSG	GeneName	Transcript	TxBaseFRom	TxBaseTo	AminoStart	AminoEnd	AAFrom	AATo	Consequence	Exon Rank	Transcript GeneName	HUGO GeneName	Description	Deleted	SNP	NormalMutCount	NormalRawCoverage	NormalPhredCoverage	NormalEffectiveCoverage	NormalDistinctRawCoverage	NormalDistinctPhredCoverage	NormalDistinctEffectiveCoverage	GermlineNormMutPct	Germline?	TotalNormalMutCount	NormalDistinctMutPairs	ExcludeConsequence?	Silent?	NormMutPct	CosmicGene	CosmicTx	CosmicAAChange	CosmicEffect	CosmicID	DistMutPairsEORA	DistMutPairsEORB	NormalDistMutPairsEORA	NormalDistMutPairsEORB	DistMutPairsEORA+B	EORMutPct	NormalEORMutPct	Ignore	IgnoreB	AddlInfo	LookupKeyB	AAChange	ReportedMutation	ReportedConsequence	PGDX Transcript	PGDX CDS Length	PGDX Protein Length	LiftOver ID	Liftover hg18 Position	LiftOver hg19 position	sameLocation_Lookup	Changes_SameLocation	Changes_Adjacent	polyN:ChangeUID	PolyN_Dust	Sample Name	CDD: #Gene	CDD: Key	CDD: Size Check	CDD: Position of Mutation Within a Protein Domain	CDD: Position of Mutation Near to a Protein Domain	COSMIC: Key	COSMIC: Samples reported with the exact genomic change	COSMIC: Samples reported with a change in the same AA (Missense)	COSMIC: Samples reported with a nearby change	COSMIC: Samples reported with any mutation in this gene	COSMIC: Number of Exact Hits	PGDX Clinical: Gene_symbol	PGDX Clinical: Gene_name	PGDX Clinical: Gene_summary	PGDX Clinical: Gene_aliases	PGDX Clinical: Pathway	PGDX Clinical: Prognostic text	PGDX Clinical: Prognostic ref	PGDX Clinical: Prognostic fig	PGDX Clinical: Prognostic fig legend	PGDX Clinical: Prognostic fig ref	PGDX Clinical: Predictive/Therapeutic text	PGDX Clinical: Predictive/Therapeutic ref	PGDX Clinical: Predictive/Therapeutic fig	PGDX Clinical: Predictive/Therapeutic fig legend	PGDX Clinical: Predictive/Therapeutic fig ref	PGDX: Gene Lookup	PGDX: Biologically significant gene	PGDX: Clinically significant gene	PGDX: Chip Gene	CHASM: MUTID	CHASM: MUT	CHASM: CHASM BRCA	CHASM: PValue BRCA	CHASM: BHFDR BRCA	VEST: MUTID	VEST: MUT	VEST: VEST	VEST: PValue	VEST: BHFDR	PANTHER: Gene Symbol	PANTHER: Gene Identifier	PANTHER: Protein ID	PANTHER: SF ID	PANTHER: Family Name	PANTHER: Subfamily Name	PANTHER: Molecular function	PANTHER: Biological process	PANTHER: Cellular components	PANTHER: Protein class	PANTHER: Pathway	OMIM_gene_symbol	OMIM_status	OMIM_method	OMIM_diseases	OMIM_mim	VEP: ChangeUID	VEP: Position	VEP: Gene	VEP: Transcript	VEP: Consequence	VEP: cDNA Position	VEP: CDS Position	VEP: Protein Position	VEP: Strand	VEP: AAChange	VEP: Codon Change	VEP: HGVS Codon Change	VEP: HGVS AAChange	snpEff360: ChangeUID	snpEff360: GeneID	snpEff360: GeneName	snpEff360: Transcript	snpEff360: CodonFrom	snpEff360: CodonTo	snpEff360: codonStart	snpEff360: codonEnd	snpEff360: AAFrom	snpEff360: AATo	snpEff360: Consequence	snpEff360: Score	dbSNP: Sample	dbSNP: Other dbSNP hits	dbSNP: SNPLookup	dbSNP: Chrom	dbSNP: Start	dbSNP: End	dbSNP: Name	dbSNP: Strand	dbSNP: refUCSC	dbSNP: Observed	dbSNP: Class	dbSNP: Valid	dbSNP: AvHet	dbSNP: AvHetSE	dbSNP: Func	dbSNP: Weight	dbSNP: Exceptions	dbSNP: Submitters	dbSNP: AlleleFreqCount	dbSNP: Alleles	dbSNP: AlleleNs	dbSNP: AlleleFreqs	dbSNP: Bitfields	dbSNP: isCommon	dbSNP: isFlagged	dbSNP: isMultiple	ESP: Chrom	ESP: Start	ESP: End	ESP: ESPKey	ESP: dbsnp hit	ESP: European Allele Count	ESP: African Allele Count	ESP: Total Allele	ESP: MAF	ESP: Observed	ESP: European Genotype Count	ESP: African Genotype Count	ESP: Total Genotype Count	ESP: Average Sample Depth	ESP: GeneList	ESP: scorePhastCons	ESP: consScoreGERP	ESP: chimpAllele	ESP: ClinicalAssociation	ESP: EXOME_CHIP	ESP: GWAS_PUBMED	ESP: Accession	ESP: functionGVS	ESP: aminoAcidChange	ESP: proteinPosition	ESP: cDNAPosition	ESP: granthamScore	ESP: polyPhen	AutoBLATHuman	Seq window	BLAT sequence	BLAT URL	PGDX Norm: Count	PGDX Norm: rs	Report: Sample Name	Report: Alternate ID	Report: Tumor Type	Report: GeneName	Report: Description	Report: Transcript	Report: LookupKey	Report: CodonChange	Report: AAChange	Report: Exon Rank	Report: ReportedMutation	Report: ReportedConsequence	Report: Seq window	Report: SupermutantMutPct	Report: 95% Confidence Interval for % Mutant Reads	Report: SupermutantCov	Report: SupermutantCount	Report: Mutant Molecules per mL	Report: ENSG	Report: Pathway Analysis (GO Molecular Function)	Report: Pathway Analysis (GO Biological Process)	Report: Pathway Analysis (Additional Information)	Report: Samples with the Identical Somatic Mutation	Report: Somatic Mutations in the Same Amino Acid Residue	Report: Somatic Mutations in Nearby Amino Acid Residues	Report: Gene Somatically Mutated in the Following Cancers	Report: Position of Mutation Within a Protein Domain	Report: Position of Mutation Near to a Protein Domain	Report: CHASM Score	Report: PValue	Report: BHFDR	Report: refUCSC	Report: Observed	Report: Class	Report: Valid	Report: AvHet	Report: AvHetSE	Report: Func	Report: Weight	Report: Exceptions	Report: Submitters	Report: AlleleFreqCount	Report: Alleles	Report: AlleleNs	Report: AlleleFreqs	Report: VEST	Report: VEST(PValue)	Report: VEST(BHFDR)	Report: OMIM Diseases	Report: MIM#	Report: PGDX: Chip Gene	CleanDistinctPairs	CleanMutPct	OverlapsTumor	OverlapsNormal	IndelCount	NumAlleles	NumIndelAlleles	Supermutant	SupermutantAvg	SupermutantPct	SupermutantCov	CycleDist	Read1Dist	Read2Dist	MutReadDist	ProperPairs	ProperPairsPct	MMTumor	LQTumor	MMAvg	MutMMAvg	LQAvg	MutLQAvg	MaskedPairs	MaskedMutPct	PolyN	PolyNN	PolyNNN	PolyMut	Dust	RptMask	MutCountCov	SNP_Allele_Fraction_Normal	SNP_Allele_Fraction_Tumor	Ref_Allele_Fraction_Tumor	Observed_MAF	Calculated_MAF_Amplification	dbSNP:ChangeUID	ESPKEY	ESP:ESPLookupID	PGDX Norm: ChangeUID	CI ChangeUID	95% Confidence Interval	CUID	HematopoiesisAssociations	SMChangeUID	SMExcludeCUID	IChangeUID	OlapIndels	ExcludeIndel	HChangeUID	HotList	CHChangeUID	CosmicHotSpot	Row	Row	Total	Strand Bias Percentage (minimum strand)	Strand Bias p-value	BaseFrom/BaseTo	Strand Bias Percentage Result	Strand Bias p-value Result	Strand Bias Mutation Type	OverallStrandBiasResult
